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Abstract 
BACKGROUND: Of the world’s four million neonatal deaths, 99% occur in low/middle-
income countries, but most information relates to the 1% dying in high-income countries. 
Reliable cause-of-death data are lacking. The aim of this thesis is to develop programmatically-
relevant, national estimates for neonatal cause-of-death, focusing on “birth asphyxia” to 
illustrate specific challenges in the available data and for systematic national estimates. 
 
OBJECTIVES: 
1.  Review estimation methods, giving implications for neonatal cause-of-death estimation. 
2.  Propose programmatic categories for neonatal cause-of-death, reviewing measurement 
options for intrapartum-related outcomes (“birth asphyxia”). 
3.  Identify and analyse existing neonatal cause-of-death data.  
4.  Estimate intrapartum-related neonatal deaths for all countries, comparing single-cause and 
multi-cause models. 
5.  Summarise priorities for improving neonatal cause-of-death estimates and input data. 
 
DATA INPUTS: Case definitions were reviewed for neonatal cause-of-death and intrapartum-
related outcomes. Six programmatically relevant cause-of-death categories were defined, plus a 
residual “other neonatal” category. Two sources of neonatal cause-of-death data were examined: 
Vital Registration (VR) datasets for countries with high coverage (>90%) based on a new 
analysis from 83 countries; and published/unpublished studies identified through systematic 
searches. Inclusion criteria for representativeness and comparability were applied. Data from 44 
countries with VR (96,797 neonatal deaths) and from 56 studies (29 countries, 13,685 neonatal 
deaths) met inclusion criteria, despite screening almost 7,000 abstracts. These data represent 
<3% of the world’s neonatal deaths. Thus estimation is necessary for global level information. 
No useable data were identified from Central and North-West Africa, or Central Asia.  
 
MODELLING:  Methods were developed to estimate intrapartum-related neonatal deaths 
(single-cause), and then simultaneously estimate seven causes of neonatal death (multi-cause). 
Applying these proportions to the numbers of neonatal deaths in 192 countries gives a global 
estimate of intrapartum-related neonatal deaths of 0.90 (0.65-1.17) million using single-cause 
and 0.91 (0.60-1.08) million using multi-cause methods. 
 
DISCUSSION: The multi-cause model has become WHO’s standard method for neonatal 
cause-of-death estimates. However, complex statistical models are not a panacea. More 
representative data are required. Simplified case definitions and consistent hierarchical cause-
of-death attribution would improve comparability, especially for intrapartum-related deaths.  
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Definitions  
 
Epidemiological Definitions 
 
Figure １1.0 Epidemiological time periods and definitions 
 
*Adapted from Lawn JE, Kerber KJ eds 2006 
 
 
 
 
 
 
 
 
Adapted from Lawn JE et al 2001
1 
 
Stillbirths: Stillbirth rate for international comparison is the annual number of babies born dead 
after 28 weeks of gestation (late fetal deaths) per 1,000 total births.  
According to the International Classification of Diseases, Revision 10 a stillbirth, or late fetal 
death, is death of a fetus weighing at least 500 g (or, if birth weight is unavailable, after 22 
completed weeks gestation, or with a crown-heel length of 25 cm or more).
2  For the purposes 
of international comparison, it is recommended that stillbirth be defined as a late fetal death 
weighing at least 1000 g (or a gestational age of 28 completed weeks or a crown-heel length of 
35 cm or more).
3  Birthweight is prioritised over gestational age because it is believed to be 
more reliably reported.  
 
Newborns: Neonatal mortality rate is the number of neonatal deaths (deaths in the first 28 days 
of life) per 1,000 live births. 
Early neonatal deaths are those that occur within the first week of life (day 0 to 6.9). 
Late neonatal deaths are deaths occurring between the second and fourth weeks, i.e. from days 
7 to 28. 
Newborn refers to the newborn baby and does not have a defined duration, but is often assumed 
to refer to the first month of life. 
Throughout this thesis the day of birth is referred to as day zero. 
 
Small babies: Low birthweight refers to babies born with a birth weight of less than 2,500 g. 
This can be due to: 
•  Poor growth in utero – babies who are born after the full number of weeks of gestation (37 
to 42 weeks gestation, or term births) but are smaller than expected based on accepted 
Infancy  Neonatal / 
postnatal 
Pre- pregnancy  Pregnancy
Birth
Early fetal  Late fetal 
1 year 
  4 weeks  28 weeks  22 weeks 
Early   Late  
Neonatal   Stillbirth 
1 week 
5 years 
 
Childhood   15
growth standards  (small for gestational age). This may be due to a number of causes, 
including small maternal size, obstetric causes (such as twins or multiple pregnancy, 
hypertension in pregnancy), infections, poor maternal nutrition or overwork.  
•  Preterm or born too early – babies are born before the normal 37 weeks of gestation. 
Preterm babies generally have a much higher risk of death than babies born at full term who 
are of normal size, and a risk that is 3 to 10 times higher than full term babies who were 
growth restricted.
4 
•  Some babies are both preterm and have poor growth in-utero – this applies to many twins or 
other multiple births. Malaria in pregnancy can cause preterm birth, in-utero growth 
restriction or both. 
 
Time periods: Postnatal is the period after birth for both mother and baby. The exact period is 
not well defined, but in this review we will assume that it is 6 weeks after birth. 
Postpartum describes the same time period, but refers specifically to the mother.   
Perinatal is the period that includes some of the end of pregnancy and some or all of the first 
month of life, and can refer to 10 different time periods depending on the cut-offs used. 
Perinatal is also used to refer to some, but not all causes of neonatal deaths in the International 
Classification of Diseases
2; however, this grouping does not include sepsis, pneumonias or 
congenital abnormalities. Hence the term can cause confusion, and this thesis will refer to the 
actual period (e.g. late fetal), the outcome (e.g. stillbirth, neonatal death), or the specific cause-
of-death. 
 
Geographical Regions  
Throughout this review, countries are the units of analysis. A variety of regional groupings of 
countries are commonly used. In this thesis the most commonly used regional grouping is the 
six WHO regions: AFR (Africa), AMR (Americas), EUR (Europe), EMR (Eastern 
Mediterranean), SEA (South East Asia), and WPR (Western Pacific).
5 For some methodological 
work the 14 WHO sub-regions promoted by the first phase of the Global Burden of Disease are 
used (table B1 in the appendix). 
 
Data collection systems 
Civil registration: As defined by the UN is the continuous, permanent, compulsory, and 
universal recording of the occurrence and characteristics of vital events (livebirths, deaths, fetal 
deaths, marriages, and divorces) and other civil status events pertaining to the population as 
provided by decree, law, or regulation, in accordance with the legal requirements in each 
country. It establishes and provides legal documentation of such events and a source of vital 
statistics.
6 
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Demographic surveillance site: The continuous registration of all demographic events, in a 
geographically defined population; usually research purposes. Cause-of-death analysis through 
verbal autopsy may be linked to the surveillance.
6 INDEPTH network is the largest network of 
Demographic surveillance sites including at least 37 sites in 19 countries, mainly in Africa, 
collectively monitoring 1,800,000 people at household-level. http://www.indepth-network.org/  
 
International Classification of Disease: The international standard diagnostic classification for 
epidemiological and health management purposes. The latest version is International 
Classification of Disease revision 10 (ICD 10), published by WHO in 1993.
2 Three-digit codes 
or even more detailed four-digit codes are listed and then a condensed classification suggested.
7 
Around two-thirds of causes of death in the neonatal period have codes in the Perinatal chapter 
and all these are combined as “Perinatal causes”. 
 
Sample registration system: The longitudinal registration of demographic events, including 
cause-of-death by verbal autopsy, in a nationally representative sample of clusters (e.g. China, 
India).
6 
 
Verbal autopsy: A structured interview with caregivers or family members of households after a 
death occurs; used to establish probable cause-of-death in the absence of direct medical 
certification.  
 
Vital event: As defined by the UN, is the occurrence of a live birth, death, fetal death, marriage, 
divorce, adoption, recognition of parenthood, annulment of marriage, or legal separation.
6 
 
Vital registration: All sanctioned modes of registering individuals and reporting on vital events. 
These modes can include registration activities through complementary systems that are not part 
of the civil formal registration system and do not produce legal birth or death certificates. 
 
Vital statistics: Summary measures of vital events drawn from all of sources of vital events 
data. Particularly in developing country settings, where civil registration functions poorly or not 
at all, the UN acknowledges that many data sources and systems are used to derive estimates of 
vital statistics. 
 
Vital statistics system: As defined by the UN, is the total process of (1) obtaining information 
by civil registration or enumeration on the frequency or occurrence of specified and defined 
vital events, and relevant characteristics of the events themselves; and (2) of compiling, 
processing, analysing, evaluating, presenting, and disseminating these data in statistical form. 
   17
Estimation modelling terminology  
Single cause proportionate model: A statistical model to estimate the proportion of deaths due 
to a single cause-of-death (e.g., intrapartum-related neonatal deaths or neonatal tetanus) in a 
defined population by age-at-death such as neonatal, or by place such as national or by other 
criteria. 
 
Multi-cause proportionate model: A statistical model to estimate the proportionate distribution 
of all deaths from all causes in a defined population. For example all major causes of death 
within the neonatal period for a specific population such as national level. 
 
“Corner cause” in multi-cause modelling: One cause is selected to be the corner cause, and 
must be represented in each input dataset. A ratio of each of the other causes of death against 
this corner cause is converted to a log ratio.  Regression modelling is applied to develop 
estimation equations for each log ratio of cause to the corner cause. Then all the equations are 
estimated simultaneously and the output constrained to a total of 1.0. The corner cause is 
estimated as the remainder after all the other proportions have been predicted.    18
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Introduction  
Scope of the thesis 
This thesis comprises part of a wider body of epidemiological work to advance the data and 
national level estimates for rates, numbers and cause-of-death for both causes neonatal deaths 
and stillbirths. The work included in the thesis focuses on neonatal cause-of-death and is drawn 
from two major streams of work led by the investigator. The first stream of work was 
undertaken between 2002 and 2005, to generate improved national estimates for neonatal deaths 
due to birth asphyxia for the Global Burden of Disease (GBD), which also resulted in estimates 
of intrapartum stillbirths. The second stream of work was undertaken between 2004 and 2007, 
to produce the first set of systematic, national level estimates for cause-of-death in the neonatal 
period, in collaboration with the Child Health Epidemiology Reference Group (CHERG) and 
commissioned by the World Health Organisation. At the start of the work for this thesis credible 
estimates and visibility were lacking and the publication of these estimates, particularly through 
The Lancet Neonatal series contributed to increased visibility of the global problem of newborn 
deaths. 
 
My focus here is on two core questions. Firstly, how to produce systematic national level 
estimates for cause of neonatal deaths based on current data? Secondly, how to improve future 
estimates and strengthen the input data on neonatal cause-of-death? In order to gain more depth 
I have selected one cause of neonatal death that is of public health importance and is particularly 
challenging to define and measure – “birth asphyxia” or intrapartum-related neonatal death. The 
thesis is primarily on the epidemiological inputs and outputs and not on the detailed statistics of 
the modelling methods, but a description of the main steps involved particularly for the multi-
cause model is essential for discussion of potential strengths and limitations of the multi-cause 
estimation results and also for implications for future estimation methods. 
 
Associated topics not covered in this thesis 
There are important areas of perinatal epidemiology that will not be covered in detail in this 
thesis, despite the associated new work by this investigator and colleagues. The focus here is on 
proportionate mortality within the envelope of neonatal deaths estimated to occur in each 
country. The numbers of deaths and validity of neonatal mortality rate estimates raise major 
questions, but the improvement of these data is not the focus of this thesis, although sources of 
national data for neonatal mortality rates and numbers are summarised. In addition despite 
systematic country level estimates
8, stillbirths remain even more neglected than neonatal deaths 
on the global agenda, but are not detailed in this thesis. Stillbirths are estimated to account for at 
least 3.2 million deaths
8 and are closely linked to neonatal deaths, particularly the obvious 
linkage of intrapartum stillbirths and neonatal deaths related to birth asphyxia. Finally, 
intervention priorities from the epidemiology will be highlighted, but interventions to reduce   20
neonatal deaths are not in the scope of the thesis although the main purpose of improved 
epidemiological estimates and data is to help guide public health prioritisation for interventions.  
 
Role of the investigator 
Given the novel work being undertaken and complexity of modelling required in global 
estimates, and the requirement for critical appraisal for each assumption, no investigator can 
undertake credible estimates on their own. Many individuals and agencies have been involved, 
but the final responsibility for each stage of both these sets of estimates was mine including 
designing the overall approach, gaining consensus around the case definitions, compiling the 
input datasets, writing the papers and reports and ensuring the overall quality. In both estimation 
processes the modelling was undertaken in association with a statistician but as the lead 
investigator I was involved with the many cycles of refining the various models.  
 
For the single-case estimates of intrapartum related neonatal deaths the searches and the 
database construction was undertaken by me and I highlight Dr Kenji Shibuya, previously of 
WHO, for expert inputs and developing the multiple regression model used for countries 
without vital registration data. For the neonatal multiple cause-of-death work, I had the 
assistance of several assistants hired through WHO funding whom I supervised in undertaking 
parts of the searches, locating publications and helping to abstract data, especially for double 
data abstraction. Katarzyna Wilckynska-Ketende worked with me for around 6 months part-time 
in this role and a number of others added inputs for shorter periods. Professor Simon Cousens of 
the London School of Hygiene and Tropical Medicine, one of the supervisors on this thesis, 
undertook the complex modelling required which involved multiple interactions over the period 
of around a year. His hard work and willingness to try multiple approaches to improve the 
modelling, and critical appraisal were essential to success.  
 
Invaluable and insightful review was provided by the CHERG, and particularly Professor Bob 
Black (John Hopkins Bloomberg School of Public Health), at several meetings hosted by WHO 
and UNICEF. These meetings also provided opportunities to hear from groups working on 
estimates for other causes of child death such as malaria or diarrhoea which were invaluable to 
me as the leader of the neonatal estimates. 
 
I developed the figures and tables in this thesis apart from the following: 
-  Figure 1.4 which is cited to the United Nations (WHO) 
-  Several figures were developed with Simon Cousens notably Figures 5.6 and 5.7 
-  I am grateful to Igor Rudan for assistance with the maps in Fig 5.3 and 7.2. 
-  The layout of several graphics were improved by The Lancet and I have used these versions 
with references to the relevant publications where appropriate.   21
Thesis structure  
The thesis begins with a brief review of the world’s four million neonatal deaths. The 
Millennium Development Goal 4 for child survival has helped to focus attention on neonatal 
deaths, which account for an increasing proportion of under five deaths since progress in 
reducing neonatal deaths has been slower than for postnatal deaths. However, an important gap 
affecting attention and public health planning was the lack of programmatically relevant 
neonatal cause-of-death estimates. 
 
Chapter Two sets out the aim and objectives of the thesis.  
 
Chapter Three summarises recent advances in the science of systematic epidemiological 
estimates, and implications for undertaking neonatal cause-of-death estimates.  Systematic steps 
for estimation are defined which form the basis of the rest of the thesis. 
 
Chapter Four proposes six programmatically relevant case definitions for cause-of-death in the 
neonatal period, with a residual seventh category. These standard categories allow multiple ICD 
9 and 10 codes to be mapped onto these seven comparable cause-of-death groups so that 
comparisons can be made between countries with varying data sources. Case definitions and 
measurement options for intrapartum-related related outcomes (“birth asphyxia”) are reviewed 
in more detail. 
 
Chapter Five reports the identification, and review of available, comparable data for the selected 
cause-of-death categories reporting on a new analysis of Vital Registration data for multiple 
countries, and systematic searches for useable published data. The quantity and quality of 
useable data are described, with a focus on the data for intrapartum-related outcomes. 
 
Chapter Six describes the methods developed and applied to estimate national level 
proportionate mortality for the neonatal period using a single cause model for intrapartum-
related outcomes, and multi-cause modelling methods. 
 
Chapter Seven provides results from these two modelling exercises and compares the results for 
intrapartum-related estimates from the single and multi-cause models.  
 
Chapter Eight sets out the overall findings, the strengths and limitations of the existing data and 
methods as well as highlighting priorities for improving the data and questions for further 
analysis and research.  
 
Finally, Chapter Nine gives brief overall conclusions.   22
 
The appendices include a list of the papers published to date in relation to the research presented 
in this thesis, as well as associated chapters and books. Relevant presentations are also listed. In 
addition the appendix contains supplementary data tables and the study data abstraction form. 
 
The companion bound volume (Volume II) includes copies of selected associated peer reviewed 
papers and a chapter published y the investigator in association with the work in this thesis. 
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Chapter 1                                                             
Counting neonatal deaths and making them count 
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1.1.  Neonatal deaths count   
 
1.1.1  Counting the world’s newborn deaths 
Each year some 130 million babies are born
9 and an estimated 4 million die in their first 4 
weeks of life, the neonatal period.
10  A similar number of babies are stillborn—dying in-utero 
during the last three months of pregnancy.
8 Most of these deaths (99%) occur in low- and 
middle-income countries,
10 and approximately half occur at home.
4 In poor communities, many 
babies die unnamed and unrecorded, reflecting the perceived inevitability of these deaths.
11 In 
contrast, the 1% of neonatal deaths that occur in rich countries are the subject of confidential 
enquires and public outcry if services are considered substandard.
12 The majority of published 
trials of neonatal interventions focus on these relatively few deaths in rich countries. The 
“Inverse Care Law,” first described in Britain in the 1960s, still holds today:  
"The availability of good medical care tends to vary inversely with the need
 for it in the 
population served.”
13 
For newborn survival, this law could appropriately be extended to the “Inverse Information and 
Inverse Care Law”: those communities with the most neonatal deaths have the least information 
on them and the least access to cost-effective interventions to prevent them.  
 
Global demand for information on neonatal deaths is growing with the recent recognition that 
an increasing proportion of global under-five mortality occurs in the first 28 days of life. The 
second half of the twentieth century witnessed a remarkable reduction in child mortality, with a 
halving of the risk of death before the age of 5 years. The majority of this reduction, however, 
has been due to lives saved after the first four weeks of life, with relatively little reduction in the 
risk of death in the neonatal period. Neonatal deaths, estimated at 3.95 million annually, 
accounted for 38% of the world’s under-five deaths in the year 2000. The Millennium 
Development Goals (MDGs) represent the widest commitment in history to addressing global 
poverty and ill-health.
14 MDG 4, for child survival aims for a two-thirds reduction in under-five 
mortality by the year 2015 compared to the baseline of 1990 (Figure 1.1). This results in a target 
under five mortality rate of 31 per 1000.
15 However, the global neonatal mortality rate is 
estimated to be 31 per 1000 live births – hence the entire target for under five mortality is 
currently taken up by neonatal deaths.
8 If MDG 4 is to be achieved, then reducing neonatal 
deaths must become a major public health priority.   25
Figure ２1.1 Meeting the Millennium Development Goal 4 for child survival: Trends in mortality 
for children under 5 years of age and in the first month of life (neonatal period), 1965 to 2015  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sources:  Under-5 mortality estimates from Ahmad OB, Lopez AD & Inoue M. Bull WHO, 2000, 70(10). 
Trend fitted assuming constant proportional reduction each year. Neonatal mortality data based on WHO 
estimates 1980, 1995, 2000.  
Figure from Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet 2005; 
365: 891-90 
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1.1.2  Four million newborn deaths – do they count? 
 
The mismatch of a low policy imperative for newborn deaths (despite huge numbers of deaths) 
and close linkages to other issues which do have policy momentum such as child survival and 
maternal health, raises a question. Do the data gaps, the lack of coherence for programme 
priorities, and the lack of champions explain the attention gap? Or are there specific policy 
conflicts that keep newborns off the agenda? Shiffman’s classic article on the political 
imperative for safe motherhood questioned “Why do some global health initiatives receive 
priority from international and national political leaders whereas others receive little 
attention?” 
16 Table  1.1 examines some of the factors shaping political priority for neonates, 
adapting from Shiffman’s work.
16  Since 2005 there has been a paradigm shift with global 
policy beginning to recognise and address neonatal mortality.
17 In order to understand this shift 
from relative invisibility to increasing attention for neonatal deaths, a brief review of the 
visibility of newborn deaths on the global policy agenda is useful. 
 
1.  Framing the problem 
The majority of neonatal mortality occurs without record of birth or death.
18  While in rich 
countries birth is accompanied by a fanfare, in many poorer countries, childbirth is accompanied 
by apprehension for the mother and baby who may remain hidden at home with limited access 
to care. Often the baby is unnamed until one or even six weeks have passed, reflecting a sense 
of fatalism and cultural acceptance of high mortality.
19  
 
Most babies who die in the neonatal period have neither birth nor death certificates. Thus the 
numbers of neonatal deaths are dependent on estimates. To date, these estimates have been 
generated by WHO and released every 10 years (1986, 1996
3, 2006
10). The 2006 release 
provided estimates for the year 2000 and did not include clear methods or provide uncertainty 
ranges. This contrasts with HIV/AIDS estimates which are released every two years at a large 
international meeting and are generated using methods that are widely debated
20 and involve a 
country-level clearance process. Yet the numbers of deaths are similar – 3 million for 
HIV/AIDS and 4 million for neonatal deaths. Improving the process, frequency and visibility of 
neonatal mortality rate estimates is fundamental to keeping this large number of deaths on the 
agenda. The major global report for maternal, newborn and child health data, UNICEF’s State 
of the World’s Children,  has included national level NMR estimates since 2007.
9 The source 
has been data from the WHO estimates for 2000, but it is anticipated that the United Nations 
Child Mortality Group, which oversees child mortality estimates, will include the NMR 
estimates. Global attention for the annual release of the number of child deaths has increased in 
recent years. The announcement in 2007 of child deaths falling below the 10 million threshold 
for the first time ever received wide coverage, as did the 2008 announcement of further progress   27
to 9.2 million child deaths. Linking the annual estimates and release of child and neonatal 
mortality numbers would increase visibility and link the deaths clearly with progress towards 
MDG-4. 
 
Another important factor in framing the issue is the need for cause-of-death estimates that are 
credible and country based. Four million deaths are an overwhelming number and splitting these 
in to causal categories is the first step to public health solutions.  This is the main theme of this 
thesis and will be introduced in section 1.3. 
 
2.  Prioritising and communicating solutions 
One barrier to action is the perceived impossibility of reducing neonatal deaths. In industrialised 
countries newborn care is associated with intensive technological approaches. In Northern 
European countries it was not the introduction of neonatal intensive care in the early 1980s that 
produced the greatest mortality reduction. The current average neonatal mortality rate globally 
is around 31 per 1000 births. In England the neonatal mortality rate fell from a similar level in 
1940 to 10 per 1000 in 1979.
9 This mortality reduction coincided with the introduction of free 
antenatal care, improved care in childbirth and the availability of antibiotics. Importantly, some 
developing countries such as Sri Lanka have also been able to improve neonatal health by 
investing in similar strategies.
10,21  
 
Interventions to reduce neonatal deaths belong in two health system programmes: in maternal 
health programmes covering pregnancy, childbirth and early neonatal care; and in child health 
programmes, which extend through infancy into childhood. Addressing neonatal mortality 
requires continuity between these elements of care which is lacking in many settings. Care for 
the neonate often receives little attention in either maternal or child health programmes. The 
greatest gap in coverage of care falls during the critical first week of life, when the majority of 
neonatal and also maternal deaths occur, often at home and with no contact with the formal 
health care system. In addition, behaviours such as breastfeeding, which influence survival after 
the neonatal period, are initiated in the first days of life. Functioning health systems, caring for 
the dyad of mother and foetus/child during pregnancy, childbirth and in the early neonatal 
period, are essential if neonatal mortality is to be reduced, and indeed also stillbirths and 
maternal deaths.
22  
 
Recent influential community-based newborn care studies have focused attention on this gap 
and highlighted potential solutions that work even in weak health system contexts,
23 reporting 
reductions in neonatal mortality by around a third with community mobilisation through 
women’s groups
24 and up to two-thirds with a comprehensive community-based package 
including curative care at home.
25 These studies have demonstrated proof of concept. The   28
Lancet Neonatal series helped progress towards consensus for priority actions in varying health 
system contexts,  and emphasising  the message that in weak health system contexts up to one 
third of neonatal deaths could be prevented with community-based preventive care.
26 However, 
in contrast with malaria, for example, and the easily understood solution of bednets, there is no 
single solution for reducing NMR - newborn care involves many interventions and apparently 
complex packages. Different solutions may be the priority in differing contexts even within one 
country.
27-29  This apparent complexity and variability may diffuse the clear call to action and 
result in dichotomies similar to the 30 year conflict between “vertical” and “horizontal” 
approaches that followed the Declaration of Alma Ata.
30 In addition, consensus for community 
solutions is affected by maternal health policy conflicts regarding skilled attendants and training 
traditional birth attendants.
27;31  
 
3.  The strength of organisations  and individuals concerned with the issue 
Issues that have gained major traction on the global agenda usually have a wide network of 
agencies, civil society involvement in rich and poor countries and visible champions – for 
example HIV/AIDS and malaria (table 1.1).  For child survival, UNICEF has been a champion 
in the past
32 and is returning to this as a core vision. From the first child survival revolution, the 
focus of child survival has been primarily on deaths in the postneonatal period due to causes 
such as malaria, diarrhoea, and pneumonia, and to malnutrition as a major risk factor.
30 
Newborn survival is gradually being added to this, as reflected in their 2008 Child Survival 
report.
9 Overall there is more coalescence of United Nations agencies with the formation of the 
so-called Health 8, linking the main health agencies to present a united voice at G8 meetings.
33 
However, there remains a lack of clarity as to which agency or even which professional body 
carries responsibility for newborn health or how the roles and accountability would be most 
effectively shared. National champions from within low income countries are a crucial part of 
moving to greater attention and action. There are a number of high profile champions for 
newborn health in Asia,
21;34 but as yet few in Africa.  
 
4.  Political and investment opportunities, or conflicts 
Attention and investment for global health has increased dramatically in recent years.
35 Funding 
for maternal, newborn and child survival rose by more than 60 percent over the last 2 years, 
although a large proportion of this is earmarked for immunisation.
36 The paradigm shift from 
Maternal and Child Health (MCH), to Maternal Newborn and Child Health (MNCH) with 
increasing focus on health systems provides an opportunity for integration and strengthening of 
newborn care. However not all policymaker within MNCH have fully embraced a joint 
approach. For example, some maternal advocates continue to see the child and newborn issues 
as a competition. Specifically some policymakers for maternal health perceive a conflict with   29
investment in community-based care, being concerned that this may reduce progress towards 
skilled care at facility level (Table 1.1). 
 
In summary, during the lifespan of this thesis the subject of newborn survival shifted from 
virtual invisibility to increasing global visibility assisted by the publication of The Lancet 
Neonatal series.
17 There is some consensus on intervention priorities and some increase in 
investment. However in order to address the four million annual neonatal deaths, two-thirds of 
which could be prevented with existing, low tech interventions,
9 we need better information on -  
newborns are dying how many, where and when? To prioritise programmatic actions we 
particularly need to know why these deaths occur and we need this data at country and regional 
level not just at global level.
4  
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Table  1.1 Newborns counting in policy and programme priorities 
 
Determinant Description  Factors favouring prioritisation of newborns Factors diminishing prioritisation of newborns
Issues  Framing the 
problem 
 
Large numbers of deaths – around 4 million 
 
 
Closely linked to maternal and child deaths, which have 
political priority and momentum in MDGs 
 
Public attention for parental grief following newborn 
deaths. Civil society involvement with information 
regarding newborn deaths and outcomes 
Poor visibility of the NMR estimates released every 10 years by WHO; no clear 
description of methods. Previously no cause-of-death estimates so all 4 million 
grouped without sub-categories to guide public health priorities 
 
No direct mention of neonatal survival in MDGs or Global Burden of Disease  
Neonatal outcomes are often discounted in summary statistics e.g. in DALYs. 
 
Perception of newborns as not “fully human”, or being disposable in poor 
countries “Mothers in Africa have too many babies anyway”. Less importance 
than for example adult deaths due to HIV. 
Ideas  Prioritising and 
communicating 
solutions 
 
Close linkages with child survival programmes and 
maternal health programmes. Integrating newborn health 
has helped to advance concept of integrated packages of 
service delivery within continuum of care and promote 
paradigm shift from MCH to MNCH 
 
Influential community-based newborn care studies  and 
Lancet Neonatal series have provided call and actions 
required to scale up newborn care with wide technical 
agreement on actions and priorities 
Perceived impossibility still particularly for some health care professionals and 
policy makers – newborn care associated with intensive neonatal care units 
 
No single solution in contrast for example with malaria and bednets, newborn care 
involves many interventions and apparently complex packages. Different 
solutions may be the priority in differing contexts even within one country 
 
Community solutions required in weak health system settings are affected by 
maternal health policymakers conflicts about skilled attendance  and training 
traditional birth attendants  
Power of the 
actors 
The strength of 
organisations  
and individuals 
concerned with 
the issue 
More coalescence of UN and partner messages with 
respect to MNCH, and some stronger agency and 
advocacy voices 
 
Some more attention from professional organisations e.g. 
obstetricians and midwives  
 
Gates Foundation investments in newborn health, e.g. 
through Save the Children/Saving Newborn Lives 
Newborns in low income countries have no professional body that “owns” them – 
e.g. obstetricians and midwives primary allegiance is for mothers, paediatricians 
for the child. High income countries have a new cadre (neonatalogists) which is 
absent in many African countries and few in many Asian countries 
 
Focus is on mothers, and children, some attention to newborns and few mentions 
of stillbirths, and no clear voice from agencies or individuals 
 
Parent lobby groups have limited power, except in high income countries 
Political context Political and 
investment 
opportunities, 
conflicts 
Increasing investment in MNCH although the majority 
remains linked to “vertical” issues such as immunisation, 
malaria and HIV 
 
Newborns rarely mentioned in maternal health priorities and advocacy and seem 
to still be perceived as a competition by maternal health community. 
 
 
Source: adapted  from Shiffman et al  framework for assessing political prioritisation for maternal health
16   31
1.2.      Counting neonatal deaths – Where? When? 
 
1.2.1 Where? 
Only 1% of neonatal deaths occur in the 39 high-income countries where the neonatal mortality 
rate (NMR) is an average of 4 per 1000 live births. The remaining 99% of neonatal deaths occur 
in low and middle income countries where the average NMR is 33 per 1000 (Table 1.2). The 
rates are highest in Africa which has 12% of the world’s population but over 25% of the world’s 
newborn deaths (Figure 1.2). Of the 20 countries with the highest NMRs, 15 are African 
nations, many with recent conflict. South Asia accounts for a third of the world’s neonatal 
deaths, with over a million a year in India alone. Ten highly populous countries account for 
67% of the global total of neonatal deaths (Table 1.3) 
 
There is regional variation in the proportion of under five deaths that are in neonatal period, 
ranging from 63% in high income countries to 24% in Africa, but it is clear that no region or 
country can afford to ignore these deaths. As postneonatal mortality falls the proportion of 
deaths in the neonatal period increases.  
 
Between 1960 and 1990, the risk of dying in the first five years of life was halved—a major 
achievement.
 Since 1990, child mortality after the first month of life (i.e., from 1 month to 5 
years of age) has declined by one-third, while the NMR has declined by only about one-quarter, 
mainly reflecting progress in the world’s richest countries and in transitional countries in South 
East Asia and Latin America.
8  The survival gap between rich and poor countries is such that a 
newborn in West Africa is over 15 times more likely to die in the neonatal period than a 
newborn in Western Europe (NMRs of 46 and 3 per 1000 live births respectively).
10 Since 1990, 
Latin America has made the fastest progress. South East Asia has made steady progress, 
although faster in some countries than others.
37 South Asia and North Africa/Middle East have 
shown an average annual decline of 2.4% and 2.6% per year, but would need 6.2 and 5.9% per 
year to reach MDG 4 (Table 1.1). This is challenging but achievable. For the South Asian 
regional target – if not the global target – much rests on India, where 2.2 million children die 
every year, half of them being neonatal deaths. Africa needs to increase its annual rate of 
mortality reduction from 0.7% to over 8% per year –a ten-fold increase in the rate of progress. 
The regional average for Africa is strongly influenced by progress in Nigeria
38 which has an 
estimated 247,000 newborn deaths each year (Table 1.3).  
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Table  1.2  Regional variations in neonatal mortality rates and numbers of neonatal deaths, showing the percentage of under-5 deaths that are neonatal, and the regional 
trends for the year 2000 
 
Region or country 
categorization 
NMR per 1000 
livebirths 
(range across 
countries)
Number of 
neonatal 
deaths 
(1000s)
Percentage of all 
neonatal deaths 
in a given region
Percentage of 
under-5 deaths in 
the neonatal 
period
Percentage change in 
NMR between 1996 
and 2005 estimates* 
Total  30 (1-70)         3,998  100%  38% -16%
Income groups          
High-income countries    4 (1-11)              42  1%  63%  -29% 
Low- and middle-income countries  33 (2-70)          3,956  99%  38%  -8% 
WHO Regions            
Africa  44 (9-70)          1,128   28%  24%  +5% 
Americas  12 (4-34)             195  5%  48%  -40% 
Eastern Mediterranean  40 (4-63)             603  15%  40%  -9% 
Europe  11 (2-38)             116  3%  49%  -18% 
South East Asia   38 (11-43)          1,443  36%  50%  -21% 
Western Pacific  19 (1-40)             512  13%  56%  -39% 
NMR: neonatal mortality rate. Sources: Neonatal mortality from WHO estimates. (around 1995 and 2005).
 Under-5 deaths from UNICEF 2005 (data around the year 2000) 
The data inputs cover at least a 5 year period before each set of estimates.  Regions according to WHO. Countries listed Appendix Table B.1  
High-income countries comprise 39 countries with NMR data out of the 54 countries with GNI per capita of >US$9,386 as listed 
http://www.worldbank.org/data/countryclass/classgroups.htm#High_income  
 
Table adapted from Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet 2005; 365: 891-900. 
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Figure ３1.2  Variation between countries for neonatal mortality rates per 1000 live births for the year 2000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NMR=neonatal mortality rate Source: Neonatal mortality from WHO 2000 estimates. 2005
10 
Map from Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet 2005; 365: 891-90.  34
Table  1.3 The ten countries with largest numbers of neonatal deaths in the year 2000 
 
  Rank for 
number of 
neonatal 
deaths 
Number 
neonatal 
deaths 
(1000s) 
Percentage 
of global 
neonatal 
deaths 
Neonatal 
mortality 
rate (per 
1000 live 
births) 
India  1  1098  27%  43 
China  2  416  10%  21 
Pakistan  3  298    7%  57 
Nigeria  4  247    6%  53 
Bangladesh  5  153    4%  36 
Ethiopia  6  147    4%  51 
Dem. Rep. of Congo  7  116    3%  47 
Indonesia  8  82    2%  18 
Afghanistan  9  63    2%  60 
United Republic of Tanzania  10  62    2%  43 
Total    2,681  67% 
 
Source: Neonatal mortality from WHO 2000 estimates. 2005.
1   
Table from Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet 2005; 
365: 891-900 
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1.2.2. When? 
The neonatal period is only 28 days and yet accounts for 38% of all under-5 child deaths. The 
remaining 62% of under-5 deaths occur over a period of almost 1800 days. Thus the average 
daily mortality rate during the neonatal period is close to 30-fold higher than during the post-
neonatal period. Even within the neonatal period there is considerable variation in the daily risk 
of death (figure 1.3). Mortality is extremely high in the first 24 hours after birth (25-45% of all 
neonatal deaths in this analysis) and globally some three-quarters of neonatal deaths (75%) 
occur in the first week after birth. 
4 
 
Figure ４ 1.3 Daily risk of death during the first month of life  
Based on analysis of 47 Demographic Health Survey (DHS) datasets (1995 – 2003) with 10,048 neonatal 
deaths. Source Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet 
2005; 365: 891-900. 
 
Data quality can effect on the analysis and interpretation of timing of death on day zero. In 
retrospective surveys such as Demographic Health Surveys (DHS), day zero deaths are affected 
by misclassification between stillbirths and neonatal deaths, but also compounded deaths by 
miscoding from day zero into day one. These surveys involve asking a woman about her births 
usually over her whole reproductive history with one separate question about stillbirths. Most 
survey tools concentrate on asking about live births with a subsequent question about child 
death and age at death. Although in perinatal epidemiology terms the day of birth is officially 
considered to be day zero, and this is how the data in DHS is analysed, not all field workers   36
apply this concept which differs from common use and they may enter day zero deaths for day 
one. In addition, respondents in societies where the 24 hour clock is not used may consider the 
next day to start after sunrise so deaths 12 hours after birth but after a sunrise, for example, may 
be described as taking place the next day. An analysis of DHS surveys in Africa revels that in 
some countries particularly in West Africa there are apparently more neonatal deaths on day one 
than day zero and day of death distribution reveals an atypical pattern that does not follow the 
usual steep drop in deaths by day, whereby around a third of neonatal deaths occur on day one, 
50% in the 48 hours and 75% in the first week (Lawn, unpublished analysis). If all or most of 
the deaths are captured and simply recorded on the wrong day then the overall neonatal 
mortality rate would be not affected. However, it is possible that an apparent lack of day zero 
deaths could be due to deaths being missed entirely or to misclassification of day zero deaths 
with intrapartum stillbirths. To fully understand the underlying data issues further analysis is 
required including stillbirths and comparing DHS (retrospective data) with prospective 
pregnancy surveillance data.  
 
In addition preference in reporting day of death can affect analysis of time of death. This is 
apparent in Figure 1.3, with obvious age heaping around days 7, 14 and 21. This preference for 
reporting deaths on certain days is common in DHS data, or indeed most retrospective survey 
data. There is also some heaping on day 30 which could result in misclassification of deaths out 
of the neonatal period. However, this is usually a small proportionate effect compared to the age 
heaping on day seven, which results in misclassification out of the early into the late neonatal 
period (Hill, K unpublished analysis for CHERG). It is currently being proposed to the United 
Nations Child Mortality Group that DHS data should be smoothed to correct for age heaping on 
day 7 and day 30 to overcome the effect on early neonatal mortality rates, and potential effect 
on neonatal mortality rates. 
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1.3.     Four million neonatal deaths - the need for cause-of-
death data 
 
Many neonatal deaths are preventable with existing low-cost interventions,
3;4 but to make 
effective use of limited resources, planners and policymakers require reliable cause-of-death 
information.
5 Information regarding causes of neonatal death, particularly in the first week of 
life when three-quarters of neonatal deaths occur, is fundamental for developing and tracking 
public health strategies. However, most of the world’s neonatal deaths occur in low- and 
middle-income countries of which few have high vital registration (VR) coverage. Thus, 
estimation is the only option currently available to meet this gap in information for the vast 
majority of neonatal deaths.  
 
Systematic global estimates for single or multiple causes of neonatal deaths have not been 
published in the peer reviewed literature prior to this thesis. Prior to 2005, the World Health 
Organisation (WHO) which is responsible for global estimates and data, provided little detail 
with respect to the causes of neonatal deaths in categories that relate to programmatic decision-
making.
39  In the global burden of disease tables in the annual World Health Report the biggest 
single category of deaths is “perinatal causes” - 2.6 million deaths grouped together.
40;41 This 
grouping is poorly understood by both epidemiologists and programme managers, as it is often 
assumed to include stillbirths. “Perinatal causes” refers to any codes for cause-of-death in the 
Perinatal chapter of the International Classification of Disease (ICD) volumes
2 and combines 
several distinct causes of death with differing programmatic solutions which together account 
for approximately two-thirds of neonatal deaths. However the category omits important groups 
such as most neonatal infections, neonatal tetanus and all congenital abnormalities. Neonatal 
infections, the single largest cause of neonatal deaths globally, and eminently preventable and 
treatable are not distinguishable in the tables despite the need for alternative prevention and 
treatment strategies.
39  
 
Furthermore, the data inputs and methods for these estimates are not in the public domain. 
Understanding the strengths and weaknesses of estimates is a necessary foundation before using 
them for programmatic decision making. In addition, the provision of such information 
highlights the need for more data and gives a basis to improve on methods used.   38
For many policymakers focused on global child survival, priorities are based on the global pie 
chart of estimated causes of child death. This pie chart, produced by WHO department of Child 
and Adolescent Health, was used by UN agencies including UNICEF in their publications and 
on their website, and has been well disseminated within the global child health community. In 
2004 this pie chart had no programmatically meaningful components included for neonatal 
cause-of-death, referring only to “perinatal causes” (figure 1.4). The percentage attributed to 
“perinatal” was 22%, although at the time 36% of deaths were in the neonatal period. The slice 
called “Other” included the remaining 14% of neonatal deaths. Hence this classification masked 
the size of the problem for neonatal deaths, and also failed to show meaningful programmatic 
causes to address such as tetanus, neonatal infections, preterm birth complications and 
intrapartum neonatal deaths.  
 
Finally, saving newborn lives does not occur at the global level – action is required within 
countries and there is substantial variation in cause-proportionate mortality between and even 
within countries. For more visibility and investment in countries and for more effective 
prioritisation and tracking of programmes, cause-of-death distributions at national or even sub-
national level are required.   
 
Figure５1.4: Estimated global causes of death for children under the age of five around the year 
2004 
 
 
Source WHO and UNICEF websites, February 2005 
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Chapter 2                                                             
Aim and Objectives 
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Aim 
The purpose of this thesis is to review information on the causes of four million neonatal deaths, 
and to generate systematic, country-based estimates, advancing the estimation process for the 
major programmatically-relevant causes of neonatal death with a specific focus on “birth 
asphyxia”. 
 
Objectives 
1.  Review approaches and statistical modelling methods for systematic estimation of 
global epidemiological parameters, distilling the implications for improving estimates 
for causes of death within the neonatal period. [Chapter 3] 
 
2.  Consider case definitions for causes of death within the neonatal period and propose a 
minimum list of programmatically relevant causal categories which are comparable in 
vital registration and other data sources, examining in more detail the case definitions 
and measurement options for intrapartum-related outcomes. [Chapter 4] 
 
3.  Undertake a systematic assessment of the coverage and quality of data for neonatal 
cause-of-death through vital registration systems and in published and unpublished 
literature in all countries. [Chapter 5] 
 
4.  Estimate intrapartum-related neonatal deaths for all countries using two different 
approaches (single-cause and multi-cause models), and to compare the methods and 
results. [Chapters 6 and 7] 
 
5.  Summarise actions to improve estimates and input data for neonatal cause-of-death, 
listing research priorities. [Chapter 8] 
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Chapter 3                                                             
Cause-of-death estimation methods                               
(Objective 1) 
 
 
 
Objective 1 
Review approaches and statistical modelling methods  
for systematic estimation of global epidemiological parameters,  
distilling the implications for improving  
estimates for causes of death within the neonatal period. 
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3.1.  Cause-of-death estimation methods 
 
3.1.1 Overview of the new science of systematic global estimates 
Given that most neonatal deaths are unrecorded,
6 estimation is the only option currently 
available for global level information on neonatal deaths.
42  The science of systematic reviews 
of interventions is advanced, with guidelines for search strategies and inclusion criteria such as 
used in the standards for Cochrane reviews (http://www.cochrane.org/resources/ handbook/). In 
contrast, however, the science of disease burden estimation is less advanced and at times 
controversial.
43 Nevertheless, there has been a gradual shift from “back of the envelope” 
estimates to a new science of global estimates requiring application of quality standards to the 
input data, transparency regarding assumptions and modelling and a peer review process.  
 
3.1.2. Improving the quality of cause-of-death estimates 
Most of the recent guidelines on improving global estimates have set out generic principles, but 
as yet specific guidelines have not been published regarding recommendations for cause-of-
death estimates.
44 However, based on recently published papers providing cause-of-death 
estimates particularly from the Child Health Epidemiology Reference Group (CHERG),
5 and 
from guidelines for the GBD (2005)
45 a number of principles can be summarised regarding the 
inputs and the estimation process (table 3.1). 
 
1.  Case definitions for cause-of-death: One of the greatest challenges in estimation of disease 
burden is to establish if the reported variability in a parameter is true epidemiological 
variation or if it is affected by variability in application of case definitions. Case definitions 
are most likely to be variably applied if there is a lack of consensus around the case 
definition and especially if there are co-existing morbidities and a hierarchy has to be 
applied in attributing cause-of-death. The reality is that for many deaths several conditions 
contribute, but ICD rules stipulate enforce a “one death, one cause” approach. For a 
condition such as a road traffic accident or neonatal tetanus which is easy to define and 
widely accepted to take precedence over other causes, there may be more consistent cause-
of-death attribution. However, for conditions with less consensus or even confusion around 
case definitions and especially for conditions which commonly co-exist with others, then 
the reproducibility of cause-of-death attribution may be affected. A notable example is 
“birth asphyxia” where terminology is confused, case definitions vary and a hierarchy is 
required with other co-morbidities such as preterm birth or infection. This is a recurrent 
theme for neonatal cause-of death estimation. While the ICD 10 instruction manual provides 
general guidelines on selection of the underlying cause-of-death (the primary or direct 
cause), and several pages of notes on perinatal causes, ambiguity remains.
7  
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Estimation exercises should be explicit regarding case definitions used, as well as any 
hierarchy of causes of death. Standardised data extraction and additional information from 
authors may be required to combine data from varying sources. 
 
2.  Input data: Comprehensive, systematic searches for data should be the norm, and the 
application of explicit inclusion and exclusion criteria is to be encouraged.
5;46 The use of a 
standard data extraction form and examination of quality of study have been used in several 
recent data extraction exercises. In some cases double data extraction has been applied with 
a supervisor to resolve differences.
46 In the interests of transparency the input data should be 
detailed and be publicly available, in an online database for example.
47 Single cause-of-
death estimates may be susceptible to systematic upward bias since many single cause 
studies are designed by groups aiming to undertake intervention trials and likely to select 
populations with high prevalence of the condition of interest. Consideration should be given 
to excluding studies with just one cause-of-death reported. 
 
3.  Methods and modelling: Varying the assumptions applied to data inputs and modelling can 
alter results markedly. Methods, assumptions and models should be described in full, and 
ideally sensitivity analysis performed to assess the effect on the results of any major 
assumptions. Global estimates often attempt to combine VR data and other sources at the 
end of the process, and the quality assurance criteria may be unspecified and the choices of 
varying inputs may be subjective. An alternative approach is to have transparent 
inclusion/exclusion criteria to apply to all data sources and then combine data and estimates 
using a defined set of rules. If all the input data are from low mortality settings, the model 
will not be appropriate to use for estimation in high mortality settings. 
 
4.  Single proportionate cause-of-death modelling versus multiple: Methodological approaches 
simultaneously estimating multiple causes of death in a given age band are more attractive 
than attempting to combine several single cause estimates generated through varying 
methods, the sum of which often exceeds the total number of deaths.
48;49 Previously, most 
cause-of-death modelling has focused on single cause models, for example for pneumonia, 
or diarrhoea. Once several sets of estimates are available, the numbers of several causes of 
child death have to be combined by country to fit within the envelope of child deaths. This 
has been referred to as the “smoke filled room” approach and has been criticised as non-
repeatable and non-transparent. Recommendations are to move towards simultaneously 
estimating multiple causes of death as proportions within an envelope constrained to 1.0. 
This is attractive in theory but raises major data, methodological and statistical challenges.
 50  
Firstly, given that input data are lacking for cause-of-death in high mortality settings, multi-
cause approaches restrict the input data further to only those sources with several   44
comparable causes of death in a given time period. The lack of high quality data covering 
several causes of death may mean that the very process of selection results in other biases 
and reduces external validity. The second challenge is the complexity of the modelling 
methods required. 
 
The first published use of multi-cause modelling for child mortality estimates was 
developed within CHERG by Morris and Black
48 and applied using a modelling method 
entitled Seemingly Unrelated Regression.  The Morris model aimed to include neonatal as 
one causal group, but was unable to find enough datasets that included it as well as 
pneumonia, diarrhoea, malaria and measles. Hence, neonatal causes were combined with 
“Other” in the residual category. For the multi-cause modelling a “corner cause” is selected, 
which must be a cause that is available in every dataset. Then a ratio of each of the other 
causes of death against this corner cause is converted to a log ratio (see definitions page 17 
for more detail).  Regression modelling is applied to develop estimation equations for the 
log of the ratio of each cause to the selected corner cause. Then all the equations are 
estimated simultaneously and the output constrained to a total of 1.0 eliminating the 
subjective step of combining single cause so they add up to 100% of the deaths. The corner 
cause is estimated as the remainder after all the other proportions have been predicted. This 
pioneering work of Morris at el advanced the use of multi-cause modelling but highlighted 
two key methodological problems.
48 Firstly any dataset with a missing value for any cell 
had to be excluded from the Seemingly Unrelated Regression model, and hence the data 
available were highly restricted and risked systematic bias. Secondly, smaller proportionate 
causes (e.g. measles) appeared to be systematically underestimated. Any future attempts to 
undertake multi-cause modelling would have to attempt to address these problems. 
 
5.  Uncertainty ranges: Given the inherent uncertainty surrounding the process of using a small 
minority of deaths to predict global point estimates, the provision of uncertainty estimates 
should be considered standard practice. Policymakers often prefer a point estimate, but 
presenting the point estimate with an uncertainty range would promote more understanding 
of the limitations of such estimates, and the need to invest in improving the information. 
Global estimation processes have often been produced by advocacy groups and discussion 
of data limitations was considered a risk to diluting the message for action to address the 
condition.  
 
6.  Review process: Given the complexity of the process and how certain assumptions in 
inclusion or exclusion criteria or in the modelling process may have a major effect on the 
estimate results, it is crucial to build expert external review into the process, similar to the 
quality of peer review in a high level journal.    45
3.2. Implications for estimation of neonatal cause-of-death  
 
This chapter of the thesis set out to answer the first objective of the thesis, reviewing approaches 
and statistical modelling methods for systematic estimation of global epidemiological 
parameters and distil the implications for improving estimates for causes of death within the 
neonatal period. The need for systematic and credible neonatal cause-of-death estimates is 
apparent, as are the challenges. Transparency in the estimation process is to be promoted, since 
this helps to create a demand for further advances in the estimation methods and improved data 
collection. While improved estimation methods are increasingly being advocated, as yet few 
global estimates, particularly for cause-of-death, have applied any let alone all of these 
principles. The main implications for improving neonatal cause-of-death estimates  are 
summarised in Table 3.1. A further advance that has not yet been seen in practice would be to 
test the model predictions against real study data to assess model performance. 
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Table  3.1: Improving cause-of-death estimates, and specific implications for neonatal cause-of-death estimation 
 
Step in estimation 
process
General principle Implication for neonatal cause-of-death estimation in this thesis 
1.  Case definitions 
for cause-of-
death  
Programmatically relevant case definitions 
 
Clear case definitions, comparable in high and low 
income settings, linking to ICD coding 
 
Shift from “perinatal causes” to programmatically relevant categories of cause-of-death 
 
Agreement on a minimum list of cause-of-death categories that are comparable with more 
complex specific causes in high income countries  
New analysis of ICD 9 and ICD10 codes in the neonatal period to map multiple ICD codes 
to the agreed minimum neonatal cause-of-death categories  
 
2.  Input data  Combining multiple data sources; for example vital 
registration, published studies, unpublished datasets 
 
 
Explicit inclusion criteria to ensure minimisation of 
selection bias and maximisation of comparability 
All data sources must be examined including a new analysis of VR data from countries 
with high coverage of registration, systematic searches of published literature and attempts 
to identify unpublished literature 
 
Inclusion criteria for data regarding population representativeness and regarding 
comparability for causes of death 
 
3.  Methods and 
modelling 
 
Models based on low mortality data only (e.g. vital 
registration) should not be applied to high mortality 
regions 
  
 
Models should be fully explained and equation(s) 
published  
VR data to be used for the country of origin or for modelling for countries with similar 
NMR, or as an input to a model with other data covering high NMR countries. VR data 
from low NMR countries should not be used as the sole data to predict proportionate 
mortality in high NMR countries 
 
Explain the models, and assumptions and publish equation(s) 
 
4.  Single or 
multiple 
proportionate 
cause-of-death 
modelling 
If estimating one cause-of-death, single cause model may 
be appropriate, but for estimation of proportionate cause 
within a given period a multi-cause model is preferable to 
avoid non-repeatable expert opinion fitting multiple 
single cause estimates together  
Compare the single and multi-cause modelling approaches in order to better understand the 
advantages and disadvantages 
5.  Uncertainty 
ranges 
Uncertainty estimates should be provided and should not 
be based on 95% CI, but should take account of as many 
sources of uncertainty in the inputs as possible  
 
Provide uncertainty estimates that show more realistically the level of uncertainty around 
estimation outputs 
6.  Review process  External expert group process should review the inputs, 
methods and results  
External expert group process should review the inputs, methods and results 
ICD, International Classification of Disease  47
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Objective 2 
Consider case definitions for causes of death  
within the neonatal period and propose  
a minimum list of programmatically relevant causal categories 
 which are comparable in vital registration and other data sources, 
 examining in more detail the case definitions 
 and measurement options for intrapartum-related outcomes. 
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4.1  Challenges in the estimation of neonatal cause-of-death 
 
4.1.1 Sources of cause-of-death data 
There are a variety of data sources for causes of neonatal death, but good quality, nationally 
representative data for low-income countries are rare (Table 4.1). While around one-quarter of 
births occur in countries with nationally representative vital registration data, few countries (46) 
have vital registration systems with both high coverage and high quality of cause-of-death 
classification. In analyses undertaken during 2004, less than 3% of the world’s neonatal deaths 
had certificate data meeting inclusion criteria for quality and comparability.
18 Household 
surveys such as DHS and MICS do not routinely investigate cause-of-death, although in some 
countries follow-up studies have used verbal autopsy to investigate perinatal
19,20 or child 
deaths.
14 In most countries without high coverage of vital registration the only sources of cause-
of-death data are health facility audits, or special studies. National studies have been undertaken 
in some countries, the example of Jamaica being well-known.
21 
 
4.1.2 Verbal autopsy tools 
Community-based studies frequently utilise verbal autopsy (VA) approaches, whereby an 
interviewer administers a questionnaire interview to surviving family members after a death and 
based on this information a single cause is assigned.
52 Verbal autopsy methods vary from a non-
structured interview, to detailed post-mortem questionnaires with computer algorithms, or 
several experts assigning a cause-of-death.
53 The numbers of causes of neonatal death also vary 
between tools, from four simple groupings to multiple specific diagnoses. A few countries have 
undertaken national VA studies as a follow-up to DHS surveys – for example, investigating 
child deaths in Bangladesh,
54 and perinatal deaths in Egypt.
55 
 
Verbal autopsy methods have progressed in recent years and there have been several attempts to 
develop structured standard questionnaires, including a neonatal VA questionnaire developed by 
WHO and Saving Newborn Lives.
56 The network of around 37 Demographic Surveillance sites 
mainly in Africa also identified the need for a neonatal VA and a number of INDEPTH sites 
have developed tools, including two in Ghana.
57 (see Definitions section, page 15 for more 
details on INDEPTH). Some investigators have developed tools that map onto ICD codes. 
58;59 
 
The VA definitions for neonatal tetanus have higher sensitivity and specificity that for other 
neonatal causes of death.
52;60 Congenital abnormalities, especially cardiac defects, are often 
missed, and are especially hard to capture in VA studies where family reports of poor feeding 
and fast breathing are likely to result in misclassification into pneumonia or severe infections. 
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More important than variation in the data collection forms, the proportionate mortality results 
are highly dependent on the cause-of-death categories chosen, the case definitions and hierarchy 
applied for coding cause-of-death, bearing in mind that several causes often co-exist. For 
example, if a moderately preterm baby dies of an infection, the ICD would attribute the death to 
infection, with preterm as a contributing factor;
22 but if an extremely preterm baby dies of 
hyaline membrane disease, prematurity is the underlying or main cause. The proportion of 
intrapartum-related neonatal deaths is especially open to variation with different case 
definitions. If the traditional clinical case definition of “not breathing at birth” is applied, then 
any baby not breathing at birth would be included (for example preterm infants) falsely inflating 
the intrapartum-related proportion. This is not an academic nicety since it has implications for 
the public health strategy required. Improved tools with explicit hierarchies, linking VA and VR 
data and with known performance characteristics are required.
61 Chapter 4 (specifically 4.3) 
details the specific issues regarding “birth asphyxia” case definitions and measurement. 
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4.2. Case definitions for multi-cause neonatal death analysis 
 
4.2.1 Shifting from “perinatal causes” to programmatic categories 
Cause-of-death classification should be meaningful for programmatic action.  The classification 
used for neonatal deaths is enmeshed in history. In ICD terminology ‘perinatal cause’ refers to 
any code in the perinatal chapter of the ICD.
22 In the WHO’s World Health Report and the GBD 
summary tables the largest single number of deaths falls under the heading of “perinatal 
causes”, a total of 2.6 million deaths in one row.
23 This contrasts with single rows for some other 
very specific categories; for example Trachoma has a single row but no deaths in the row. Otitis 
media lies just two rows above “Perinatal causes” and includes 4,000 deaths. The GBD   
webtables provide a breakdown of “perinatal causes” into just three sub groups – “birth 
asphyxia”, “low birth weight” and “perinatal other”. 
 
The “perinatal causes” category has a number of disadvantages in terms of the use of data for 
policy and programmes: 
1.  Misunderstanding of the category:  The term is not well understood by epidemiologists 
or programme managers, and is frequently assumed to refer to perinatal mortality and 
the perinatal period and to include stillbirths.  
 
2.  Programmatic relevance: This is the largest number in the burden of disease tables but 
not directly correlated to specific programmatic solutions such as improved intrapartum 
care, or case management of neonatal infections, or improved care of preterm neonates. 
 
3.  Excludes several major and closely linked causes of mortality and morbidity:  
Conditions which are not in the Perinatal chapter of ICD are excluded from the 
“perinatal causes” group, notably neonatal infections, neonatal tetanus, and congenital 
abnormalities, which has a separate ICD chapter. Neonatal tetanus has a separate row 
within the section related to immunisable conditions. However,  neonatal infections are 
not possible to distinguish in this tabulation, despite being the single largest cause of 
neonatal deaths and the most feasible to prevent in low income settings.
24  
 
4.  The time period is not restricted: Thus a death at any age can be ascribed a perinatal 
code if a cause within the perinatal chapter was considered to be the underlying cause. 
In some countries adults dying of cerebral palsy are coded to “birth asphyxia” codes. 
The application of perinatal chapter codes for deaths late in adult life is practised 
differently in different countries, with some countries registering significant numbers of 
adult deaths to perinatal cause categories (personal communication Kenji Shibuya, 
WHO). 
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These factors have contributed to the invisibility of neonatal deaths on the global agenda as 
exhibited in the global pie chart for causes of child death (Fig 1. 4). Around half of neonatal 
deaths are in the 22% slice for “perinatal causes” and the remaining 14% of neonatal deaths are 
in the “Other child deaths” category. Adopting easily understood and programmatically relevant 
categories for cause-of-death is an important first step in using data to reduce neonatal 
mortality. Increasing the availability of useful, comparable cause-of-death data to inform public 
health decision-making will require wide application of a standard set of programmatically 
relevant cause-of-death categories, with standard case definitions that can be applied in both 
vital registration and verbal autopsy data. 
 
4.2.2 Consensus process to agree on causal categories 
The Child Health Epidemiology Reference Group, (CHERG) and external group of experts 
working with WHO and UNICEF, undertook an expert consensus process to select a minimum 
set of categories for cause-of-death within the neonatal period. The process involved the 
following steps: (1) background work reviewing categories used to date and hierarchical 
approaches (undertaken by the investigator); (2) Preliminary discussion at a CHERG meeting to 
agree on criteria and likely categories (3) a one day face-to-face meeting of most members of 
the CHERG neonatal group in Geneva (April 2004). This one day meeting was requested and 
coordinated by the investigator with participation by CHERG neonatal group members 
including Jose Martines, Kenji Shibuya, Martin Weber, and Jelka Zupan (all WHO, Geneva) as 
well as Simon Cousens and Robert Black. The purpose of the meeting was to finalise the list of 
causal categories and agree on case definitions and a hierarchy to apply.  
 
Step 1: Finalising the list of causal categories 
It was agreed by the expert group in advance of the meeting that the selection of the causal 
categories should be based on three key considerations: 
1.  Causal categories with public health significance and differing programmatic 
implications; 
2.  Clinically distinguishable  categories in low income settings and particularly in VA; and  
3.  Data availability in existing multi-cause datasets. 
 
Background work was presented by the investigator regarding causal categories in current use. 
The list of causes for ICD tabulation only included “Low birth weight”, “Birth Asphyxia” and 
“Perinatal other” and was considered inadequate to guide policy and programmes. For the 
majority of countries the only data sources is VA and the cause of death categories for neonatal  
in VA tools often gave only two or three of the following categories - tetanus, infections, 
diarrhoea, “birth asphyxia” and preterm birth or even “low birth weight”.  While congenital was 
often omitted in VA data, this was considered a very important cause to include in estimates.    52
 
Six categories had been proposed during a previous CHERG meeting based on the agreed 
criteria for causal categories and including (1) preterm birth complications; (2) “birth asphyxia”; 
(3) severe neonatal infections (sepsis, pneumonia and meningitis); (4) neonatal tetanus, (5) 
diarrhoea; and (6) congenital abnormalities, and (7) residual “other neonatal” category 
comprising specific causes of neonatal death such as jaundice and haemorrhagic disease of the 
newborn (table 4.1).
18  There was strong group consensus around these causal categories as 
being of distinct programmatic relevance and being possible to define separately so during the 
one day meeting most of the discussion focused around the case definitions and the hierarchy.  
 
Step 2: Agree on case definitions  
Based on the background review, group discussion focused on two issues for case definitions 
identified as priorities for group consensus. Firstly around the desire to further delineate the 
neonatal infections group ideally into specific clinical infections syndromes; secondly how to 
deal with preterm as a direct cause of death versus preterm as a risk factor for death. These 
questions were driven by the need to be able to distinguish causes in VA data that could be 
comparable to more detailed information in VR systems, and consistent with ICD rules.  
 
Neonatal infections: Since pneumonia in a neonate cannot be distinguished on clinical 
examination alone from septicaemia or meningitis, and because case management is similar for 
all three conditions, one category, subsequently referred to as “sepsis/pneumonia”, was used for 
all three infection syndromes. Some VA tools attempt to distinguish neonatal pneumonia from 
sepsis/meningitis and as VA tools increase in sophistication, it is possible that more data with a 
reliable split will allow this causal category to be divided into more detailed subgroups. From a 
public health and clinical perspective the prevention and management priorities are the same for 
neonatal sepsis, pneumonia, and meningitis, but for ICD and GBD categories there is a desire to 
split these to be consistent with the tabulation used for adult infection deaths.  
 
Preterm birth as a direct cause of death versus as a risk factor and dealing with small for 
gestational age (SGA) as a direct cause of death: Preterm birth may be either the main cause-
of-death through specific complications of immaturity, or a risk factor for other specific causes, 
notably infections.
75 For a moderately preterm baby who dies of a community-acquired 
infection, infection is the category to highlight for intervention. ICD recommends that preterm 
birth alone should not be coded as the main condition on a death certificate, but rather the 
specific complication for example respiratory distress syndrome, or intraventricular 
haemorrhage.
7 In compliance with ICD, the category preterm was defined to include only deaths 
directly attributed to specific complications of preterm birth such as surfactant deficiency, but 
not all deaths in preterm infants.
7 However it should be noted that investigators do not always   53
specify such case definitions clearly in publications, so in secondary data analysis the quality of 
case definitions and application of these cannot always be controlled. For tabulation purposes 
the relevant specific codes for preterm direct complications can then be grouped as one category 
related to preterm birth which is the root cause for public health prevention and intervention. 
 
The category of full term infant, SGA was considered important to try to distinguish from the 
preterm direct cause-of-death category. Analysis of VR data and the study data in the CHERG 
neonatal database showed that term SGA was attributed as the main cause for less than 1% of 
neonatal deaths, although some studies did not specify this as a cause-of-death so some 
misclassification into preterm birth is possible. The expert group recommended that neonatal 
deaths directly attributed to SGA be included in the “Other” causes of neonatal death. An 
additional benefit of this approach is consistency with the cause-of-death groupings for the older 
child deaths where deaths attributed to severe malnutrition may be undercounted or 
inconsistently counted and are included in the child “Other” category. 
 
Step 3: Define a hierarchy for attributing neonatal cause of death categories 
Attributing each death to a single cause is an oversimplification. While this is necessary to 
maintain a “one death one cause” approach, this presents challenges in attributing the “correct 
cause.” The “correct cause” should link to public health solutions to prevent that death and 
follow consistent, transparent rules. Misclassification between causes of neonatal death is not 
well studied, 
62 and may especially affect the infection and preterm categories.
63 Some 
conditions may be synergistic, for example infection and asphyxia and not fit well into the “one 
death one cause” approach.
76  
 
To minimise inconsistency, explicit case definitions and hierarchical coding rules are required. 
ICD 10 includes a companion volume which gives guidelines on mortality and morbidity 
coding.
7 There is a section entitled “Perinatal mortality: guidelines for certification and rules for 
coding” which includes an example perinatal death certificate with maternal details, and a few 
details on the baby. However gestational age is not mentioned since birth weight was considered 
higher priority than gestational age in ICD 10. These rules do not give an explicit hierarchy and 
the implicit hierarchy may not always be applied in practice. An analysis of 2378 neonatal 
deaths in Sweden (1987 - 1992) looked at death certificate cause-of-death reporting, allocating 
the deaths to causal categories in Wigglesworth
13 and ICE (Intrauterine death Classification 
according to Etiology) classifications. There was very poor agreement particularly for 
attribution to the preterm and “birth asphyxia” categories. Among 328 infants dying from 
“asphyxia” according to computerised Wigglesworth classification, ICE classified 59% as 
“asphyxia” and 22% were labelled immaturity. For deaths classified in ICE as being due to 
“asphyxia”, the Wiggleworth classification matched in only 50% of cases. Among 792 infants   54
dying from immaturity according to the computerised Wigglesworth classification, 64% were 
classified as such by ICE.
63 The authors argue the need for an explicit hierarchy and also for 
computerised allocation to combined categories.
64  
 
The CHERG neonatal expert group reviewed hierarchal approaches for neonatal cause-of death 
attribution. Wigglesworth or adapted Wigglesworth categories were close to the categories 
selected by CHERG but there is not an explicit hierarchy and Wigglesworth is recognised to 
overestimate “asphyxia”
64 and implies a preference for “asphyxia” above immaturity by the 
order the cause are listed in.
 13 For the CHERG work, the desired case definition for “asphyxia” 
will shift to intrapartum-related and will exclude preterm births, or at least severely preterm 
births, from the intrapartum-related category. Therefore a hierarchy must put the preterm birth 
direct complications above intrapartum-related deaths.  
 
The group agreed that the NICE hierarchical classification (adapted from ICE) by the same 
Swedish group
65 was useful and had several important principles that all the CHERG consensus 
group agreed on such as placing congenital causes at the top of the hierarchy. However 
adaptation was required as NICE included stillbirths and also was much more focused on high 
income countries. For example, NICE does not mention tetanus and combines neonatal 
infections with preterm respiratory distress syndrome in a category called “specific infant 
conditions”.  
 
The conditions at the top of the hierarchy (congenital and neonatal tetanus) and also at the 
bottom (“Other neonatal”, diarrhoea and sepsis/pneumonia) were straightforward to agree the 
order for. The main discussion centred on how to clarify the split for intrapartum-related 
neonatal deaths and deaths directly due to preterm. Given agreement on the case definition for 
“birth asphyxia” shifting to intrapartum-related neonatal deaths and excluding preterm births it 
was agreed that at least some of the preterm deaths should come before the intrapartum-related 
neonatal deaths. At one stage the case definition for direct complications of preterm births was 
proposed as 32 weeks completed gestational age but later changed to preterm was agreed as less 
than 34 weeks (approximately 2000 gms) based on the rapid increase in the incidence of 
respiratory distress or hyaline membrane disease under 34 weeks completed gestation in the 
absence of antenatal steroids and the relatively widespread use of 2000 gms as a standard cut off 
in the absence of gestational age data. Hence this case definition for preterm birth direct 
complications was put in the hierarchy above intrapartum related deaths. The resulting 
consensus for case definitions and hierarchy is shown in Table 4.1. 
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Table  4.1: Case definitions applied for neonatal cause-of-death in vital registration and study data, 
given in order of hierarchy to be applied 
 
Cause-of-
death group 
Case definition used in VR and sought 
for study data 
Case definition 
accepted in study 
data 
Congenital 
abnormalities 
Neonatal death due to major or lethal congenital 
abnormalities  
Specific abnormality listed  
E.g. neural tube defect, cardiac defect 
 
Congenital abnormality or 
Malformation 
Neonatal 
tetanus 
Neonatal death due to tetanus 
 
Spasms and poor feeding 
after age of 3 days 
 
Preterm birth 
as a direct 
cause of death 
Neonatal death due to one or more of the following: 
- Specific complications of preterm birth such as 
surfactant deficiency (Respiratory Distress 
Syndrome), intraventricular haemorrhage, 
necrotizing enterocolitis etc. 
- Immaturity (less than 34 weeks) at which level 
preterm specific complications occur for the majority 
of babies 
- Neonatal death with birth weight < 2,000 g where 
gestational age is unknown 
 
‘Prematurity’ 
‘Very low birth weight’ 
 
 
Intrapartum-
related 
(“birth 
asphyxia”) 
Neonatal death due to: 
- Neonatal encephalopathy with criteria suggestive of 
intrapartum events 
- Early neonatal death in a term baby with no 
congenital malformations and a specific history of 
acute intrapartum insult or obstructed labour 
 
“Birth asphyxia” with 
Apgar-based definition 
but excluding preterm 
infants 
Fits and/or coma in the 
first two days of life in a 
term baby 
Acute intrapartum 
complications 
 
Sepsis/ 
pneumonia 
Neonatal death due to one or more of the following: 
- Sepsis/septicaemia 
- Meningitis 
- Pneumonia/ acute respiratory tract infection 
- Neonatal infection 
 
‘Neonatal infection’ 
Diarrhoea  Neonatal death due to diarrhoea  
 
- 
Other  Specific cause of neonatal death not included in first 
six selected causes, including: 
-  Neonatal jaundice  
-  Haemorrhagic disease of the newborn 
-  Term baby dying due to in-utero growth restriction 
-  Injury  
 
Authors’ grouping of 
“other” (as distinct from 
unknown) 
Adapted from Wigglesworth
13 and NICE
14 using a hierarchical classification approach developed by 
expert group consensus with each of the conditions being sought in the order listed.  
Note that for study input data the investigators may have applied their own hierarchy which may not be 
consistent with the one shown.   56
4.3  Case definitions and specific challenges in the estimation 
of intrapartum-related outcomes 
 
4.3.1 Overview 
“Birth asphyxia” is reported to be a major cause of global mortality and morbidity. Previous 
numbers from WHO range from 691,000 to 1.16 million neonatal deaths worldwide and are 
primarily based on a definition of “not breathing at birth”.
41;66  In previous GBD estimates, 
linking severe neurological disability to these deaths produces one of the highest Disability 
Adjusted Life Years (DALYs) for any single cause in the GBD.
66  Accurate measurement of this 
burden is hindered by general factors, particularly the overwhelming lack of information for 
most of the world’s stillbirths and immediate neonatal deaths, but also by factors specific to 
“birth asphyxia” including: 
  Lack of consensus on case definition(s) and terminology for “birth asphyxia” and 
differences in use of terminology and criteria between high and low income countries; 
  Complexity of attributing cause-of-death, particularly when multiple causation is 
common (e.g., ‘asphyxia’ and infection) and also multiple classification systems are in 
use which may have varying perspectives (obstetric, paediatric, pathophysiological); 
  Difficulties with data collection for high income country case definitions in low income 
settings, e.g., the feasibility of identification and skilled examination of babies with 
neonatal encephalopathy (NE); 
  Difficulty measuring impairment/disability, particularly in young children and 
complexity in attribution for causation of impairment/disability. 
 
Before assessing strategies to address the burden of disease, it is necessary to clarify what we 
are trying to measure. 
 
4.3.2 What do we want to measure? 
Visibility of the problem and programmatic tracking are hampered by inconsistent terminology, 
the lack of an agreed definition, and the lack of standard measurement. The situation of a baby 
in poor condition at birth has been recognised from earliest times, and the terms and definitions 
have evolved over time, driven both by a greater understanding of the pathophysiology and 
clinical manifestations, but also by increasing litigation in high-income countries. The need for 
a more sensitive and specific diagnosis of very soon after birth has recently gained importance 
because of the possibility of intervention using therapeutic hypothermia. 
 
The word “asphyxia” is based on a Greek word meaning “pulseless” and is applied to a 
combined hypoxia (low levels of oxygen) and metabolic acidosis. However, the term “birth 
asphyxia” has no agreed scientific definition, partly because there is no direct, simple measure   57
of “asphyxia” for the fetus in utero or the baby at birth.
67 Asphyxia has been commonly 
assumed to imply hypoxia in the fetus due to inadequate care during labour and/or delivery, but 
the term is most frequently applied as a clinical description of an infant who does not breathe 
spontaneously at birth. This assumption confuses the clinical state with an assumed causation 
and with subsequent outcomes. The newborn baby may not be breathing for many reasons. The 
range of possible outcomes is equally wide, including death, irreversible brain injury and 
normal survival.  
 
Case definitions differ depending on the purpose. At the individual level of clinical care, the 
delivery attendant and other health care providers require a sensitive case definition to identify 
individuals who may be at risk, in order to manage the pregnancy, birth, or clinical care and 
follow-up as safely as possible. At the population level, public health decision makers, 
epidemiologists and researchers require a specific case definition to ensure comparability of the 
selected outcome over time or place, and in controlled trials. Case definitions should take into 
account the purpose of identification and be appropriate to the capacity of the caregivers. For 
example, if clinical care at birth in the community is the purpose, then the “non-breathing 
baby”, or “not crying at birth” may be the most appropriate definition. 
 
For some conditions, using a sensitive clinical case definition as a surrogate instead of a specific 
public health definition is possible, particularly if the clinical case definition is also fairly 
specific. For example, neonatal tetanus has distinctive clinical symptoms and the clinical case 
definition works well for tracking at population level. In contrast, for the condition colloquially 
referred to as “birth asphyxia”, the clinical definition of not breathing at birth must be sensitive 
as the consequences for missing a case could rapidly be fatal, yet these symptoms are not  
specific for a given causation. The baby who is not breathing at birth has not necessarily 
experienced a major intrapartum insult – the baby may well be preterm, or could have a major 
congenital abnormality. Hence interchangeable use of the sensitive clinical case definition (e.g. 
Apgar score) with a specific epidemiological one results in major differences in attribution and 
potentially misleading programmatic implications.  
 
Three consensus statements addressing terminology and diagnosis of “birth asphyxia” have 
been released since 1996. All three statements have recommended that terms such as “birth 
asphyxia”, “perinatal asphyxia”, “fetal distress”, “hypoxic-ischaemic encephalopathy” or “post-
asphyxial encephalopathy” should not be used unless some evidence specific to acute 
intrapartum events is available.
68-70 In view of this we use inverted commas for these terms. 
Table 4.2 summarises these consensus statements.  
   58
Table  ①4.2  Summary of consensus statements regarding the diagnosis of “birth asphyxia” 
 
  American Academy of Pediatrics with 
American College of Obstetrics & 
Gynecology
68 
(1996) 
International Cerebral Palsy Task 
Force
69 
 
 (1999) 
American College of Obstetrics & 
Gynecology
70  
 
(2002)
Essential criteria - Neonatal encephalopathy 
 
- Multi-organ dysfunction 
 
- Apgar score < 3 after 5 mins 
 
- Metabolic acidosis (pH<7.0) 
 
- Neonatal encephalopathy (moderate or 
severe) 
 
 
 
 
- Metabolic acidosis (pH<7.0 and base 
deficit > 12 mmol/L) 
 
- Cerebral palsy of spastic quadriplegia or 
dyskinetic type 
 
- Neonatal encephalopathy (moderate or severe) 
 
 
 
 
 
- Metabolic acidosis (pH<7.0 and base deficit > 12 
mmol/L) 
 
- Cerebral palsy of spastic quadriplegia or 
dyskinetic type 
 
- Exclusion of other pathological causes of 
cerebral palsy 
 
Criteria suggestive 
of intrapartum 
timing 
- Criteria suggestive of intrapartum timing 
 
- Sentinel event 
 
- Abrupt change in fetal heart rate 
 
- Apgar score < 6 after 5 mins 
 
- Multi-system involvement 
 
- Imaging evidence 
 
- Sentinel event 
 
- Abrupt change in fetal heart rate 
 
- Apgar score < 6 after 5 mins 
 
- Multi-system failure in first 72 hours after birth 
 
- Imaging evidence 
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The recommendations remain broadly the same across the three statements but in each case the 
criteria have become more restrictive (Table 4.2). The emphasis is to diagnose in a syndromic 
fashion with essential criteria primarily based on evidence of NE (i.e. abnormal neurological 
behaviour such as convulsions, coma) instead of low Apgar or perinatal depression at birth. 
Other causes of NE should be excluded such as central nervous system malformations or 
metabolic abnormalities. Additional criteria are required to assess the likelihood of intrapartum 
timing such as history of a sentinel event (e.g. antepartum haemorrhage), prolonged low Apgar 
score, multi-system involvement and imaging evidence. In the intervening years since the 2002 
statement the published studies place increasing emphasis on complex imaging or 
electrographic techniques.
71;72 
 
Neurological damage in the preterm infant has a different pattern and may be particularly 
related to injury after delivery.
73;74All these consensus statements refer to term infants although 
there is not yet a clear consensus if all preterm infants (<37 weeks gestation) or very preterm 
infants (<34 weeks) or some intermediate cut off (e.g. 36 weeks) should be applied. 
 
These consensus statements are primarily designed to clarify difficult medico-legal issues when 
determining cause and liability for cases of perinatal brain injury in North America and other 
settings where inadequate obstetric care or resuscitation is a dwindling cause of NE. Even in 
these settings where extensive investigation is available, the origin of the presumed hypoxic 
event is often unresolved.
72 There is little doubt that the approach in the 19
th and early 20
th 
century over attributed deaths and cerebral palsy to “birth asphyxia”. Little implied that most 
cerebral palsy cases could be attributed to “birth asphyxia” brain damage whereas more recent 
work particularly from Nelson et al in the US and Stanley and Blair et al in Australia suggest 
that perhaps less than 20% of children with spastic cerebral palsy had evidence of asphyxia and 
in less than half of these was the perinatal insult judged to be causative.
75-78 
 
Currently there is a dichotomy whereby the low mortality countries have moved to a more 
restrictive syndromic diagnosis based on NE, yet most low income, high mortality countries and 
indeed researchers and UN policymakers and even the Burden of Disease continue to use the 
term “birth asphyxia” and in many cases use this term interchangeably for the baby not 
breathing at birth and the epidemiological causation of intrapartum injury.  The more specific 
approach presents many challenges in application in the settings where the vast majority of 
deaths related to acute intrapartum events occur.  For most of the world’s 130 million births, 
emergency obstetric care and neonatal resuscitation are the exception and the major outcomes 
related to intrapartum emergencies hence intrapartum stillbirths and neonatal deaths before the 
onset of NE are a large proportion of the burden. For those babies who do survive to develop 
NE, the consensus statement would require evidence of NE (necessitating a high level of   60
clinical skill), fetal acidaemia (necessitating blood gas analysis and all that this entails) and 
exclusion of other causes of NE (requiring metabolic assessment). This case definition would be 
hard to apply even in teaching hospitals in much of South Asia and Sub Saharan Africa.  
 
The rest of this chapter presents a brief discussion of the underlying causal pathways in 
intrapartum insults and then provides a conceptual framework and case definitions for defining 
and measuring outcomes related to acute intrapartum events, particularly focusing on how to 
advance to more specific and yet feasible measurement in low or middle income countries. The 
chapter concludes with a recommended case definition for use in mortality estimation. 
 
4.3.3  When and what causes the insult? 
The successful transition of the newborn baby from life in-utero to life at birth is based on a 
complex balance of the health of the mother, the course of the pregnancy, and the process of 
delivery. During normal labour, the fetus will experience hypoxia but is able to tolerate this 
remarkably well. Problems occur if there is severe or sustained lack of oxygen to the fetus, 
which may occur before, during or after labour. Studies in industrialised settings give varying 
estimates for the proportion of NE in term infants which occurs during intrapartum ranging 
from very low levels in some studies
79;80 to much higher levels in other more recent studies 
using MRI scanning. For example one large study in the UK found that 197 of 351 term babies 
with NE had MRI evidence of an acute intrapartum insult.
72  Reviews suggest perhaps 10% of 
cases the injury may occur postnatally.
74;77 However, even in high income countries many 
questions remain unanswered. The proposal of causal web analysis to take into account co-
existing antenatal and intrapartum factors has been an important advance in understanding.
81;82  
Studies assessing the timing of insult are not available from low income country settings, but it 
is likely that intrapartum causes account for a larger proportion, given the higher incidence of 
serious complications in labour and reduced availability of skilled care during delivery.
83  
 
The initial hypoxic injury precipitates a derangement of cellular energy metabolism, which may 
initially be reversible. If hypoxia continues or if the initial insult was very severe and acute, 
however, then acidosis and depletion of cellular energy precipitate an irreversible cascade of 
cellular damage, resulting either in death or in typical patterns of brain injury such as 
parasagittal necrosis in the term infant.
74 Delayed cell death is linked to increasing cerebral 
oedema, which explains the clinical picture of the baby who appears stable after resuscitation 
and then after 4-6 hours begins to convulse, showing the typical features of NE. Although all 
the major systems may be injured, the brain is more susceptible to injury, and is less likely to 
recover. Thus, the most significant effect of severe hypoxia is on the fetal/neonatal brain. The 
degree of injury to the baby varies with the nature of the insult (severity and length), and the 
vulnerability of the baby. For example, preterm babies are more susceptible than term babies to   61
severe injury and death following hypoxia. In addition, the growth restricted fetus who has 
experienced chronic hypoxia related to placental insufficiency during pregnancy is at greater 
risk of further damage from superimposed acute hypoxia at the time of birth. Maternal infection 
is apparently synergistic with a hypoxic insult.
84 
 
Insult may result from a variety of factors and which may be acute, or chronic or acute-on-
chronic as follows:
85  
1.  Interruption of the umbilical circulation (e.g., cord compression, cord prolapse, knot in 
the cord); 
2.  Altered placental gas exchange (placenta praevia, placental abruption or insufficiency, 
abnormal/prolonged uterine contractions); 
3.  Inadequate maternal perfusion of the placenta (maternal hypertension or hypotension); 
4.  Failure of newborn respiration during transit from fetal to neonatal life (e.g., the effect 
of maternal anaesthesia).  
 
Causation can be considered in terms of causal pathways, an approach which has been applied 
to the aetiology of cerebral palsy.
81;82 Each pathway consists of a network of factors, and 
prevention of a necessary factor high up the network may prevent the condition. However, given 
the possible combinations of timing of multiple insults, it is clear that there is much we do not 
yet understand, especially given the high level of antepartum factors such as maternal 
malnutrition and maternal infections in the settings where acute intrapartum events are also 
common.
84 The important programmatic message from a causal pathway approach is that 
prevention is more effective if the major initiating factors are addressed. For example a larger 
impact would be expected from improved maternal health and healthcare, rather than from 
neonatal resuscitation or care of the neonate with encephalopathy. 
 
Birth trauma as a direct cause-of-death is rare compared to the direct effect of hypoxia on the 
brain, but is included in the same group of death for programmatic reasons. The analysis in this 
thesis of vital registration data for 45 countries suggests that hypoxic brain injury is about 100 
times more common than birth trauma as a cause-of-death. While injuries such as fractures and 
nerve palsies are not uncommon, fatal trauma such as organ rupture is rare. It may be argued 
that birth trauma is expected to be a larger problem in countries without vital registration where 
obstetric care is limited. However, a number of studies from less developed countries also 
suggest that birth trauma is an infrequent primary cause-of-death, and the death is more often 
due to associated hypoxic injury to the brain.
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4.3.4 Defining intrapartum-related fetal and neonatal outcomes  
There are 3 clusters of terms for intrapartum-related measurement including: 
  Measures of abnormal obstetric process, such as ‘fetal distress’; 
  Measures of the clinical condition of the neonate at birth, such as the Apgar score; and 
  Outcomes for the fetus or neonate, such as death, acute morbidity (NE) or disability. 
Unfortunately there is no sensitive and specific measure of the obstetric process. The surrogate 
measures applied in high-income countries, such as fetal heart monitoring or fetal blood gases, 
are not specific
90 and are not likely to be applicable to most of the world’s deliveries in the near 
future. Similarly, measures of the clinical condition of the neonate at birth such as the Apgar 
score were intended to identify the infant requiring resuscitation, not to measure the burden of 
disease due to a specific cause. Hence, of several hundred articles examining the Apgar score, 
there is no clear conclusion regarding long term prognostic value.  
 
Given the complexity and limitations of measuring an abnormal intrapartum process involving 
hypoxia a more feasible approach is to focus on specific morbidity, mortality or disability 
outcomes with standard case definitions. Furthermore, these outcomes will be directly relevant 
to programmes involving improved intrapartum care, and so there will be more motivation to 
collect the data. Figure 4.1 is a simplified disease model depicting the major conditions and 
outcomes for the fetus and neonate that are associated with the intrapartum period and 
contribute to the disease burden. These include: 
1.  Intrapartum stillbirths; 
2.  Neonatal encephalopathy  
3.  Neonatal deaths including:  
  the newly born live infant who cannot be resuscitated/no resuscitation is available 
(excluding lethal congenital malformations and preterm birth (less than 28 weeks 
or 1000 g)); 
  neonatal death as a sequela of NE;  
4.  Neurological disability as a sequela of NE. 
 
The case definitions for these conditions are detailed in Table 4.3, along with the relevant ICD 
10 codes, and the next section of this chapter then covers the measurement for each. 
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Figure 4.1.   Adverse intrapartum-related outcomes for the fetus and neonate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The case definitions for these conditions are detailed in Table 4.3, along with the relevant International 
Classification of Diseases version 10 (ICD-10, 1992) codes 
 
 
 
Impairment 
 
Severe 
Moderate 
Mild 
Healthy development 
Acute intrapartum 
events  
e.g. antepartum haemorrhage 
Not breathing  
at birth 
 
Severe 
(Apgar < 6 beyond 5 
minutes) 
 
Mild 
(Apgar < 6 at 1 min) 
Neonatal 
Encephalopathy 
 
   Severe 
   Moderate 
   Mild 
Not resuscited or  
not resucitatable 
term (>2000g) baby 
Other factors,  
e.g., congenital abnormalities 
Antenatal  factors 
e.g. In utero growth restriction 
Intrapartum-related 
neonatal death  
Intrapartum  
Stillbirth    64
Table  ②4.3 Case definitions for intrapartum-related outcomes for the fetus and neonate 
 
Outcome  Case definition  ICD-10 codes          
(4 digit) 
Intrapartum 
stillbirth 
 
Fresh stillbirth 
The birth of a fetus after 28 weeks of 
gestation/weighing >1000 g and showing no signs of 
life, and which has intact skin, and is assumed to have 
died less than 12 hours prior to delivery 
P017 to P019 , P030 to 
039 (specific obstetric 
complications) 
P95 covers fetal death 
unspecified  
 
Severe 
respiratory 
depression at 
birth   
 
A newly born infant that does not breathe at birth, and 
has an Apgar at 5 minute of 6 or less 
Note that the causes are broader than intrapartum 
factors 
P210 to P219  
 
Not 
resuscitatable at 
time of birth 
A newly born infant who shows signs of life (such as 
heart beat) and cannot be successfully resuscitated or 
no resuscitation is available, but excluding severe 
congenital abnormalities and gestational age <34 
weeks (or  birth weight < 2000g)  
P200 to P209 
P210 to P219  
P030 to 039, P017 to 
P019 (specific obstetric 
complications) 
 
Neonatal  
encephalopathy  
 
Neonatal encephalopathy is “a disturbance of 
neurological function in the earliest days of life in the 
term infant manifested by...abnormal level of 
consciousness and often by seizures”
91  
 
Classified as mild, moderate and severe. 
 
For a diagnosis of intrapartum-related NE, other causes 
(e.g. metabolic) should be excluded 
 
Exclusion of preterm birth is recommended but there is 
no clear consensus on the cut off with a range of 34 to 
37 weeks gestation applied. 
 
P210 to P219  
P910 to P919 
 
 
Death following 
neonatal 
encephalopathy  
or birth injury or 
meconium 
aspiration 
A live born infant who dies following neonatal 
encephalopathy  related to  acute intrapartum events 
 
P210 to P219: Hypoxic 
ischaemic 
encephalopathy 
P100 to P150: Birth 
injury 
P240: Meconium 
aspiration 
 
Neurological 
disability 
following 
neonatal 
encephalopathy 
 
Severe disability: presence of  major impairment (such 
as cerebral palsy, hemiplegia, diplegia) with or without 
blindness, deafness and/or moderate/severe mental 
impairment (IQ < 70) 
 
Mild disability: learning disability, vision or hearing 
impairment 
 
International 
Classification of 
Functioning, 1999 
References: ICD-9 and ICD-10, ICF 1999 
Fenichel et al 
91 
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4.3.5 Measuring intrapartum-related outcomes 
The key intrapartum-related measurements for the fetus and baby can be considered by time 
period (before birth, at birth, after birth and after death), and are summarised in Table 4.4, and 
then discussed in more detail in each case considering the definition, its usefulness and 
feasibility in low income settings especially at community level. Recognition of fetal distress is 
clearly crucial for obstetric intervention but detailing the possible measurement options is not 
within the remit of this thesis, and the focus will be on mortality and major morbidity outcomes 
that have implications of relevance for measurement intrapartum related neonatal deaths.  
 
Table  ③4.4  Methods to recognise and measure intrapartum-related outcomes for fetus and 
neonate 
 
Timing of identification 
 
Method to define or measure 
1. Before birth 
 
  “Fetal distress” 
  Meconium staining of the liquor 
 
2. At birth 
 
  Stillbirth (specifically fresh stillbirth)* 
  Recognition of one or more simple  clinical characteristics  
       (e.g., not crying or not breathing)*
 # 
  Apgar score 
 
3. After birth    Neonatal encephalopathy score
# 
4. After death in community    Verbal autopsy
# 
 
5. After hospital discharge or 
death 
  ICD codes in Vital Registration data 
  Post mortem 
6. During infancy/childhood    Identification of asphyxia-related disability
# 
*Methods likely to be useful and feasible for regular use at community level 
# Methods likely to be useful for research studies, possible scope to simplify more for routine use 
 
At birth  
Intrapartum or ‘fresh’ stillbirth 
Definition: A stillbirth is a baby who shows no signs of life at delivery and weighs more than 
1000 g or is greater than 28 weeks gestation. A fresh stillbirth is a stillborn baby that has intact 
skin and is assumed to have died less than 12 hours prior to delivery. The single most likely 
cause of fresh stillbirth is intrapartum hypoxia.  
 
Usefulness: Intrapartum stillbirths are more frequent than intrapartum-related neonatal deaths, 
especially in settings with limited emergency obstetric care. Intrapartum stillbirths and   66
intrapartum neonatal deaths are closely linked in terms of measurement through 
misclassification, but also in terms of programmatic solutions.
51 A mature fetus dying during 
childbirth is usually considered to be a preventable death.
12;92-95 Hospital-based studies suggest 
that 25–62% of intrapartum stillbirths are avoidable with better obstetric care and more rapid 
responses to intrapartum complications, including reducing delays at home and in 
transportation. The fresh stillbirth rate for babies weighing >2000 g has been proposed as a 
surrogate indicator for intrapartum stillbirths.
89;96  In high mortality settings the fresh stillbirth 
rate probably underestimates the true rate of intrapartum stillbirths since with poor access to 
obstetric care, labour lasting more than 24 hours is not infrequent and the labour in excess of 12 
hours usually results in a macerated stillbirth.
89 Conversely, a small proportion of fresh 
stillbirths may be due to non-hypoxic causes (undetected congenital abnormalities or severe 
infection). Studies have identified few fresh stillbirths due to causes other than asphyxia.
97-99 
The extent of such misclassification biases, or of the misclassification between fresh stillbirths 
and intrapartum-related early neonatal deaths cannot be quantified without further study. 
 
Feasibility: In an institution providing childbirth services recording all intrapartum stillbirths is 
a feasible measure
100 and indeed a basic outcome to include on the labour ward register and to 
compile regularly. In practice, however, there are a number of barriers to feasibility that are 
magnified at community level. One issue for accuracy is that of distinguishing a stillbirth from 
an early neonatal death. According to the definition of stillbirth, if the baby has any sign of life 
(such as a heart beat) at the time of delivery, and then dies even within a few minutes, the death 
should be classified as an early neonatal death.
2 In reality, especially in low resource settings, a 
subtle sign of life may be missed even in hospital settings and an early death may be considered 
as a stillbirth, or socio-cultural factors and possibility of blame may lead to systematic 
misclassification. An important influence on the recognition and counting of stillbirths are the 
multiple taboos that surround the subject, particularly in traditional cultures. The mother may be 
given little if any information by health care workers or traditional birth attendant (TBA), who 
may fear blame. Sometimes the health workers believe that the mother will handle the loss 
better if she is told the baby was already dead at birth. For example, TBAs in Bangladesh report 
that they prefer to tell the mother the baby died inside her in cases of failed resuscitation even if 
the infant showed signs of life at birth (Ellis M, personal communication). The relatives and the 
mother may also deny the occurrence of a stillbirth for fear the admission may evoke spiritual 
forces that will eventuate in a recurrence. Especially where health information is based on 
retrospective surveys of mothers, this could lead to significant under-estimation, although this 
has not been well studied. In addition, those late fetal deaths where the mother was a maternal 
death will be invisible in surveys of surviving women. 
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Recommendation: Efforts must be made to count stillbirths, particularly intrapartum stillbirths.
89 
These deaths constitute the largest burden of mortality due to acute intrapartum events in low 
income countries – an estimated 1.02 (0.66-1.48) million a year.
51 As care during delivery 
improves, historical data have shown that the babies who no longer die as stillbirths may then 
present as early neonatal deaths, before care improves enough for them to survive. If the 
stillbirths are not recorded then programmes will first record a rise in early neonatal deaths and 
miss the reducing stillbirths.
8 Stillbirths should be included in mortality surveys, and verbal 
autopsy tools covering neonatal deaths should include stillbirths, further evaluate causal 
categories and particularly develop strategies to minimise misclassification between intrapartum 
stillbirths and neonatal deaths. 
 
Recognition of one or more simple markers of “poor condition at birth”, such as 
no cry or not breathing. 
Definition: The definition would depend on the chosen characteristic(s). The simplest and most 
frequently used are “not breathing at birth” and “no cry at birth”.  
 
Usefulness: The simplicity of this approach results in a sensitive rather than specific assessment, 
which is appropriate for the decision to resuscitate but less so for epidemiological measurement. 
While there are descriptions of this approach at community level using village health workers 
and TBAs,
101;102 no literature was identified which formally assessed the positive predictive 
value of these simple markers for the need for resuscitation. Certain characteristics, such as no 
cry at birth have been evaluated in validation studies of neonatal verbal autopsy for assigning 
causes of death in the community are summarised in Table 4.5.
52;103;104  
 
Feasibility: These methods are the simplest approach and may be the most likely to work for a 
community health worker (CHW) or TBA. However, this has not been formally assessed. Table 
4.5 summarises the studies that have applied these simple methods of identification. In low 
resource settings, simple methods of recognition of the individual baby requiring resuscitation 
(e.g., not breathing, no cry, floppy) generally are more likely to be effective and result in early 
action than more complex scores. More research is required to assess which clinical markers are 
sensitive and yet feasible to recognise.
102   
 
Recommendation: Simple clinical identification is appropriate for clinical care, although it is 
possible that if every baby who did not cry at birth was resuscitated, significant harm may come 
to some unnecessarily resuscitated, so evaluation is required. These simple indicators alone are 
not helpful for epidemiological definition of cause-of-death, although they have may be useful 
in programmatic action or a place as part of an algorithm in a verbal autopsy tool. Indeed these 
are the only criteria used in some VA studies.   68
Table  4.5 Identification at community level of “birth asphyxia” for the purpose of resuscitation  
 
Method of identification  Place
 
User Number of 
cases 
Usefulness of method
No cry 
 
Rural Gambia 
(Leach A et al 1999) 
104 
Mothers, TBAs, 
nurses, doctors 
1254 neonatal deaths  Good predictor of neonatal death but not specific for 
“birth asphyxia” 
Sensitivity= 36% 
Specificity= 99% PVV =60% 
Assessment based on one or more of: 
-  Delayed/absent cry 
-  Delayed absent breathing 
-  Irregular/shallow breathing 
-  Limp/less active 
-  Blue/pale/white 
Community-based project 
in Haryana State, India 
(Kumar R 1995)
102 
TBAs  53 of 1977 births  Sensitivity/specificity not formally assessed  
 Apparently feasible to apply although has as many 
components as the Apgar score 
Assessment based on one or more of: 
-  Cry  
-  Breathing  
-  Colour 
-  Activity 
-  Reflex response 
-  Cord pulsation 
-  (each scored 0, 1, or 2 by pre-set 
criteria similar to Apgar) 
Validated in a hospital 
setting 
(Ghosh D et al 1997)
105 
Researchers. Score 
validated against 
Apgar and cord 
pH. 
62 newborns with 1 
min Apgar < 6.  
A combination of cry, colour and activity was the best 
predictor of metabolic acidosis 
(r = 0.38, P< 0.1, Correlation coefficient = 0.71) 
 
Complex to apply -  at least as complicated as the 
Apgar scoring and requires skills e.g. to assess cord 
pulsation 
TBA: Traditional birth attendant 
Note: No studies were found which assessed ‘not beathing’ or ‘floppy’ as single identifiers.    69
Apgar score 
Definition: The physical condition of the baby is traditionally recorded as the Apgar score. 
Virginia Apgar, an American anaesthesiologist, described this score in 1953, providing a 
standard record of the condition of the infant at birth, including breathing, heart rate, colour, 
muscle tone and response to insertion of a suction catheter (Table 4.6). Each of these 5 
characteristics is given a score of between 0 and 2 by a trained observer, giving a maximum 
score of 10. In reality the maximum at 1 minute is 9 as virtually all babies will still have blue 
extremities at this point. The score recorded is a total for the baby’s condition at 1 minute and at 
5 minutes, and was intended to improve comparability of condition at birth, and speed the 
commencement of resuscitation when required. In addition, Professor Apgar hoped that the 
score would reduce unnecessary manipulation of the healthy newly born infant.
106;107 The most 
commonly applied categories are as follows: 
•  severe or “white asphyxia” with a 1 minute Apgar of 0-3;  
•  mild/moderate “asphyxia” with a 1 minute Apgar of 4-7; 
•  severe respiratory depression at birth with an Apgar still less than 6 after 5 mins 
 
Table  4.6 The Apgar Score 
 
Characteristic 
 
Score 0 Score 1 Score 3
Heart rate 
 
0 < 100  > 100 
Respiration 
 
No respiration  Gasping or irregular  Regular or clear cry 
Muscle tone  Limp  Reduced tone/normal 
tone but reduced 
movement 
 
Normal with active 
movements 
Response to pharyngeal 
catheter 
 
No response  Grimace  Cough 
Colour of trunk  White or blue  Pink with blue 
extremities 
 
Pink 
Reference: Apgar V 1957
88; 
 
Usefulness: The Apgar score is widely used, and also widely abused, both in terms of inaccurate 
assessment (simply giving a number out of 10 rather than scoring by each characteristic) and in 
terms of over-interpretation of results.
68  There are other causes of a low Apgar score apart from 
acute intrapartum events, including preterm birth and influence of maternal drugs, especially 
opiates and anaesthesia. The score was not designed as a predictor of outcome, and even if 
applied correctly, the correlation with outcome is limited apart from extreme cases such as a 
baby who has a score of zero at birth
108 or a very low score at 20 minutes of life.
109;110 Neither is   70
the 1–minute Apgar score a good predictor of later disability; in one study, only 12% of 99 
children with a 1 minute Apgar <3 developed cerebral palsy.
111  On the other hand, a recent 
assessment of 151,891 births found that a 5-minute Apgar of < 3 in term infants was strongly 
predictive of death (RR 1460, 95% CI 835 - 2555). 
112  The best use of a low 1-minute Apgar 
score (< 3) may be as a screening test for development of early complications, notably NE, with 
a negative predictive value of  99.9%, despite a sensitivity of only 14%.
113  
 
Feasibility: Even with highly trained staff in teaching hospitals, the Apgar score is often scored 
incorrectly. The score is unlikely to be realistic or useful for CHWs. 
 
Recommendation: Apgars may be applicable at peripheral health centre level as a criterion for 
transfer to a higher level of care, where this is feasible. 
105  For example urgent transfer of all 
babies with a one or five minute Apgar of < 3 once they are stable enough for transfer. 
113  
Apgar scoring may well have a role at institutional level as a marker of condition at birth, but 
quality assurance in application of the score is required.
114 Early Apgar scores (<10 mins) do not 
have a high positive predictive value for the later onset of developmental disability. Late Apgar 
scores are useful (20 mins +) but should be augmented with systematic assessment of NE in 
survivors. 
113 
 
 
After birth 
Neonatal encephalopathy (NE) 
Definition: “A clinically defined syndrome of disturbed neurological function in the earliest 
days of life in the term infant, manifested by difficulty initiating and maintaining respiration, 
depression of tone and reflexes, abnormal level of consciousness and often by seizures”, which 
may follow an intrapartum hypoxic insult or be due to another cause.
115  The principle is of an 
“abnormal neurobehavioral state” starting in a term infant within 24 hours of birth. 
91 In the 
1970s, the term Hypoxic Ischaemic Encephalopathy achieved wide usage, referring specifically 
to NE due to perinatal asphyxia although it is frequently used as if Hypoxic Ischaemic 
Encephalopathy were directly equivalent to NE. NE is preferred now, in view of the possibility 
of other causes of NE and the difficulties in establishing definitive causation.
116 NE may have 
several causes, including infection, jaundice and hypoglycaemia, so perinatal hypoxia is not the 
exclusive cause.
117 
 
There are several systems for categorising NE. Three categories of mild, moderate and severe 
were delineated by Sarnat and Sarnat
118 and developed into clinical criteria by Fenichel. 
91 Table 
4.7 outlines a grading system for NE, and adapting from Sarnat,
118 Fenichel,
91 Badawi
119 and 
Ellis.
120 The Apgar score and the clinical scoring systems for NE do not apply to preterm infant   71
as their neurological immaturity affects the scoring so this scoring system assumes exclusion of 
preterm infants although there is no clear consensus if all preterm infants (<37 weeks gestation) 
or very preterm infants (<34 weeks) or some other interim gestational age level should be 
excluded. 
 
To assign the grade, the infant is assessed daily during the first week of life, or until death or 
recovery if this is sooner.  The grade assigned is the highest reached. An alternative approach 
developed in Cape Town by Thompson et al scores the infant according to a set of criteria 
derived from Fenichel.
70 A comparison of the grading and scoring systems suggests both have 
similar predictive qualities and the key aspect is the careful daily examination of infant’s 
neurobehavioural state.
120  
 
Table  4.7 Clinical staging system for neonatal encephalopathy 
 
Clinical finding  Mild
(Stage 1) 
Moderate
(Stage 2) 
Severe
(Stage 3) 
 
Conscious level  Irritable / hyper-alert 
 
Lethargic Comatose 
Tone Mildly  abnormal 
(Hypo- or hyper- tonic) 
 
Moderately abnormal 
(hypotonic or dissociated) 
Severely abnormal 
(hypotonic, flaccid) 
Suck Reduced 
 
Poor Absent 
Seizures 
(EEG) 
Absent 
(normal) 
 
Present 
(periodic or paroxysmal) 
Frequent 
(periodic or 
isoelectric) 
Respiration  Rapid (< 60 /minute) 
 
Occasional apnoeas  Severe apnoea 
Primitive reflexes  Exaggerated 
 
Depressed Absent 
Brainstem reflexes  Normal 
 
Normal Impaired 
Duration  
 
< 24 hours  2 – 14 days  Days to weeks 
Severe adverse 
outcome following 
post-asphyxial  NE 
(%)  
                  
 
0 
(5 studies, 52 cases) 
 
 
24 to 67% 
(6 studies, 118 cases) 
 
94 – 100% 
(5 studies, 72 cases) 
Notes: Primitive reflexes refer to moro and grasp. Brainstem reflexes refer to gag and corneal reflex 
Adapted from Sarnat
118 Fenichel 
91, Badawi
119 and Ellis.
120 
Severe adverse outcome defined as death, cerebral palsy or cognitive impairment 2SD below norm, from 
Pin et al 
121 
 
Usefulness:  There is a wide literature assessing various scores for Hypoxic Ischaemic 
Encephalopathy, and a growing number of studies for NE. A recent review of screened 3152 
publications regarding NE but was only able to included 13 studies in a systematic analysis to 
examine outcomes in term infants with post asphyxial NE. All these studies are from   72
industrialised countries. All the infants with Stage 3 (mild) NE survived intact, whereas 94 to 
100% of neonates with Stage 3 (severe) NE died or were severely impaired.
121 NE is more 
prevalent and more severe in low income than in high income countries.
120;122 There are limited 
data on survival by NE grade for low income countries. While NE scores have been shown to be 
the most accurate predictor of long term outcome, particularly death and disability,
121  they are 
not performed for the first time until later on the first day of life, or on subsequent days, and so 
are not useful to guide initial resuscitation or early management. A new incentive to improve 
early detection of injury is the possibility of instituting therapeutic hypothermia,
123;124 an 
intervention which also has the potential for a for use in low income settings.
125 
 
Feasibility: The advantage of NE scoring is that no technical investigations are required, but a 
degree of skill is necessary that is likely to be found only in hospitals, possibly even only in 
referral hospitals in low income settings. The only literature regarding the use of scoring 
systems for NE in low income countries is from teaching hospitals in Nepal
126 and South 
Africa.
122 While this may be the most accurate method, the current scoring systems are too 
complex for routine use by CHWs. A skilled attendant should be able to apply this score if 
trained to do so, as it is potentially less complex than the partogram (which is considered a norm 
for use by all midwives) and definitely more predictive of outcome than the Apgar score. 
 
Recommendation: More research is required, both for feasibility for accurate scoring, but also re 
usefulness in management decisions. Scores for NE are unlikely to be feasible for use by TBAs 
and CHWs in most settings, and it may also be argued that babies with recognizable NE and 
convulsions should be cared for in an institution, so such a score is not relevant at community 
level. Further research is required to validate simpler NE scoring systems, particularly without 
primitive reflexes. In addition further research is required to incorporate some of the more 
specific symptoms and signs used for NE scoring into VA tools to see if specificity of verbal 
autopsy diagnosis of intrapartum neonatal deaths could be improved.  
 
Additional high technology methods 
There are technological approaches, such as MRI scans, that have been shown to be sensitive in 
detecting early neurological damage.
71;72 However, these are unlikely to be of relevance to most 
neonates in low income countries and will not be covered here. 
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After death in the community 
 
Verbal autopsy 
Definition: A verbal autopsy (VA) is an assessment tool used to assign cause-of-death after the 
event, using information collected from the family, community and, possibly from the health 
care system.
127 VA relies on recognizable clinical features which can if necessary be reported by 
family or lay workers.
128;128 VA tools vary from very simple to long, complex questionnaires. 
Several neonatal cause-of-death VA tools have been developed, mainly since the mid 1990s.  
 
Usefulness: Due to overlapping signs with neonatal tetanus, pneumonia and septicaemia, 
sensitivity and specificity remain only moderately high when compared to hospital diagnosis 
(Table 4.8). To date most VA studies to date have used a non-specific definition for “birth 
asphyxia” such as “not breathing at birth” and very few such studies have added convulsions to 
the case definition or specify the hierarchy used with some recent exceptions published after the 
input data used in this thesis was finalised.
56;99 Recent analytical work comparing varying 
hierarchies, particularly between “birth asphyxia” and preterm birth highlights the potential 
overlap or co-morbidity issues and the large effect on proportionate mortality from changes in 
the hierarchy.
129;130 
 
Feasibility: In many settings where the majority of fetal and neonatal deaths occur at home, this 
approach is the only feasible manner to collect information on cause-of-death. However, the 
assessment is costly and time consuming and is usually restricted to research studies or 
Demographic Surveillance Sites. In addition, some familiarity with the VA tool and with the 
underlying clinical problems of the fetus and neonate is required, although well-trained and 
supervised CHWs may be capable of administering the questionnaire. There are a variety of 
tools in use and under development and there is a need for a standard tool
131;132 with algorithms 
that follow ICD rules to apportion underlying cause-of-death and so are as comparable as 
possible with VR data, given the limitations of both.  
 
Table  4.8 Performance of neonatal verbal autopsy for assigning “birth asphyxia” as a cause-of-
death 
 
Condition Sensitivity
(%) 
Specificity
(%) 
Number of cases 
(hospital reference) 
Country/
reference 
“Birth  asphyxia”  58 78 52  Pakistan 
Marsh et al 
87 69 
(72)
 a 
19 Bangladesh 
Kalter et al 
a Exclusion of neonatal tetanus added to algorithm/hierarchy 
 
   74
After hospital discharge/death 
 
ICD codes for “birth asphyxia” 
Definition: ICD codes for “birth asphyxia” have changed with time, as summarised in table 4.9. 
There are over 5000 codes in detailed ICD10 coding that can be applied to neonatal deaths, and 
139 of relevance to ‘birth asphyxia.’ The tendency has been to add more codes, or more detail to 
existing codes for example using the fourth digit. The last revision was published in 1993 and 
did not reflect as shift towards a syndromic diagnosis – neither HIE nor NE are listed. Indeed 
“birth asphyxia” categorised as severe, mild/moderate or unspecified which is not the approach 
recommended in recent consensus statements. Coding to the intrapartum sentinel event or even 
to maternal risk factors such as pre-eclampsia is also catered for. Birth trauma also has a long 
list of codes, although in reality this is a rarer direct cause-of-death (Chapter 5). 
 
Table  4.9 Changes in ICD codes of relevance for “birth asphyxia” 
 
References: ICD8, ICD-9 and ICD-10 
ICD version  Code 
ICD-8  776 Anoxic and hypoxic conditions not elsewhere classified 
      776.3  Foetal distress 
      776.4  Intra-uterine asphyxia 
776.9  Asphyxia of newborn unspecified 
ICD-9 
(1975) 
768 Intrauterine hypoxia and birth asphyxia 
     768.0   Fetal death from asphyxia/ anoxia before labour or unspecified time 
      768.1  Fetal death from asphyxia or anoxia during labour 
      768.2  Fetal distress before onset of labour, in liveborn infant 
      768.3  Fetal distress first noted during labour, in liveborn infant 
      768.4  Fetal distress unspecified as to time of onset, in liveborn infant 
      768.5  Severe birth asphyxia 
      768.6  Mild or moderate birth asphyxia 
      768.9  Unspecified birth asphyxia in liveborn infant 
ICD-10 
(1993) 
P00.0- P05.0 
     P00.0 – P04.9  Maternal antenatal conditions e.g. pre-eclampsia 
     P05.0 – P05.9  Maternal intrapartum events e.g. obstructed  labour, 
haemorrhage 
P10.0- 15.9 Birth injury 
    P10.0-1.09   Sudurals and other interracial head injuries 
    P11.0 – 159 Specific bone and nerve injuries 
 
P20.0 – 20.9  Intrauterine asphyxia  
      P20.0  Intrauterine hypoxia before the onset of labour 
      P20.1 Intrauterine hypoxia first noted during labour and delivery 
      P20.9 Intrauterine hypoxia unspecified 
 
P21.0- 2.20 Birth asphyxia 
      P21.0   Severe birth asphyxia 
      P21.1   Mild or  moderate birth asphyxia 
      P21.9   Birth asphyxia unspecified 
      P240    Neonatal meconium aspiration syndrome 
 
P90.0 – 91.9 Acquired neonatal cerebral ischemia  
     P91.0   Neonatal cerebral ischaemia 
     P91.9   Neonatal coma unspecified 
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Usefulness: Accuracy of cause-of-death in VR requires an unbroken chain from correct 
diagnosis at death, accurate filing of the death certificate particularly the line regarding 
underlying or main cause-of-death, correct coding of the information, and accurate 
categorization of this detailed cause into a group cause of relevance to programmes. The 
usefulness will depend on consistency and appropriate coding, avoiding the more nebulous 
codes some of which are symptoms an could be considered  “garbage codes”.
133   
 
Feasibility: ICD codes are most feasible in countries with high coverage of VR, currently only 
46 countries, covering less than 3% of neonatal deaths. Even in transitional countries with 
higher rates of VR, perinatal death certificates around the year 2000 were more likely to be 
coded using ICD-9 than ICD-10 although a number of large countries have recently increased 
coverage and transited to ICD 10 – e.g. Brazil. To increase use of ICD-10 in lower resource 
settings, a simplified short list of ICD codes is required for use in hospitals. VA diagnosis can 
then use the same ICD codes. A large scale project in Tanzania used 3-digit ICD-10 cause of 
neonatal death  codes for verbal autopsy coding using a computer algorithm
134 
59 
 
Recommendation:  Although ICD-10 is looked to as the highest standard for classification of 
cause-of death, the intrapartum-related codes do not reflect global consensus statements over the 
last decade. “Birth asphyxia” is the major coding option offered and symptom based and 
maternal risk factors can also be coded. Revisions for ICD 11 could take the opportunity to 
reduce or clarify these nebulous codes and update the terminology to reflect shifts in 
epidemiological case definitions, notably NE.   
 
 
Post-mortem 
Definition: A post-mortem examination involves assessment and dissection of the body of the 
fetus/baby after death, and includes expert histopathological examinations, often with 
microbiological and metabolic investigations.  
 
Usefulness: This method is considered the definitive approach to assigning cause-of-
death.
96;135;136 However, even with the highest skills and investigations available, around 10 – 
30% of stillbirths and 10% of neonatal deaths may remain of undetermined cause even in high 
quality data such as the UK CEMACH reports.
98;137  
 
Feasibility: Even in high-income settings, many babies do not undergo post-mortem 
examination because of the sensitivity of the issue for parents. Indeed, in the UK neonatal 
postmorterm rates are falling.
138 In some cultures, particularly of Islamic faith, postmortem 
examinations are prohibited. In addition, expert perinatal pathologists are uncommon, and the 
procedure is expensive.   76
4.4 Summary and case definition for intrapartum-related 
neonatal deaths used in this thesis  
 
The second objective of the thesis was to propose a minimum list of programmatically relevant 
causal categories which are comparable in vital registration and other data sources, and examine 
in more detail the case definitions and measurement options for birth asphyxia related 
outcomes. Six programmatic categories of neonatal cause-of-death have been defined, plus a 
residual “other neonatal” category which will be used for multi-cause analysis for the remainder 
of the thesis. These are a minimum list of causal categories but more detailed cause-of-death 
information can be mapped onto these seven groups – for example dividing the “other neonatal” 
category to specify neonatal jaundice or haemorrhagic disease of the newborn as causes of 
death. 
 
The selection of a focus on “birth asphyxia” in the thesis is deliberate since this issue is of 
public health relevance, yet major shifts in terminology and case definitions in high income 
countries have not been reflected in the language and case definitions used in many low income 
countries or indeed by UN and GBD.  Previous estimates refer to the more nebulous condition 
of “birth asphyxia” usually referring to “not breathing at birth” which has multiple causes, 
including preterm birth, though historically the term “birth asphyxia” implies a causal link with 
intrapartum hypoxia. Epidemiological measurement of intrapartum injury has moved from 
process-based (e.g., long labour) and symptom-based (e.g., Apgar score) definitions to multiple 
indicator outcomes particularly NE which is a good predictor of outcome.
91;118 If preterm babies 
or those with congenital malformations continue to be misclassified into the intrapartum-related 
category, programmatic solutions may be misinformed as different interventions are required to 
prevent deaths due to these other causes. More specific diagnosis has also been driven by 
litigation issues in high income countries. However some aspects of measurement specified in 
increasingly complex consensus statements
68-70 such as blood gas analysis are unlikely to be 
possible even in most hospitals in low income countries, let alone for the world’s 50 million 
home births a year. Simpler surrogate definitions are required and to test in verbal autopsy tools 
(Chapter 8). These simpler definitions may also be valuable for population-level programme 
tracking even in high income countries. 
 
The case definition used in this thesis for intrapartum-related neonatal deaths is as follows:  
Intrapartum-related neonatal deaths, including neonatal deaths with NE or term neonates 
who cannot be resuscitated (or for whom resuscitation is not available) or specific birth 
trauma. Where possible other causes should be excluded such as lethal congenital 
malformations and preterm birth complications (less than 34 completed weeks’ gestation or 
birthweight <2000 g).  77
  
 
 
 
Chapter 5                                                             
Cause of neonatal death data: quantity and quality                           
(Objective 3)                                                                 
 
 
 
 
Objective 3:  
Undertake a systematic assessment of the coverage and quality of data 
for neonatal cause-of-death through vital registration systems  
and in published and unpublished literature in all countries. 
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5.1  Sources and data for neonatal mortality rate and numbers 
of neonatal deaths  
 
5.1.1 Overview 
Timely data on births and deaths is a cornerstone for rational planning in the health sector and 
beyond. Yet “most people in Africa and Asia are born and die without leaving a trace in any 
legal record or official statistic” – a so-called “scandal of invisibility”.
6 Data for counting 
neonatal deaths, and the necessary denominator of live births are available from a variety of 
sources predominantly from VR or household surveys (Table 5.1). For a smaller group of 
countries (33) accounting for about 5% of births, there are no nationally representative data on 
neonatal deaths. These are mainly conflict or post-conflict settings, or small nations such as 
Pacific islands. For these countries, under five mortality is estimated annually by the United 
Nations Child Mortality Group
11 and, intermittently, WHO has used these estimates to predict 
neonatal mortality rates.
3,12 The uncertainty around these may be considerable although formal 
uncertainty bounds around estimates of child or neonatal mortality are not usually provided. 
While it is not been customary to present detailed descriptions of inputs, methods and 
uncertainty estimates, these are becoming the norm to which global health estimates aspire.
13,14 
 
Table  5.1 Sources of data for numbers and rates of neonatal deaths around the year 2005 
 
  Countries Percent of 
world’s births
Vital registration  
 
81 27% 
Population-based survey  
        since 2003 
        before 2003 
 
 
41 
48 
 
39% 
29% 
No available data (estimates based on 
regression on under five mortality) 
 
33 5% 
Nationally representative sample 
surveillance sites 
 
2 
(India and China in process) 
- 
Demographic surveillance sites 
E.g. INDEPTH network in Africa 
 
Subnational  and currently not 
suitable for national estimates   
- 
Data from: 
4;10 
For details on Demographic surveillance sites and INDEPTH network please see Definitions section, page 16 
 
5.1.2. Vital registration (VR) data for neonatal mortality 
There have been recent improvements in VR coverage and quality in some transitional countries 
and 81 countries now have high coverage VR systems, although these countries only account 
for 27% of the world’s births (Table 5.1). In high income countries VR data are taken for 
granted, but in most low income countries and even many transitional countries the coverage 
and quality of VR data makes it unreliable for population-based data. Even in transitional   79
societies, early neonatal deaths are often under-registered and stillbirths rarely registered.
139 
Functional VR systems provide countries with data on numbers of births and deaths, reasonably 
quickly: the time lag is usually one or two years.
10 In addition, timeliness or availability may 
further reduce usefulness for decision makers.
133  
 
Stillbirths are important to record, for programmatic reasons but also as part of effective 
tracking of pregnancy outcomes. In countries where VR is the source for stillbirth data, there is 
marked variation in stillbirth definitions. National definitions reflect various combinations of 
gestational age, weight and documentation regarding signs of life. For example, gestational age 
cut-offs range from 12 to 28 weeks, and weight cut-offs are as low as 400 g. In a survey on 
stillbirths sent to vital registration offices, responses from 25 developed countries and 5 middle-
income countries showed 17 different definitions of stillbirth.
8 
 
5.1.3. Household survey data for neonatal mortality 
Without household surveys we would have little information globally for child or neonatal 
mortality, or for coverage of priority interventions. There are two major systems for such 
surveys: Demographic and Health Surveys (DHS), funded largely by USA government aid but 
usually in partnership with national statistics offices; and Multiple Indicator Cluster Surveys 
(MICS), run by UNICEF. Such surveys use a questionnaire to ask women about previous births, 
child deaths and coverage of care. They tend to be repeated every five years. DHS report under-
five mortality, neonatal mortality and stillbirth rates for over 80 countries which account for 
two-thirds of the world’s births. However, only approximately 50 countries have data within the 
last five years. The data and results are open access (www.measure.dhs.com). MICS report 
under-five mortality and coverage of interventions in many of the same countries, but do not 
routinely analyse or report on stillbirths or neonatal deaths. Indeed MICS do not directly 
measure under-five deaths through a birth history, but use indirect methods. Summary results 
are available (www.childinfo.org), but not the datasets. Availability of neonatal mortality data 
would be increased if this outcome was estimated from MICS survey results, also giving 
uncertainty bounds as MICS are not usually powered for neonatal mortality estimation. The 
Malawi MICS did increase sample size specifically to estimate the national NMR. 
 
The importance of surveys as data sources makes recognition of their limitations essential. One 
limitation is their frequency. The expense and challenge of data collection and analysis in low 
resource settings - using a survey tool with over 700 questions in the case of DHS - means that 
in most countries they are only conducted every five years. Their ability to detect rapid changes 
in mortality or to disentangle contributory factors is therefore limited.
140 With increasing 
investment in maternal, newborn and child health there is a desire on the part of governments 
and donors for data to detect short-term trends, particularly in the years up to 2015, the target   80
for the MDGs. To change from a five year birth retrospective to a one year retrospective would 
require huge increases in sample size. For example, in Nigeria it would mean a five-fold 
expansion from the sample of 7,225 households that already constitutes a major feat of 
organisation. 
 
Surveys have particular limitations with respect to neonatal deaths and stillbirths, of which the 
most important is the potential for under-ascertainment of deaths compared with prospective 
surveillance. There are limited systematic analyses of the extent of this problem, but one study 
from rural India suggests that under-reporting, especially in traditional societies, may halve the 
numbers of deaths captured.
16 Ghana’s Kintampo study took advantage of intensive monthly 
household surveillance established for a trial of vitamin A supplementation during pregnancy to 
obtain high quality data in a country where vital registration remains low, although in this 
particular population over half of the births were in facilities.
141 There are no retrospective 
survey data with which to compare the findings, although interestingly the NMR of 32 per 1000 
in this study site is lower than the Ghana national NMR of 43 reported by the DHS.  
 
Misclassification between stillbirths and early neonatal deaths is another important issue, and 
was one of the arguments in favour of a combined measure of perinatal mortality, although 
expert opinion now favours separate reporting of stillbirths and neonatal deaths.
17 Most DHS 
surveys use birth histories and so the stillbirth data may rely on other sections of the 
questionnaire such as analysis of contraceptive calendar data, which results in much wider 
uncertainty and in many surveys the reported stillbirth rates are around half the expected value 
when compared with prospective surveillance in the same countries.
8 The use of pregnancy 
history in all DHS would be a major step forward in increasing the quantity and quality of 
stillbirth rate data, and this might also reduce under-ascertainment of early neonatal deaths 
although there is a dearth of systematic comparison of birth history and pregnancy history data.
8 
Other issues of data quality in DHS include age-heaping on certain days, notably days 7, 14 and 
30, and miscoding between day zero and day one.
4  More systematic analytical work is required 
to develop objective scores of survey data quality for example a composite of a age heaping 
index and a measure of stillbirth/neonatal death misclassification. Such an analysis could 
provide a basis for adjusting estimates to correct for biases in survey data.  
 
There are a number of epidemiological and programmatic arguments for the measurement of 
stillbirths, and for routinely collecting stillbirth data in household surveys.  Firstly, counting all 
births – dead or alive – increases the likelihood of correctly recording stillbirths, neonatal deaths 
and improving the denominator of all births. Babies who die very soon after birth are less likely 
to be registered than babies dying after a few days of life, and stillbirths are even less likely to 
be recorded than live births who then die.
139;142 Promoting the measurement of all birth   81
outcomes - live births, stillbirths, and early neonatal deaths is likely to capture events that might 
otherwise go unreported. If both stillbirths and early neonatal deaths are counted, then early 
neonatal deaths misclassified as stillbirths are at least recorded, even if misclassified. Live 
babies may be misclassified as stillbirths and vice versa for a number of reasons: lack of 
knowledge; lack of careful assessment for signs of life; less blame or review for the birth 
attendant or reasons of perceived gain or loss to the family.  For example, the registration of a 
live birth may encumber the family with funeral arrangements and costs, whereas a stillbirth 
usually does not require burial.  On the other hand the mother may be entitled to social benefits 
only with a live birth.    
 
Secondly, not counting stillbirths better will underestimate programme impact, and possibly 
mislead programmatic decision making since when intrapartum care improves historical data 
suggest that stillbirth rates may be reduced first, and early neonatal deaths may rise.
143;144  
 
Finally, stillbirths are important to prevent in their own right. The death of a baby during the last 
trimester is a source of pain to mothers and to fathers, and indeed is reported to be associated 
with grief reactions more protracted than for early neonatal deaths, partly because of the social 
taboos associated with open grieving for a stillbirth.
145;146 
 
To improve the quantity and quality of data the solution is clearly to improve routine 
registration systems to achieve high coverage of vital statistics including births, stillbirths, and 
deaths for mothers or children.
15 DSS are another valuable source of data on trends, especially if 
they are selected to be nationally representative. Such sample registration systems are being 
tried in China and India, with the support of the Health Metrics Network and similar initiatives. 
In other countries, demographic surveillance sites which are not nationally representative may 
nevertheless provide useful data on mortality trends.
57 For example the INDEPTH network has 
multiple DSS mainly in Africa (http://www.indepth-network.org/. See Definitions section, page 
16 for more details on INDEPTH).  In the interim, household surveys could include pregnancy 
history modules instead of birth modules, increasing capture of early neonatal deaths and 
allowing measurement of stillbirths. There is a move to increase the frequency of UNICEF’s 
MICS, using fewer questions and focusing on coverage of selected interventions, to provide 
more responsive data on programme if not on mortality outcomes.   82
5.2  Sources of neonatal cause-of-death data 
 
5.2.1 Overview 
The objective of this chapter, and the third objective of the thesis, was to identify, screen for 
inclusion and analyse all available data which may include the selected neonatal cause-of-death 
categories as described in Chapter 4 (Table 4.1). There are two major sources for such data: 
vital registration (VR) data and published and unpublished reports of research studies (study 
data) many of which rely on verbal autopsy. A number of large countries without full coverage 
VR data (notably China and India) are in the process of setting up large-scale sample 
registration sites. However neonatal cause-of-death data are not yet available from these 
surveillance systems. For both data sources a two-step screening process was applied (Table 
5.2). The first filter was to exclude data that was not considered to be population-based and the 
second filter was to maximise data quality and comparability of cause-of-death attribution. The 
process for the VR data will be described first and then the details of the study data searches and 
screening. 
 
Table  5.2 Systematic search strategy and inclusion criteria filters applied to screen the data 
identified 
 
Filter  Vital 
Registration 
Study Data 
Search 
strategy 
 
All data in WHO 
mortality database 
as of January 2004 
(in the case of the 
asphyxia single 
cause estimates, 
VR data up until 
May 2004 were 
available) 
 
Searches in multiple databases as follows: 
PubMed, Popline, LILACS, WHO regional databases (Emro, 
African Index Medicus, PAHO), 
 
Search terms: 
All cause mortality (neonatal mortality, perinatal mortality) 
Cause-specific terms covering multiple terms for each of the 7 
selected groups of cause of neonatal death. For example tetanus, 
neonatal tetanus, tetanus neonatorum. 
 
Search limits: 
Publication after 1980 
Human 
 
Filter 1: 
Population-
based 
Countries with 
high (>90%) 
coverage of VR of 
adult deaths 
 
 
Study set in one of 9 (of a total of 14) subregions with no or few 
countries with >90% VR coverage 
  
Community-based study or hospital based in populations with 
over 90% hospital delivery and defined catchment population. 
 
Case ascertainment: follow up of newly born infants from birth 
to at least 7 or 28 days 
 
Filter 2: 
Comparable 
cause-of-
death 
attribution 
Countries with 
detailed ICD data 
for ICD9 or ICD10 
within the last 5 
years, and averaged 
for 3 years if < 500 
neonatal deaths per 
year 
Studies with all of the following: 
–  Study duration ≥ 12 months,  
–  Number of deaths with known cause >20,  
–  Included 4 or more of the 6 selected programme relevant 
causes of neonatal death (preterm, intrapartum-related, 
infections, tetanus, congenital, diarrhoea, other),  
–  <25% deaths of unknown cause, cause attribution based on 
skilled clinical investigation, post mortem or verbal autopsy,  
–  Case definitions specified and comparable    83
5.2.2 Vital registration data screening and analysis 
The World Health Organization (WHO) supplied a database of VR data since 1990 covering 83 
countries with two different ICD coding systems (ICD9 and ICD10)
15. Data were screened 
using the inclusion criteria (Table 5.2). WHO consider VR to be a reliable source of population-
based data when 90% of adult deaths are captured.
133 However, even at 90% coverage, one tenth 
of adult deaths are missed and systematic bias in cause-of-death is probable since the 
unregistered deaths are more likely to be among the poorest families who experience different 
health risks from the richest families. Child death registration is lower than that for adults and 
neonatal is lower still.  
 
For countries with more than 500 neonatal deaths a year, the data from the closest year to the 
year 2000 were analysed. If the annual number of neonatal deaths in the country was less than 
500, in order to minimise chance variability in proportionate mortality the three years closest to 
the year 2000 were used. 
 
There are a large range of detailed codes in ICD 9 and 10 that can be applied to neonatal deaths, 
therefore new analysis was required to allocate these multiple codes to the seven selected cause-
of death categories, being as comparable as possible to the study data. The majority of the ICD 
codes used in the neonatal period were from the Perinatal causes (approximately 60% of the 
deaths), and Congenital chapters but codes from almost every chapter of ICD are also used 
including infections, trauma and most of the systems chapters (e.g., cardiac, renal). Excel 
spreadsheets (Microsoft XP, 2000) and Stata version 8 programmes (Stata Corporation, College 
Station, Texas, USA) were written to categorise the > 5,000 possible codes in ICD10 into the 
seven neonatal cause-of-death categories selected. The initial analysis was undertaken with ICD 
10 datasets and several cycles of analysis and rewriting of codes were required as many 
unexpected codes were used for deaths in the neonatal period. Some of the codes are those 
considered “garbage codes” by ICD experts – for example symptom based codes such as heart 
failure. WHO has a process to either allocate these codes to a “garbage code” category (assume 
they can be redistributed equally over all causes of death), or else to review the codes and 
reallocate to a specific cause which is considered the most likely cause related to that 
symptom.
133  Once the ICD 10 analysis was finalised and able to account for all codes used for 
deaths in the neonatal period for countries with ICD 10 data, then an ICD9- to-10 translation 
guide was used to generate the equivalent ICD 9 codes to maximise consistency between the 
two classification systems for the analysis. An analysis of countries with ICD 9 and ICD 10 data 
within a few years of each other was undertaken to examine any big changes in proportionate 
mortality that may be due to coding errors, but there was remarkable consistency in the 
proportionate mortality between the ICD 9 and ICD 10 analysis in these countries. In addition 
the proportionate mortality output from these new analysis were compared to national high-  84
quality audit data (e.g. Confidential Enquiries into Maternal and Child Health (CEMACH) in 
the United Kingdom) and found to be very similar (Table 7.5c).  The ICD code categorisation 
used for this new analysis is now the standard grouping used by WHO and the GBD. 
5.2.3. Study data screening and abstraction 
Systematic searches of the published literature were carried out in all the major electronic 
databases in addition to the WHO regional databases (Table 5.2). These are the databases 
considered essential by WHO for systematic searches on international health. A very wide range 
of search terms were used based on mesh terms in PubMed and then adapted for use in other 
databases. Searches were undertaken in all languages and extensive attempts made to identify 
non-English language publications by searching in regional databases and writing to neonatal 
experts and WHO Collaborating centres especially in China. In addition international neonatal 
researchers were contacted to request access to unpublished datasets of relevance.  
 
Initial screening was undertaken on abstracts and titles. Then full text versions of possible 
relevance were located and screened. Any studies that met the criteria as population-based, were 
abstracted and then evaluated for the quality criteria set (Table 5.2, filter 2). These quality 
criteria were based on adaptation by the CHERG neonatal group of criteria set by the other 
CHERG groups and then some specific criteria for this multi-cause analysis. For example other 
CHERG groups, especially those dealing with malaria, pneumonia and diarrhoea, were 
concerned about seasonality. For neonatal cause-of-death, seasonality is not thought to be a 
major factor for most causes of death, with the exception of diarrhoea which is a very small 
proportionate cause. However there is annual variation in the birth cohort in many cultures (for 
example a peak in birth 9 months after major holiday seasons) and therefore to be conservative 
study duration of at least 12 months was sought. Other quality criteria applied were specific to 
the neonatal multi-cause of death work and necessary as minimum standards for the consistency 
and comparability of the data including the following: 
–  Number of deaths with known cause more than 20,  
–  Included 4 or more of the 6 selected programme relevant causes of neonatal death (preterm, 
intrapartum-related, infections, tetanus, congenital, diarrhoea, other),  
–  <25% deaths of unknown cause, cause attribution based on skilled clinical investigation, post 
mortem or verbal autopsy,  
–  Case definitions specified and comparable 
 
The possible studies were abstracted by two independent abstractors using a standard form 
(Appendix C) and entered into an Excel database. Abstractors who were students at London 
School of Hygiene and Tropical Medicine assisted with the abstraction of the 112 identified 
studies meeting criteria as population based. An abstraction guide was developed and both 
abstractors were trained and closely supervised by the investigator. The abstractors worked   85
independently and then met to review dually abstracted studies and resolve any differences. Any 
unresolved differences or key questions were brought to the supervisor. Some differences were 
simple to resolve – for example those found to be related to errors in re-calculating proportions 
when combining non standard causes reported to the standard causes desired. Other differences 
related to different interpretations of case definitions or hierarchies but agreement was possible 
after discussion. If agreement had not been reached the investigator would have taken the final 
decision.  
 
All the unpublished datasets were analysed and abstracted by the investigator and one of the two 
abstractors.  The abstraction form is shown in Appendix C. Translation from six languages was 
required for abstraction and data entry (French, Spanish, Portuguese, Polish, Bahasi Indonesian 
and Chinese) and students at the London School of Hygiene of Tropical Medicine (LSHTM) 
who spoke these languages were recruited using the LSHTM student listserve. Each translator 
was briefed by the investigator and then linked to one of the abstractors to transcribe the 
necessary information, which was then double checked by the supervisor (JL). Deaths were 
allocated among the standard seven cause-of-death categories using the author’s cause-of-death 
attribution. If authors gave more than one cause-of-death per neonate then a fixed hierarchy was 
applied, following ICD rules where possible (Table 4.1). For example, a death in a neonate with 
a neural tube defect and infection was classified as due to congenital abnormality.  
 
Fifty five principal investigators were contacted to obtain additional information on causes of 
death and local explanatory variables. Initial contacts were by email or by fax by the 
investigator working alongside a research assistant. A 59% response rate was achieved, 
although in some cases this necessitated four letters. For a few of the authors phone calls or 
meetings were required to further discuss the data and in all these cases such personal follow up 
was undertaken by the investigator. In three cases the databases were re-analysed by the 
CHERG neonatal investigators to increase consistency of causal attribution, or to combine non-
standard categories. For example neonatal tetanus may not be recorded in the paper and further 
information from the investigators was sought to clarify if the omission reflected zero tetanus 
cases or if no attempt had been made to attribute deaths to tetanus as a specific category.  Some 
studies included unclear or non-standard causes. For example, if a neonatal death was attributed 
to “feeding difficulties” the authors were asked to supply additional information regarding the 
death to allow allocation to a standard category. Deaths from unknown causes were excluded 
from subsequent analysis, but if more than 25% of deaths were unknown the study was 
excluded (Table 5.2). The abstraction form included data for a range of variables which might 
explain the proportional distribution of causes in a study and in many cases this was poorly 
recorded in the original publications, but additional data was supplied by authors. This predictor 
information and its uses will be discussed in more detail in Chapter 6.    86
5.3 Quantity of neonatal cause-of-death data after screening 
and analysis 
 
5.3.1 Vital registration data inputs 
A total of 45 countries had VR data which met the initial inclusion criteria (Figure 5.1). A 
further 3 countries (small Caribbean islands) were available for input for the single cause 
asphyxia estimates as data could be used from ICD summary tables but detailed codes were not 
available for the multiple cause of death analysis for these island states.
51 An almost equal 
number of countries were excluded based on their VR coverage (18 countries) and lack of 
useable ICD data for analysis (19).  Several large countries such as Brazil were excluded on the 
basis of VR coverage, but their coverage was close to 90%. Mauritius was excluded from the 
multi-cause estimation input dataset as it was the only African country with high coverage VR 
data and Mauritius is not representative of other African countries given that the NMR is 12 per 
1000 live births compared to a regional average of 44 (table 1).
4 Hence for Mauritius the VR 
data was used as reported for neonatal cause-of-death proportions for their national estimates 
based on the novel analysis undertaken as for the other 44 high coverage countries but was not 
an input of the VR based model. 
 
Thus, the VR dataset comprised 96,797 deaths from 44 countries which together account for 
about 2% of the estimated global total of neonatal deaths. NMRs ranged from 2 to 18 per 1000 
live births. The annual number of deaths per country ranged from 12 (Iceland) to 23 603 
(Mexico).  
Figure ６ 5.1  Identification of data, and inclusion criteria applied for vital registration data 
 
 
Vital registration (VR) data
Countries with VR data in 
WHO database in May 2004
[total = 83]
Filter 2
Countries with detailed ICD 
9 and/or ICD 10 codes for 
cause of death for analysis
[total = 45]
Mauritius excluded as only 
country in African region 
with full coverage VR
VR dataset for multi-cause modelling input 
[44 countries, N= 96,797]
National level covariates 
(year 2000)
[14 variables]
Filter 1
Countries with full VR coverage (>90%)
[total = 65]
3 Caribbean states included 
only for births asphyxia 
single cause estimates
VR dataset for single-cause modelling input 
[48 countries, N= 97,297]
National level covariates 
(year 2000)
[14 variables]  87
5.3.2 Study data inputs 
After applying inclusion criteria, 48 studies and 8 unpublished databases were identified 
reporting a total of 13,685 deaths with known cause (Figure 6.2 and supplementary table B.2 in 
appendix D).
25;58;59;86;104;147-195 The number of deaths per study with known cause ranged from 21 to 
3638 (median = 102.5). NMRs ranged from 8 to 89 per 1000 live births. Any facility-based 
studies from populations where less than 90% of the births were in a facility were excluded as 
not being population based, and this was the most common reason for exclusion. Although 286 
studies met criteria to be considered population-based 240 were excluded on the basis of the 
quality criteria such as less than 20 neonatal deaths, or data collection for less than one year 
(Table 5.2). The proportion of deaths with unknown cause ranged from 0 to 23%, with a median 
of 2%. The multi-cause approach further restricts the already limited input data since at least 5 
of the 7 comparable causal categories have to be reported for a dataset to be included. 
Communication with authors was important in increasing the number of studies with data for 5 
or more of the 7 causal categories particularly neonatal tetanus and diarrhoea. Even after 
communication with authors, 19 studies lacked data on one of our selected causes of death nd 
two studies lacked information on two causes.  
 
Figure ７5.2   Identification of data, and inclusion criteria applied for study based data 
* Additional unpublished datasets were available for inclusion in the multi-cause modelling but were not available at 
the time of the single cause modelling  
 
 
 
 
Unpublished 
datasets
[total = 8] *
Study-based dataset for  all cause modelling input
[56 studies, N= 13,685] *
Filter 2
Inclusion criteria for comparable cause –of-death
Filter 1
Inclusion criteria as population-based
[total = 112]
After screening of 
abstracts and papers
[total = 286]
Total search results
[total = 6820]
Additional searches 
in specialized, 
regional and foreign 
language databases
[total = 16] 
Local level covariates 
close to year of study
[25 variables]
Communication with study 
investigators to increase 
consistency of cause inputs 
and availability of local 
covariate data
Study based data
Systematic searches in multiple databases 
(Pubmed, Popilne, WHO AFRO, EMRO and LILACS etc)
All cause and multiple cause specific terms
Limits – publications after 1980, human, all languages
Study-based dataset for single cause modelling input 
[46 studies, N= 12,355] *
Unpublished 
datasets
[total = 1} *
Local level covariates 
close to year of study
[25 variables] 
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entered into databases applying similar inclusion and exclusion criteria. A joint analysis 
revealed a major lack of useable data for all causes of child death. - a total of around 17,000 
documents were screened including the 6820 from the neonatal exercise, yet only 232 useable 
datasets were identified.
196 Only two groups identified any data at all from China.  No useable 
information was identified in nine of the 25 countries with the highest numbers of deaths in 
children younger than five years. 
46 
 
 
5.3.4 Age of the data and time trends in publication of neonatal cause-of-death 
data 
 
For the VR data the median year of data included was 1999, close to the target of the year 2000. 
However the study data were considerably older - the median year of data collection was 1991. 
The average time lag between data collection and publication was four years, although this 
tended to be shorter at the end of the 1990s compared to the early 1990s. The time lag was 
longer in South Asia – a median of five years and a range up to nine years. 
 
Although there is general dearth of data there have been changes over time in the number of 
studies undertaken and published, and this is more marked for some causes of child death than 
for others (Figure 5.4).  
 
Figure ９5.4   Time trends in the availability of useable data for cause-of-death amongst children 
under the age of five for major causes of child death (1982 – 1997, 2000 for neonatal) 
 
Source: Data from 
18,46 
 
There was no obvious trend for malaria visible up to the year 2000, although with recent major 
investment in malaria this may have since increased. For pneumonia and diarrhoea there was a 
marked peak in studies around the year 1990, with over 20 studies in that year for diarrhoea 
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mortality incidence. 1990 was the year of the World Summit for Children and marked major 
interest in child survival, particularly diarrhoea and management of pneumonia (previously 
referred to as acute respiratory infection or ARI). However, by the end of the 1990s, the number 
of studies per year had dropped to almost zero. Studies on neonatal cause-of-death were few, 
with a median of five per year until the late 1990s when a gradual increase in studies was 
observed. In fact this cross–group analysis within CHERG did not include several of the 
unpublished datasets identified for neonatal cause-of-death data and hence the increase in 
information availability for neonatal is even more pronounced than the graph suggests. 
However, to keep this in perspective, even at a peak of 12 information units per year, and even 
assuming the geographic distribution addressed the gap areas, this is a ratio of one information 
unit per one third of a million neonatal deaths. Hence it is clear that relying on intermittent 
studies is unlikely to ever be an adequate source of information and more systematic building of 
information systems is required.  
 
Within the neonatal datasets, there is regional variation in time trends for data collection (figure 
5.5). During the 1980s and 1990s there were remarkably few studies identified which met the 
inclusion criteria, but there appears to be a slight upward trend in the numbers of publications, 
particularly in Africa. South East Asia was the only region with significant input data in the 
1980s. This reflects a number of community-based studies in India and a few in Sri Lanka and 
Thailand, several of which were part of a WHO initiative to improve community-based 
surveillance for maternal and neonatal health, related to risk screening.
186 India also has strong 
national champions for newborn health linked to the Indian Neonatal Forum which was founded 
in 1980, promoting improved neonatal surveillance both in facilities and the community.  The 
higher number of publications out of the South and South East Asian regions has been sustained 
across the 25 year period examined, but should be interpreted in the light of the fact that this 
region accounts for one third of the world’s neonatal deaths. This results in an average of one 
study per year, in most cases reporting very small numbers of deaths, which is inadequate to 
provide information regarding around 4 million neonatal deaths a year.  
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Figure １０5.5 Regional time trends in the date of publication/release of datasets for 
neonatal cause-of-death meeting the inclusion criteria (56 studies, N = 13,685) (1980 2005) 
 
 
 
 
Source: Data from 
18,46 
 
In Latin America and the Eastern Mediterranean region there is a possible but not very 
convincing trend to increasing publications. The two studies identified from China do not allow 
trend assessment. Africa is the only region with a strong upward trend in the availability of 
useable neonatal cause-of-death data. This trend is strongly influenced by four study datasets 
from sample registration sites – three from different regions in Tanzania and one from The 
Gambia. Sample registration may be a promising model to increase useful information for 
maternal, neonatal and child health in low resource settings. Sample registration sites with 
verbal autopsy questionnaires are being piloted in India, and a neonatal verbal autopsy has 
recently been introduced in these sites. Sample registration as a strategy to increase data 
availability will be further discussed in Chapter 8. 
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5.4   Quality of available data for multi-cause analysis 
 
5.4.1 Variation of neonatal proportionate cause-of -death in the Vital Registration 
input data  
In the VR data only five of the selected seven causal groups could be assessed since there were 
no reported neonatal tetanus deaths in these countries and very few neonatal deaths due to 
diarrhoea (290 or 0.3%). The few diarrhoea deaths were allocated to the sepsis/pneumonia 
(infection) category.  
 
In both the VR and the study data there was substantial variation in the distribution of the 
different causes of death across the country (Figure 5.6a) or study inputs (Figure 5.6b). Overall 
the variability in proportionate mortality observed in the VR data was less than that in the study 
data. This may be real as in the VR countries the NMR range is only up to 15 per 1000 and 
indeed in most cases is less than 6 per 1000, yet in the study data the NMR ranges up to 81 per 
1000.  
 
In the VR input data the widest range in proportionate mortality was seen for preterm birth and 
congenital anomalies. Part of this may be real, reflecting differing case fatality rates as some 
countries with high VR coverage still have restricted access to intensive neonatal care, or 
variable quality of care. In addition differences in policies and practices for termination of 
pregnancy for fetal abnormality may have a real effect on incidence of congenital abnormalities.  
 
On the other hand, some of this variation may be an artefact, reflecting an increased ability to 
detect certain congenital conditions, notably cardiac malformations, or due to variation in case 
definitions and hierarchical cause-of-death. Variable application of the ICD guidelines 
regarding preterm birth as an underlying cause-of-death may affect the very wide range around 
the proportion of deaths attributed to complications of preterm birth (Figure 5.6a). It may also 
be that the use of detailed 4-digit codes allows more specific diagnosis; for example, there are 
multiple specific complications of preterm birth defined rather than a single category of 
prematurity. 
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5.4.1 Variation of neonatal proportionate cause-of-death in the study based input 
data 
 
The number of deaths with known cause per study ranged from 21 to 3638 (median = 102.5). 
NMR ranged from 8 to 89 per 1000 live births. In the study input data, the proportion of deaths 
with unknown cause ranged from 0 to 23%, with a median of 2%. Communication with authors 
was important in increasing information regarding cause-of-death, yet despite this 19 studies 
lacked data on one of our selected causes of death (11 diarrhoea, 4 congenital abnormalities, 3 
tetanus, 1 preterm). Two studies lacked information on two causes (congenital abnormalities 
and tetanus; congenital abnormalities and diarrhoea). Asphyxia was recorded in all the studies 
and therefore chosen as the corner cause for the multi-cause modelling.  
 
There were a number of outliers particularly for the proportion of deaths due to tetanus and to 
congenital abnormalities (Figure 5.6b). Some of the variation in proportionate mortality by 
cause shown in the input data is likely to be due to true epidemiological variation. For example, 
all the results showing a high proportion of deaths due to tetanus came from study sites with 
weak health care systems and extremely low tetanus toxoid coverage among pregnant women 
(less than 5% in many cases) and low use of skilled attendants, for example North West Frontier 
Province in Pakistan. Many of the studies with high proportions of neonatal deaths due to 
congenital abnormalities were from populations with a high prevalence of consanguinity, 
notably in Middle Eastern countries.
197  
 
However, the small size of some of the datasets and inconsistencies in the attribution of cause-
of-death may also play an important role.  Variation in proportionate mortality by cause in the 
study input data was notable in the preterm and infection categories and this may reflect a lack 
of consistency between studies in the case definitions and hierarchical cause, rather than true 
variation in cause-of-death (Figure 5.6b).  
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Figure １１ 5.6 Box plots showing the proportional distribution of causes of neonatal 
mortality for data meeting inclusion criteria 
 
Figure 5.6a  Vital Registration data (44 countries, N = 96,797) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 b.   Study data (56 studies, N = 13,685 neonatal deaths)
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5.5 Quality of the input data specifically with respect to 
intrapartum-related neonatal deaths  
 
 
5.5.1 Overview of the intrapartum-related input data  
The objective was to identify all useable data meeting specified inclusion criteria, and pertaining 
to the case definition outlined at the end of Chapter 4 for intrapartum-related neonatal deaths. 
While this was the case definition sought, it is important to note the limitation that the validity is 
determined by the validity of the reported cause-of-death in the input data, and that few papers 
give full details of case definitions and any hierarchy applied. 
 
Vital registration data inputs: The VR data used were from WHO and the inclusion criteria and 
analysis have already been described for the multi-cause-of-death analysis, although for this 
exercise only the intrapartum-related proportion was used as an input (Figure 5.1). An 
additional three countries were included, giving 48 countries as opposed to the 45 in the multi-
cause analysis. These were Caribbean island states that reported neonatal cause-of-death data 
already combined into causal groups. The intrapartum-related group was comparable with the 
case definition used here but the data did not provide comparable categories for the other six 
selected causal groups so could not be used in the multi-cause analysis. The numbers of deaths 
were small and had little effect on the total deaths included.  
 
Study data inputs: Systematic searches were performed in Medline, Popline, LILACS, BioMed 
Central, African Index Medicus, and EMRO databases. Searches were conducted in all 
languages since 1985 for multiple terms, including all-cause mortality terms (e.g., 
neonatal/perinatal mortality, stillbirths, fetal deaths) and cause-specific terms related to acute 
intrapartum events (e.g., birth asphyxia, hypoxic ischaemic encephalopathy, NE, birth trauma, 
fresh stillbirths, intrapartum stillbirths). Extensive attempts were made to identify unpublished 
databases. Over 4000 documents of potential relevance were identified through these search 
techniques for neonatal deaths. After screening abstracts the selected publications were 
examined in detail for inclusion criteria using 2 screening filters (Table 5.3). For the single 
cause modelling database total of 46 study populations from 30 countries met the inclusion 
criteria, with a cumulative sample size of 12,355 neonatal deaths (Figure 5.2). 
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Table  ④5.3  Summary of the inclusion criteria applied to the input data 
  
Method   Inclusion criteria for data inputs
 
Neonatal deaths: 
Vital registration 
(VR) data  
• Filter 1- Population based data:  
Full coverage of vital registration (>90%) as defined by WHO estimates 
based on adult mortality coverage
1 
 
•  Filter 2- Comparable cause-of-death data available:  
Detailed ICD 10 or 9 codes reported to WHO as of March 2004 
 
Neonatal deaths: 
Multiple regression 
model 
 
•  Filter 1: Population based data:  
Population-based study (either in the community, or in an institution if not a 
tertiary referral centre and over 90% of deliveries in the area were 
institutional); 
Neonatal and/or early NMR reported or could be calculated. 
 
•  Filter 2 – Comparable cause-of-death data available: 
Cause-of-death data cover at least 12 months;  
At least 20 deaths with known cause-of-death were reported; method used 
was skilled clinical investigation, post mortem or verbal autopsy and   
percentage of unknown deaths was less than 30%; 
Comparable case definition of acute intrapartum events was possible and the 
cause-specific proportion of interest was specified or could be calculated 
from the information given; 
Single cause-of-death studies excluded. 
 
1  WHO draft coverage estimates, June 2003, personal communication Doris Ma Fat 
 
In the VR data the ICD 10 codes mapped onto the intrapartum-related category included 138 
three-digit codes. As outlined in Chapter 4, there has been a transition in the ICD codes for this 
condition mirroring the global transition in terminology. However since ICD 10 was published 
in 1993 and completed in the late 1990s, some of the more recent changes may not be included 
– for example there is not a term for NE, only for Hypoxic Ischaemic Encephalopathy. In 
addition a wide range of more process-type definitions are still included e.g. low Apgar, 
“perinatal depression” etc. Almost half of the codes (60) refer to birth trauma, but these codes 
account for a small number of deaths. However, in a few countries, notably some of the Central 
Asian states, more neonatal deaths were classified as caused by birth trauma than the “birth 
asphyxia” codes, so there is local variation in application of the cause-of-death attribution and 
affecting specific code. 
  
The data screening excluded studies that reported only on birth asphyxia as a single cause-of-
death. Interestingly, there were no studies identified that reported on “birth asphyxia” and only 
one or two other causes of neonatal death. That is, apart from the studies excluded for reporting 
only on asphyxia, the studies that met inclusion criteria ended up being the same as the ones in 
the multi-cause study, although the multi-cause database was able to include 13 unpublished  
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datasets and the asphyxia estimate database closed earlier for analysis and so included only 1 of 
these unpublished datasets. Of the single cause studies excluded the proportion of neonatal 
deaths attributed to “birth asphyxia” mainly using the “not breathing at birth” definition, ranged 
up to 70% of neonatal deaths. 
 
The minor differences in the input data between the multi-cause database and the asphyxia 
estimates database do not justify separate descriptions of data quantity by time and place. The 
same conclusions stand – the data are limited in geographic spread, are not recent and are older 
in the lower income countries. The main focus of this section is on the quality of data for 
asphyxia proportionate mortality for intrapartum-related neonatal deaths. 
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5.5.2 Variation of proportion of neonatal deaths related to intrapartum events  
 
Figure 5.7 shows all the input data by country, with the countries organised by level of NMR. 
The VR data are restricted to countries with NMR of 15 per 1000 births or less and the range of 
neonatal deaths attributed to intrapartum causes is between 5 and 20%, with a median of around 
15%. Study data within the same range of NMR appeared show similar patterns.  For NMRs 
between 15 and 30 per 1000, intrapartum events were reported to cause a higher proportion of 
neonatal deaths, ranging from 23% to 37%. However, at higher NMRs (above 30 per 1000 live 
births), the cause-specific proportion fell to 15– 25% of neonatal deaths. 
 
Figure １２ 5.7:  Input data by country from vital registration (48 countries, N=97,297) and studies 
(46 populations, 30 countries, N=12,355). Countries are arranged in order of increasing NMR and 
the reported proportion of neonatal deaths related to intrapartum events is plotted 
 
There are a number of possible explanations for this variation in the reported proportion of 
neonatal deaths related to acute intrapartum events, including: 
1.  Real variation with reduced or increased proportion of neonatal deaths related to 
intrapartum events reflecting a lower or higher risk; and   
2.  Measurement artefact due to bias such as misclassification bias or reporting bias which 
may result in over or under estimation. 
 
These possibilities will be discussed in detail in Chapter 7. 
0%
10%
20%
30%
40%
0 1 02 03 04 05 06 0
Neonatal mortality rate per 1000 births
P
e
r
 
c
e
n
t
 
o
f
 
n
e
o
n
a
t
a
l
 
d
e
a
t
h
s
 
t
h
a
t
 
a
r
e
 
i
n
t
r
a
p
a
r
t
u
m
 
r
e
l
a
t
e
d
Per cent of intrapartum neonatal deaths  
(Vital Registration inputs)
Per cent of intrapartum neonatal deaths  
(Study inputs) 
99 
5.6 Summary of available data for neonatal cause-of-death 
analysis around the year 2000 
 
The third objective of the thesis was to undertake a systematic assessment of the coverage and 
quality of data for neonatal cause-of-death through vital registration systems and in published 
and unpublished study data in all countries. This chapter has presented a review and analysis of 
neonatal cause-of-death data from VR systems in 82 countries, and the available data meeting 
inclusion criteria from 45 countries (48 for VR inputs for intrapartum-related neonatal deaths). 
The searches and screening for study datasets were presented. The geographic distribution and 
time trends in publication were summarised, and compared with data for other major causes of 
child death. There is a dearth of useable data – the VR data cover less than 3% of the world’s 
neonatal deaths but at least the median year of data available was 1999. Despite wide searches 
in all languages, the study data included only 56 datasets (46 for the intrapartum-related 
analysis) and 13,685 deaths. Thus there are many geographic gaps. The study data were much 
older than the VR data with a median year of data collection of 1991, compared to 1999 for the 
VR data. The input data showed a wide range of cause proportionate mortality, some of which is 
likely to be real epidemiological variation but some of which reflects inconsistencies, 
misclassification and biases in cause attribution.  
 
Given the lack of national data for the vast majority of the world’s four million newborn deaths, 
statistical modelling is the only option and Chapter 6 details the methods developed and applied. 
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Table  ⑤5.4  Sources of data for causes of neonatal deaths around the year 2000 
 
  Countries Percent of 
neonatal deaths
Vital registration  (>90% coverage 
and comparable ICD 10 coding) 
 
45 
 
 < 3% 
(96,797 deaths, 
Median year 1999) 
 
Facility-based audit or confidential 
enquiry  
 
Most northern European countries  < 1% 
No available national data  148 
Subnational datasets from published 
and unpublished studies and 
demographic surveillance sites.  
 Not suitable for direct use for national 
estimates but possible input for 
modelling  
 
56 study datasets 
identified 
(13,685 neonatal 
deaths, median year 
1991) 
Nationally representative sample 
surveillance sites under 
development 
 
2 
(India and China) 
 
- 
Data from: 
18. 
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Chapter 6:                                                             
Modelling national-level estimates of neonatal deaths related 
to intrapartum events (birth asphyxia) using single cause 
and multi-cause methods                                              
(Objective 4) 
 
 
 
 
 
Objective 4 
Estimate intrapartum-related neonatal deaths for all countries  
using two different approaches (single-cause and multi-cause models),  
and to compare these methods and results. 
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6.1  Single cause modelling to estimate the national 
estimation of intrapartum-related neonatal deaths  
  
6.1.1 Overview of inputs and outputs for the estimation process 
The case definition for intrapartum-related neonatal deaths sought in this analysis was given at 
the end of Chapter 4, aiming to maximise consistency between the stricter criteria possible to 
apply in higher income settings, and simpler data from VA assessments. Data inputs for 
neonatal cause-of-death were identified from two sources: a new analysis of vital registration 
(VR) data as reported to WHO as of March 2004, and published and unpublished reports of 
research studies (study data). The analysis, search strategy and inclusion criteria are described in 
Chapter 5 (figures 5.1 and 5.2), as well as a description of the input data. A random effects 
model was developed using this input data to predict the proportion of neonatal deaths that were 
related to intrapartum events. A range of independent predictor variables were tested for fit in 
the model.  
 
The output national level estimates of the proportion of intrapartum-related neonatal deaths 
were obtained in one of two ways.  
1.  Vital registration data: For countries with high coverage (>90%) VR data, these data 
were analysed in a new analysis using specific ICD 9 and ICD 10 codes (48 countries) 
and this reported proportion used without adjustment. 
2.  Random effects model: For countries without reliable VR data, estimates were obtained 
by applying a regression model developed using VR and study data, and the input of 
national level covariate data for each country for the year 2000 (145 countries) 
For all countries the proportion of neonatal deaths derived either by analysis of VR data or 
model output was then applied to the national number of neonatal deaths estimated to occur in 
that country in the year 2000, to predict the numbers of intrapartum-related deaths. Uncertainty 
ranges were estimated. 
 
6.1.2 Independent predictor variables  
A variety of potential independent variables, using national level data for the year 2000, were 
obtained from databases held by World Bank, WHO, UNICEF and UNDP. A wide range of 
possible predictors were tested for fit, including any that may be predictive of the proportion of 
neonatal deaths attributed to intrapartum-related causes. In addition to a dummy variable for 
type of data (VR or others), the following indicators were tested for fit in the model: 
•  under-5 mortality rate; 
•  neonatal mortality rate (NMR);  
•  gross domestic product (GDP);  
•  health expenditures;   
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•  WHO sub-regions;  
•  coverage of care such as vaccination, skilled birth attendance and antenatal care; and 
•  measures of inequality such as Gini coefficient. 
 
The modelling could only test input predictors for which there were national data available for 
over 190 countries so that the data could be used as inputs for the national level modelled 
output. Unfortunately, many of the variables that would be likely to be most closely associated 
with the proportion of neonatal deaths related to intrapartum events are not available at national 
level in most high mortality countries. For example, coverage of caesarean section, or measure 
of quality of intrapartum care such as use of the partograph or use of fetal heart rate monitoring 
are not available at national level. Large scale surveys tend to track the overall package 
coverage (e.g. skilled attendance) rather than the specific content of the package in terms of 
high impact interventions. 
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6.1.3 Modelling methods and final model 
All analyses were performed using Stata version 8 software. A random effects model was used 
to predict the proportion of neonatal deaths related to intrapartum events. The dependent 
variable was the logit of intrapartum-related neonatal mortality proportion from VR (48 
countries) and from 46 published and unpublished studies meeting the inclusion criteria (chapter 
5). The random effects model was fitted using a parsimonious (forwards) approach, testing the 
above predictors and adding predictors if they reached significance at a level of 5%. The final 
model was used to predict the proportion of neonatal deaths related to intrapartum events for the 
145 countries without VR data.   
The final model applied to predict the proportion of intrapartum-related neonatal deaths was 
(standard errors in parentheses):   
logit (% asphyxia deaths) = -1.53 + 1.83*(lnq5) - 0.28*(lnq5)
2 - 0.30*(lnGDP) - 0.13*logit (DPT3) 
          (0.93)  (0.62)          (0.09)             (0.13)               (0.05)          
  
         - 0.05* logit (%skilled birth attendants) + 0.23*(data_type)  
                (0.03)                                                     (0.07) 
 
Where lnq5 is the natural logarithm of the national risk of dying between birth and 5 years, 
lnGDP is the natural logarithm of gross domestic product in purchasing power parity, logit 
(%DPT3) is the logit of national coverage of immunisation with 3 doses of Diphtheria, Pertussis 
and Tetanus toxoid immunisation, and data type is a dummy variable for data input type (VR or 
literature). The goodness-of-fit was satisfactory, as reflected by R-square (0.61). There was no 
systematic deviation among the residuals. National data for emergency obstetric care coverage 
were not available. Other covariates such as antenatal care were not found to be significant.  
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The numbers of intrapartum-related neonatal deaths were derived by applying the proportion to 
WHO estimates of the national number of neonatal deaths.  External validity of the estimates 
was examined by comparing model predictions to unpublished, population-based data sets 
(Chapter 7). 
 
 
6.1.4 Uncertainty analysis  
In countries with full VR coverage, 95% uncertainty levels were derived based on the standard 
errors in the reported VR data. For modelled estimates, uncertainty bounds were generated 
using the standard error of the prediction of the logit and running 10,000 Monte Carlo 
simulations. These methods do not take into account uncertainty in the birth cohort or in the 
WHO neonatal deaths envelope by country.   
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6.2  Multi-cause modelling to estimate the distribution of 
seven causal categories of neonatal deaths including 
intrapartum-related neonatal deaths 
 
6.2.1 Overview of inputs and outputs 
Six neonatal cause–of-death categories, plus one residual “other neonatal” category, were 
selected based on the considerations outlined in detail in Chapter 4, notably public health 
importance with differing implications for intervention, and ability to distinguish between them 
in low resource settings. The cause-of-death categories and case definitions used are 
summarised in Table 4.1.
13;14 
 
Input datasets for cause of neonatal death were constructed from two sources: a new analysis of 
VR data and published and unpublished reports of research studies. The inclusion criteria, 
screening and analysis are described in Chapter 5 in addition to an overview of the input data 
quantity and quality.  
 
A range of independent predictor variables were examined. Overall 25 predictors related to 
study design, risk factors, and health service provision were tested for fit in models to predict 
proportionate mortality. Sources of data were as close as possible to the population in the input 
data – either the country and year for vital registration, or the closest data available in place and 
time for study populations.  
 
National level estimates (outputs) of proportionate cause-specific mortality within the neonatal 
period were obtained in one of three ways (table 6.1):  
1.  Vital registration data analysis: For countries with high coverage (>90%) VR data, a 
new analysis was undertaken to map the data from multiple ICD 9 and ICD 10 codes 
onto the five selected cause-of-death categories (45 countries).  This analysis is 
described in Chapter 5. 
 
2.  Vital registration based model for low mortality countries: For countries without high 
coverage VR systems but with low neonatal mortality rates (less than 10 per 1000, or 
less than 15 per 1000 for the regions of Europe and Latin America), estimates were 
obtained by applying a multinomial regression model developed using VR data from 
high coverage VR countries, and producing estimates with the input of national level 
covariate data for the year 2000 (37 countries). 
 
3.  High mortality study-based model for high mortality countries: For countries without 
reliable VR data and with high NMR, (over 10 per 1000, or over 15 per 1000 for the 
regions of Europe and Latin America), estimates were obtained by applying a  
106 
multinomial regression model developed using the study data from studies meeting 
inclusion criteria and producing estimates with the input of national level covariate data 
for the year 2000 (111 countries). 
 
For all countries the estimated numbers of neonatal deaths due to a given cause were obtained 
by applying the proportionate mortality derived by one of these three methods (Table 6.1) to the  
number of neonatal deaths estimated to occur in that country in the year 2000. National 
estimates were then added up for the 193 countries to give regional and global totals. The 193 
countries here differ from the 192 countries referred to elsewhere as Timor-Leste was included 
as a UN member state. 
 
Table  ⑥6.1  Overview of the source of data or modelling for the national estimates (outputs) 
 
Country grouping  Number of 
countries 
Method applied to derive cause 
specific mortality results 
Full coverage VR data  45  VR data used 
NMR < 10 per 1000 
Or  
NMR 10 - 15 per 1000 
and region is EUR or AMR 
17 
 
20 
VR model predictions 
NMR > 10 per 1000 
Or  
NMR > 15 per 1000 
and region is EUR or AMR 
 
111  Study based model predictions 
Total   193   
  
 
6.2.2 Independent predictor variables 
 
A wide range of potential predictor variables were required to testing the fit of the model.  Some 
variables related to the data type or the study site and study design/methods. Other variables 
were selected from a long list of possible predictors for neonatal proportionate mortality for 
example, low birth weight rate, skilled-attendant coverage or to specific causes of neonatal 
deaths (e.g., tetanus-toxoid coverage or TT2+). One limitation on the selection of predictor 
variables to test in the model was the requirement that national covariate data would be 
available for all countries for when the model developed would be used for national prediction 
purposes. Some covariates of interest, such as coverage of emergency obstetric care, or early 
postnatal/newborn care, are not available at national level for enough countries to be used for 
prediction. 
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As discussed in Chapters 4 and 5, few of the input studies were nationally representative and 
indeed some study populations may be specifically selected to be non-representative, for 
example for malaria studies, or to test interventions targeting higher mortality populations. 
Conversely, some studies came from better than average populations where a DSS may have 
been present for some time. For example, the study populations in the Gambia Medical 
Research Council (MRC) sites had extremely high coverage of tetanus toxoid immunisation 
compared to the national average, and consequently had no detected cases of tetanus. Failure to 
link the local coverage data to the local cause proportionate mortality input data could result in 
systematic bias in the output estimates. In view of this possible bias, major effort was put into 
identifying data for potential predictor variables that were as close to the study population as 
possible in time and place. In some cases these data were reported in the relevant publication, 
but it was notable how few authors reported even obvious coverage data such as percent of 
births in facilities. Fifty five principal investigators were contacted to obtain additional 
information on causes of death and local explanatory variables. The process has detailed 
previously in Chapter 5. This communication was especially helpful in increasing the number of 
studies that reported five or more of the selected causes of death, notably tetanus. 
 
If predictor variable data were not available from the study report or the investigator, or other 
publications from the same site, then data were obtained from DHS surveys  giving district or 
regional breakdown and as close in time as possible to the study, or other local surveys. Table 
6.2 summarises the independent variables collected for each study dataset, and the levels at 
which the data was available. Local or subregional / regional data  were identified for over 90% 
of all 56 studies for all 12 indicators except TT2+ (83%), and those which were essentially 
national (GDP per capita,  Gini index, Child survival inequality index). The Gini coefficient is 
as a measure of inequality of income distribution where zero corresponds to perfect equality 
(everyone having exactly the same income) and 1.0 corresponds to perfect inequality. The Child 
survival inequality index was a composite score used in WHO’s World Health Report 2000 and 
calculated for each country. Gross domestic product per capita is estimated annually by the 
World Bank and a time series was used so that the GDP data came from the same year as well 
as the same country as the VR or study data. 
 
A number of variables related to study design and causes of death attribution were also 
collated for each of the study inputs. These were tested for fit in the study based model, 
including variables related to the population (global subregion, urban/rural %, median 
year of data collection) or to design (research site or not, prospective or retrospective, 
population size, duration of study) and to cause attribution (methods for cause-of-death 
attribution, numbers of causes distinguished, gestational age measured, stillbirths 
recorded or not, early neonatal mortality only compared to all neonatal period).  
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Table  ⑦6.2  Independent variables tested for fit as predictors in the study based model  
 
Predictor tested Level of source of data used
Local 
level 
%
Regional 
level 
% 
National 
level 
%
Related to the study population 
1.  Magnitude of NMR  
2.  Magnitude of IMR 
3.  Low birth weight rate 
4.  Total fertility rate  
5.  Antenatal care coverage 
6.  Tetanus toxoid coverage (TT2+) 
7.  Skilled attendant at birth 
8.  Institutional delivery 
9.  BCG coverage  
10.  Female literacy 
11.  GDP per capita* 
12.  Gini coefficient* 
13.  World Health Report 2000 child survival 
inequality index* 
 
 
100 
 59 
100 
 78 
77 
 63 
 51 
 61 
 47 
 53 
- 
- 
- 
 
- 
32 
- 
 20 
 23 
 37 
 42 
 39 
 36 
 37 
- 
- 
- 
 
- 
8 
- 
  2 
- 
- 
  7 
- 
 17 
 10 
100 
100 
100 
* National level predictor so not available locally or regionally. GDP: gross domestic product.  
Gini coefficient is as a measure of inequality of income distribution   
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6.2.3 Modelling methods and final models 
 
The focus of this thesis is on the epidemiological inputs and outputs and not primarily on the 
modelling methods, but a description of the main steps involved in the development of multi-
cause models using VR and study-based data is essential for discussion of potential strengths 
and limitations of the multi-cause estimation results and also for implications for future 
estimation methods. 
 
All analyses were performed using Stata version 8 software. Modelling was performed 
separately for the two datasets (VR and study data). This was because in the countries with high 
coverage of VR data the NMRs did not exceed 15 per 1000 births, there were almost no 
neonatal deaths due to tetanus and very few attributed to diarrhoea. Hence inclusion of these 
data in a model to predict for countries where tetanus or diarrhoea are expected to be of public 
health significance would be likely to introduce systematic bias into the predictions.  
 
As discussed in Chapter 3 of this thesis, there are theoretical advantages for estimation of 
multiple causes of death in one model, constraining the resultant proportions to sum to 1.0. 
Multi-cause modelling involves using a fixed “corner cause”, which must a cause that is present 
in each dataset in the input data and ideally a larger proportion that is fairly stable. For example 
in the VR modelling preterm birth complications was used as the corner cause in the ratios with 
all the other causes, and in the study dataset modelling, “birth asphyxia” was used as the corner 
cause. A predictive equation is then established for each the log of the ratio of selected cause 
against the corner cause. Then all the equations are run simultaneously to estimate the 
proportionate causal distribution.  
 
The only previous application of this methodology to child mortality had used Seemingly 
Unrelated Regression (Morris et al)
12 and a number of challenges were identified (Chapter 3). In 
order to address the challenges we attempted modelling initially with an adaptation of the 
Seemingly Unrelated Regression and also a multinomial approach which is reported to better 
handle missing data. Hence we tested a variety of modelling methods (as summarised in Table 
6.3), including: 
1.  Log Ratio Seemingly Unrelated Regression, (Morris method)
 12 
2.  Multinomial model  
3.  Final multinomial model 
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Table  ⑧6.3: Comparison of the initial modelling strategies with the final multinomial model for 
prediction of cause-specific neonatal deaths in countries with neonatal mortality rate greater than 
15 per 1000 births 
 
  Log Ratio 
Model 
Multinomial 
Model 
 Final multinomial 
model 
Number of 
parameters in model 
excluding constants 
65 backwards 
(18 if forwards, 
parsimonious) 
102 16 
Intrapartum-related 
neonatal deaths 
(“birth asphyxia”) 
 
21 24  23 
Preterm 30  29  27 
Infection 27  29  25 
Congenital 
abnormality 
7 5  7 
Neonatal tetanus  10  4.4  7 
Diarrhoea 2  2  2 
Other 4  7  8 
Performance in 
predicting neonatal 
tetanus deaths 
Erratic at country 
level particularly 
for smaller 
portions, notably 
neonatal tetanus 
Neonatal tetanus 
deaths at country 
level correlated with 
WHO estimates but 
lower  
Specific and  
sensitive at country level for 
neonatal tetanus deaths, 
strongly correlated with WHO 
estimates (CC=0.92). 9 of top 
10 countries the  same and 
almost same rank 
Slightly higher % at global 
level (6.5 vs 5.1%) 
Vaccines and Biologicals, WHO, unpublished neonatal tetanus estimates  
 
Using the Log Ratio model two problems were noted. Firstly, more studies had to be excluded 
because of missing data. For example diarrhoea was missing as a cause-of-death in some studies 
despite correspondence with authors. The multinomial model could deal with this by assuming 
that any diarrhoea deaths were in the infection category, which is a reasonable assumption, but 
the Log Ratio Seemingly Unrelated Regression model had to exclude these studies. In addition 
the Log Ratio model appeared to be unstable in estimation of smaller proportionate causes of 
death, notably neonatal tetanus for which comparison was possible at country level with WHO 
single cause estimates. For example, the Log Ratio Seemingly Unrelated Regression model 
predicted large numbers of neonatal tetanus deaths in Morocco (700-8000), compared with a 
low estimate of 96 from WHO Vaccines and Biologicals department. This phenomenon 
appeared to be related to the strength of the relationship of tetanus mortality with institutional 
delivery, and in countries with low institutional delivery but high tetanus coverage the Log 
Ratio model showed major overestimation of the proportion of neonatal tetanus deaths.   
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As well as the Log Ratio Seemingly Unrelated Regression model, we applied a novel approach 
using multinomial modelling which was reported to be able to cope with missing data. This 
allowed the use of all datasets with at least 6 of the 7 cause categories. However, even with a 
forwards or parsimonious approach, if the model was built simply on statistical significance 
alone, for the high mortality model 102 variables were included (table 6.3), raising the risk of 
generating spurious results. This problem did not arise for the model based on the VR data, 
possibly because of the small range of NMR and less variability in cause proportionate mortality 
in the VR data. During the review process with the CHERG, the decision was taken to apply a 
conservative approach and use an “a priori” approach to selection of predictors to test in the 
study based high mortality model, in order to minimise the risk of spurious results. Therefore 
variables were only included in a given equation if the parameter estimate had the expected 
sign, explained some variability and would be expected a priori to be associated with that ratio. 
For example, we expected that the tetanus:‘asphyxia’ ratio would be associated with the 
coverage of tetanus toxoid immunisation, with the ratio decreasing as coverage increases. This 
then resulted in a third modelling approach, the final multinomial or “a priori” model. 
 
For the final model Ordinary logistic regression was used to develop models for each ratio of 
cause to corner cause. For the VR data, we used a forward stepwise approach based on 
statistical significance testing, at the 5% level. For the study data high mortality model we used 
the a prioiri review of predictors and then only tested these indicators for fit in the model. Then 
the explanatory variables identified using the Log Ratio models as described above were fitted 
simultaneously in a multinomial model
16 including all causes to obtain parameter estimates for 
use in predictions. To allow for within-data source correlations, robust rather than model based 
standard errors were used. 
 
A further difference between the log ratio and the multinomial models is in the default weights 
they give to observations. The log ratio approach, by default, gives equal weight to each study, 
regardless of size. The multinomial model, by default, gives equal weight to each death, 
attributing too much weight to large studies when there is within study correlation.  Hence an 
intermediate weighting was selected in which each death in a given study carried a weight equal 
to 1/√N where N was the number of deaths included in that study. A sensitivity analysis using 
each weighting assumption in turn made little difference to the model outputs.  
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Vital registration – the final model 
The final model developed from the VR data used inputs from 45 countries and the parameters 
and R-squared for the equations for the 4 causes. Preterm was the corner cause and is estimated 
to be the residual proportion after the remaining causes have been predicted (table 6.4.a). The 
model explained some of the variation between countries in the congenital 
abnormalities:preterm and infection:preterm ratios, but explained none of the variation in the 
ratio of “other neonatal” to preterm deaths, and almost none for ‘asphyxia’ and preterm. 
 
Table  ⑨ 6.4a Multinomial model parameter estimates for Vital Registration data (44 
countries) 
 
Ratio  Explanatory 
variable 
R-squared 
1 
Parameter 
estimate 
95% c.i.
 2 
Infection: 
Preterm 
GDP (1000s of US$)  0.41  -0.141  -0.170, -0.112 
GDP squared    0.0024  0.0018, 0.0030 
Congenital: 
Preterm 
Low birth weight rate 
(%) 
0.46 -0.132  -0.224,  -0.041 
Country in EMR
3   1.678  1.296,  2.060 
Female literacy rate (%)    0.042  0.017, 0.066 
Intrapartum 
related 
(“Asphyxia”): 
Preterm 
Low birth weight rate 
(%) 
0.09 -0.098  -0.212,  0.017 
Other: Preterm  None  0  -  - 
1 R
2 value obtained when fitting the log(ratio) using linear regression with each study having equal weight  
2 Estimated using robust standard errors adjusting for within country correlations  
3 The majority of countries in the EMR region have relatively high proportions of consanguinity. 
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Study based data – the final model 
The final model developed from the study data used inputs from 56 studies and the parameters 
and R-squared for the equations for the 6 causal groups are shown in table 6.4b. Asphyxia was 
the corner cause and is estimated to be the residual proportion after the remaining causes have 
been predicted (table 6.4.b) The model performed quite well in explaining variation in the 
infection:‘asphyxia’ and tetanus:‘asphyxia’ ratios and explained some of the variation in the 
congenital ‘asphyxia’ and diarrhoea:‘asphyxia’ ratios. The model explained little or none of the 
variation in the ratios preterm:‘asphyxia’ and neonatal other:‘asphyxia’.  
 
Table  ⑩6.4 b  Multinomial model parameter estimates for study data (56 studies) 
 
Ratio  Explanatory variable  R
2  Parameter 
estimate 
95% c.i. 
Infection: 
‘asphyxia’ 
BCG coverage (%)  0.57  0.011  0.004, 0.017 
Neonatal mortality rate per 1000 
live births 
 0.010  -0.001,  0.020 
Female literacy rate (%)    -0.009  -0.016, -0.002 
Study of early neonatal deaths only    -0.716  -1.080, -0.351 
Tetanus: 
‘asphyxia’ 
Neonatal mortality rate per 1000 
live births 
0.55 0.037  0.002,  0.072 
Female literacy rate (%)    -0.017  -0.037, 0.003 
Antenatal tetanus toxoid coverage 
(%) 
 -0.015  -0.034,  0.004 
Study of early neonatal deaths only    -1.743  -2.616, -0.870 
Diarrhoea: 
‘asphyxia’ 
Neonatal mortality rate per 1000 
live births 
0.25 0.039  0.022,  0.057 
Study of early neonatal deaths only    -1.145  -2.573, 0.028 
Congenital: 
‘asphyxia’ 
Neonatal mortality rate per 1000 
live births 
0.27 -0.002  -0.023,  0.018 
% of institutional deliveries    0.011  0.003, 0.018 
Country in EMRO    0.670  0.303, 1.037 
Preterm: 
‘asphyxia’ 
% of skilled attendance  0.14  0.012  0.005, 0.018 
Low birth weight rate (%)    0.025  0.007, 0.044 
Study distinguished preterm and 
term small for gestational age 
infants 
 0.289  -0.116,  0.695 
Other: 
‘asphyxia’ 
Study of early neonatal deaths only  0.05  -0.683  -1.288, -0.078 
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Generating national and global estimates  
A database was constructed for all countries that are United Nations Members (192) including 
the estimated numbers of births, neonatal deaths and the predictor variables in the final models. 
All the data were reported to be from around 2000 and came from global databases of UNICEF, 
WHO and the World Bank.  
 
For countries with high VR coverage (>90%), we used the reported distribution of causes of 
death (45 countries, 2.4% of neonatal deaths). The VR model was used to predict the 
proportional distribution of causes of death in countries without high coverage VR but with an 
NMR of less than 10 per 1000 (all regions) or with an NMR of less than 15 per 1000 for 
countries in the European (EUR) and American (AMR) regions as defined by WHO (37 
countries, 2.4% of neonatal deaths). EUR and AMR regions had VR data points in the NMR 
range 10-15 per 1000. For all other higher mortality countries (111 countries, 95.2% of neonatal 
deaths), predictions were derived using the study data model. For both models, prediction of the 
distribution of causes of neonatal death at national level required national level covariate data. 
We then applied the predicted proportions to WHO estimates of the total number of neonatal 
deaths occurring in each country
1 to obtain estimates of the number of deaths by cause for each 
country. External validity of the estimates was examined by comparing model predictions to 
unpublished, population-based data sets (chapter 7). 
 
6.2.4 Uncertainty estimates for the multi-cause model 
Uncertainty estimates were obtained using the jackknife approach which involves removing 
each study or country in turn from the multinomial model estimation step and running the 
predictions for that study/country obtained using the remainder of the data.
 17 The distribution of 
the differences between the observed and estimated log ratios obtained provides an estimate of 
the standard error of out-of-sample predictions. We used Monte Carlo simulation (10,000 
simulations) to randomly perturb country-level estimates based on these standard errors and 
took the 2.5
th and 97.5
th percentiles to provide an indication of the level of uncertainty in our 
estimates. This does not capture all the potential sources of variability and uncertainty, such as 
uncertainty around the number of neonatal deaths in a country, but does provide uncertainty 
ranges around the input data and the modelling. 
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Chapter 7                                                             
Results and comparison for national                                      
neonatal cause-of death estimates using single cause and 
multi-cause modelling                                             
(Objective 4) 
 
 
 
 
Objective 4 
Estimate intrapartum-related neonatal deaths for all countries  
using two different approaches (single-cause and multi-cause models),  
and to compare these methods and results. 
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7.1  Results from single cause model for intrapartum-related 
neonatal deaths 
 
7.1.1 Overview  
An estimated 0.90 million neonatal deaths (range 0.65 to 1.17 million) are intrapartum-related, 
representing approximately 23% of annual global neonatal deaths (Table 7.1).  The numbers are 
highest in South Asia, with 316,000 in the WHO South Asia region and 129,000 in the WHO 
region of Eastern Mediterranean which includes Pakistan. Around 245,700 neonatal deaths in 
Africa are estimated to be due to intrapartum events. There is regional variation in the 
proportion of intrapartum-related neonatal deaths, ranging from 12% in North America up to 
26% in Western Pacific, which is largely reflective of China.  The causes for this variation have 
a number of possible explanations which are discussed below.  
 
Table  ⑪ 7.1  Estimated proportion and numbers of intrapartum-related neonatal deaths according to 
Vital registration and single cause model estimates for 192 countries summarised by 14 WHO subregions 
 
Subregion 
1
(in order of increasing 
NMR) 
 
Intrapartum-related neonatal deaths  
Cause-specific 
percent of 
neonatal 
deaths 
2
Estimated cause-
specific number of 
neonatal deaths 
(000s) 
2 
[Uncertainty 
bounds]
 1 
Western Pacific region A  15      0.51  [0.4 to 0.6] 
European Region A  14     2.0  [1.7 to 2.3] 
Americas A  12     2.4  [2.2 to 2.5] 
European Region C  15     3.2  [2.4 to 5.1] 
European Region B  24   15.1  [10.7 to 19.6] 
Americas B  24   31.7  [29.4 to 34.2] 
Eastern Med region B  13      6.8  [4.7 to 8.8] 
South East Asian region B  24   24.8  [17.5 to 32.3] 
Western Pacific region B  26  128.4  [91.0 to 167.5] 
Americas D  22   9.6  [6.8 to 12.5] 
South East Asian region D  24  316.0  [223.0 to 410.3] 
African region D  23   118.2  [83.6 to 151.0] 
African region E  20  116.7  [82.1 to 151.0] 
Eastern Med region D  23  129.0  [90.3 to 166.8] 
Global estimated numbers of 
deaths [uncertainty bounds] 
Percent of global neonatal 
deaths  
904,400 
[646 to 1,170] 
23 % 
Countries in the 14 subregions of the Global Burden of Disease listed in Table B1 in appendix 
1. Uncertainty estimates based on 10,000 Monte Carlo simulations of the model  
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7.1.2 Limitations and sources of bias  
Extensive efforts were made to identify the best available information. A new analysis of VR 
data ensured that the input data from VR and from studies were as comparable as possible.   
The modelling relies on variation amongst the input data. If variability is due to true 
epidemiological differences that are predictable then more robust estimates are likely.   
However if some of the variation between countries and datasets is due to measurement errors 
or inconsistencies, this affects the estimates. Plausible, but not necessarily mutually exclusive 
explanations for the variation of the proportion of intrapartum-related neonatal deaths include 
the following: 
1.  Real variation reflecting differing rates of intrapartum-related neonatal deaths:  For 
example, in the highest income countries such as New Zealand, UK, Bahrain, Oman 
and United Arab Emirates between 7 and 11% of neonatal deaths are reported in the VR 
data analysis to be intrapartum-related, with cause-specific mortality rates of less than 
0.5 per 1000. In contrast around 22% of neonatal deaths in Sub Saharan Africa are 
categorised as intrapartum, a cause-specific rate of around 10 per 1000 births. The 
proportion is double, but the cause-specific rate is 20 times greater. At high NMR levels 
the proportion of intrapartum-related deaths may be reduced by higher rates of other 
causes of neonatal death, notably infections and tetanus. In addition, in very high NMR 
settings obstetric care may be so distant or low quality that acute intrapartum events are 
more likely to produce intrapartum stillbirths than in neonatal deaths.
89  
2.  Over-estimation:  The use of older case definitions based on clinical status at birth, for 
example “not breathing at birth” or low Apgar may misclassify into the intrapartum-
related deaths category if these older case definitions are applied without a specific 
hierarchy to remove very preterm babies from the intrapartum category. In addition 
undetected congenital abnormalities resulting in early death may be misclassified as 
intrapartum related, although these are more commonly misclassified into the infection 
categories in VA studies. Measurement tools, particularly the simplest verbal autopsy 
tools, may overestimate intrapartum-related neonatal deaths because of these factors. 
3.  Under-estimation: For example, under-estimation could occur due to misclassification 
of live births as stillbirths, particularly affecting fresh stillbirth and intrapartum-related 
neonatal deaths. This may be genuine error or may be a means to avoid response on a 
VA tool or filling of death certificates. Other misclassification away from the 
intrapartum category may occur for example where a simple hierarchy is applied 
removing all preterm infants prior to the intrapartum-related category.
56;129;130 
Systematic avoidance of the terms “intrapartum” or “birth asphyxia” may occur in 
litigious societies where there may be consequences for use of these terms on death 
certificates.   
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7.2  Results from multi-cause model for all causes of neonatal 
deaths including intrapartum-related neonatal deaths 
 
7.2.1 Model results 
The results of model prediction for both the VR low mortality and the study-based high 
mortality models are shown in Table 7.2, along with the jackknife analyses used to estimate the 
uncertainty range. For the VR model, the mean observed and predicted proportions were close 
in both absolute and relative terms (maximum absolute difference 0.7%, maximum relative 
difference 7%). Differences were slightly larger for the study data model (maximum absolute 
difference 2.1% [asphyxia], maximum relative difference 21% [diarrhoea]).  
 
Table  7.2 Estimated proportionate cause-of-death for 4 million neonatal deaths in the year 2000 
based on multi-cause Vital registration and study data models  
 
Cause  Vital registration  Study data Estimated 
global 
number 
(%) of 
deaths 
(millions) 
Uncertainty 
range 
around the 
global point 
estimate
1
Mean proportion 
of deaths across 
44 countries 
Mean proportion 
of deaths across 
35 studies with all 
causes recorded
 
Observed 
(Range) 
Predicted Observed  Predicted 
 
Preterm 40.3% 
(17-66%) 
 
40.5% 32.7% 
(8-71%) 
32.0% 
 
1.12  
(27.9%) 
0.74 – 1.38 
Infection    9.2% 
(2-26%) 
 
  9.8%  23.6% 
(3-58%) 
22.3% 
 
1.04  
(26.0%) 
0.69 – 1.24 
Intrapartum-
related (“birth 
asphyxia”) 
 
14.4% 
(6-33%) 
13.8% 19.9% 
(4-42%) 
22.0% 0.91   
(22.8%) 
0.60 – 1.08 
Congenital 30.1% 
(9-53%) 
29.8%    8.5% 
(0-39%) 
 
  7.8%  0.30   
(7.4%) 
0.22 – 0.48 
Diarrhoea  -  -    2.9% 
(0-21%) 
 
  2.4% 
 
0.11  
(2.8%) 
0.08 – 0.41 
Tetanus  -  -    7.0% 
(0-50%) 
 
  7.9% 
 
0.26  
(6.5%) 
0.20 – 0.79 
Other    5.9% 
(0-13%) 
  6.1%    5.4% 
(0-23%) 
 
  5.6%  0.26  
(6.6%) 
0.19 – 0.62 
Total         4.00     
(100%) 
 
For the observed data the range is shown. For the predicted proportion, the 95% CI by parameter are shown in Table 
6.4a for the VR modelled estimates and Table 6.4b for the study data modelled estimates 
1 Uncertainty estimates around the global point based on jackknife analysis and 10,000 Monte Carlo simulations 
whereby each input observation in turn is dropped from the database for the multinomial modelling. The distribution 
of the differences between the observed and predicted log ratios provides an estimate of the standard error of the out-
of-sample predictions (see 6.2.4 for more detail)  
119 
7.2.2 Global and regional distribution of causes of neonatal deaths 
The estimated global distribution of the causes of neonatal deaths is shown in Figure 7.1, with 
global point estimates and uncertainty ranges in Table 7.2. Three major cause groups 
predominate - preterm birth, birth asphyxia and infections (sepsis or pneumonia, diarrhoea, 
tetanus) – with each responsible for approximately one quarter to one third of all neonatal 
deaths. The remaining deaths (approximately half a million) are distributed across the remaining 
causes of congenital, and “other neonatal” The “other neonatal” category includes specific 
conditions such as haemorrhagic disease of the newborn and jaundice which were specified in 
too few of the input datasets to be estimated separately, although such delineation is possible in 
the VR data.  
 
Figure １３ 7. 1  Estimated distribution of direct causes of 4 million neonatal deaths for the year 
2000 
 
Source: Lawn JE, Cousens SN, Zupan J Lancet 2005 for 192 countries based on cause specific mortality 
data and multi cause modelled estimates.  
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The multi-cause estimates are broadly consistent with the available single cause estimates at 
global level (Table 7.3). Using different approaches, deaths in the year 2000 have been 
estimated at 220,000 for neonatal tetanus
7, at 904 400 for acute intrapartum events,
 6 and at 1.33 
million for prematurity, although the latter includes deaths attributed to preterm birth up to the 
age of 5 years.
7  Each of these estimates lies well within the uncertainty range in the multi-cause 
estimates. A comparison of these country-level estimates for neonatal tetanus deaths with those 
produced by WHO Vaccines and Biologicals Department shows reasonable agreement; seven of 
the ten countries with the highest numbers of neonatal tetanus deaths according to WHO are in 
agreement with these predictions. 
 
Table  7.3  Comparison of neonatal multi-cause results with existing estimates 
 
Neonatal 
COD category 
Neonatal multi-
cause model 
Global Burden of 
Disease version 
2004
Other single 
cause estimates 
Intrapartum events 
(“Birth asphyxia”) 
910,000
(0.69 – 1.24 million) 
 
751,545* 904,400
51 
(0.65 – 1.17 million) 
Preterm 
(‘LBW’) 
1,120,000
(0.74 – 1.38 million) 
 
1,330,269*   
Congenital  300,000
(0.22 – 0.48 million) 
 
462,574*   
Neonatal tetanus  260,000
(0.2 – 0.79 million) 
 
214,604* 200,285 # 
Infection/ARI 1,040,000
(0.69 – 1.24 million) 
 
NA   
Diarrhoea  110,000
(0.08 – 0.41 million) 
 
NA   
Other  260,000
(0.19 – 0.62 million) 
 
NA   
 * applies to the entire period 0 to 4.99 years, not restricted to the neonatal period 
# Tetanus estimates from WHO Vaccines and Biologicals unpublished estimates 
 
There is considerable variation in proportionate cause by region, particularly for neonatal 
tetanus, diarrhoea and congenital malformations (Fig 7.2) but in all cases the three main causes 
predominate. Neonatal tetanus is mainly confined to Africa, South Asia and the Eastern 
Mediterranean regions, and in these higher mortality regions infections and diarrhoea account 
for 30 to 33% of neonatal deaths. The proportion of deaths attributed to preterm complications 
in the Americas (41%) is almost double that in Africa (23%). Western Pacific is the only region 
where the proportion of deaths attributed to intrapartum exceeds that attributed to preterm – 
more analysis and better data are required to ascertain whether this is a true reflection of the 
lower preterm birth prevalence in the region or a measurement artefact. 
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Source: Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol 2006; 35(3):706-718. 
 
 
 
Figure １４7.2  The estimated distribution of causes for 4 million neonatal deaths for the six WHO regions in the year 2000 
 
 
 
Size of circle represents number of deaths in each region. AFR=Africa. AMR=Americas. 
EMR=Eastern Mediterranean. EUR=Europe. SEAR=Southeast Asia. WPR=Western  
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7.3  Comparison of model results with local data 
 
7.3.1 Comparison of single cause model results with local data 
Table 7.4 compares model predictions with unpublished population-based data from 4 high-
mortality countries. These datasets met the inclusion criteria (Chapter 5), but were not included 
in modelling. A paired t-test did not detect a statistically significant difference between 
observed and predicted proportions (p=0.76). The average absolute difference between observed 
and predicted proportionate mortality was only 4%.  
 
Table  7.4.  Consistency of single cause estimates with unpublished data from population-based 
datasets  
 
 
 
Country 
 
 
Study site 
 
 
Percentage of neonatal deaths related 
to  
intrapartum events 
Unpublished 
population-based 
data 
(Number of neonatal 
deaths) 
[95% Confidence Interval] 
National 
estimate 
predicted by 
model (%) 
[uncertainty 
range]
 #
 
Gambia
1 
 
Rural community with primary 
healthcare and some access to 
emergency obstetric care  
 
 
19 % 
(78) 
[18-20] 
 
22 
[16-28]  
 
Tanzania
2 
 
Urban (Dar es Salaam):   
Rural (Hai):                  
Rural (Morogoro):      
National weighted result 
 
18 %  (91) 
25 %   (142) 
33 %   (158) 
29 % 
[28-30] 
 
26 
[19-33] 
Bangladesh
3  
Peri-urban community in Dhaka 
with potential access to 
emergency obstetric care  
 
 
24 % 
(124) 
[23-25] 
 
30 
[22-38] 
Pakistan
4  
Rural site with limited access to 
basic and emergency obstetric 
care 
  
 
26 % 
(154) 
[25-27] 
 
 
23 
[18-29] 
No significant difference detected between observed and predicted proportions. Paired t test 0.76 
1. Walraven G, personal communication, March 2004  
2. Setel P, Whiting D, Hemed Y, personal communication March 2004. National result derived from 3 sites using p-
weights based on census data for 2002 
3. Perry H, personal communication, March 2004 
4. Bhutta Z, personal communication, April 2004 
#Uncertainty range based on standard error of the logit using 10,000 Mote Carlo simulations (see 6.1.4 for more 
detail)  
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7.3.2 Comparison of multi-cause model results with local data 
 
Comparison of the multi-cause model predictions with unpublished population-based data from 
2 high-mortality countries (India and Ghana) are shown in Tables 7.5 a, b. These datasets met 
the inclusion criteria (Chapter 5), but were not included in modelling. The four studies used to 
compare the model predictions from the single cause model could not be used for comparison 
with multi-cause model estimations because they were included as input data in the multi-cause 
model. The VR data analysis categories and results (without predictive modelling) are compared 
with national surveillance confidential enquiry data for England, Wales and Northern Ireland 
(Table 7.5b). 
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The study from India is a setting with high NMR (57 per 1000) – almost 50% higher than the 
national average (Table 7.5a).
56 Overall the study and model data match reasonably well, 
although for the small proportionate causes (diarrhoea, congenital) small absolute differences 
are large in percentage terms. Not surprisingly, the study data have a higher proportion of deaths 
attributed to tetanus and neonatal infections – this would be expected at such a high NMR. 
While the preterm birth proportion predicted by the model and the study are the same (35%), the 
study attributes a much lower proportion of neonatal deaths to birth asphyxia. The algorithm or 
hierarchy used in this study places all deaths in preterm neonates above asphyxia. This 
hierarchy may explain the low asphyxia and high preterm proportions for this level of NMR, 
especially as gestational age data were not available; the preterm category here is apparently 
dependent on maternal perception of gestational age and/or size. In this population where the 
LBW rate is around 30%, hence term babies who were small for gestational age (and at higher 
risk of intrapartum injury) or borderline preterm infants could be misclassified into preterm 
cause-of-death category from intrapartum–related category of neonatal deaths.  
 
The study from Ghana (Table 7.5b) has a moderate NMR level (31 per 1000), but is lower than 
the national average NMR of 42 based on DHS.
99;141 Differences between the study data and 
model predictions are more than for the Indian study but have plausible explanations. Fewer 
tetanus deaths in the study area are to be expected as the NMR is lower than national level, 
although the study reports a higher proportion of infections. The multi-cause model predicts 
congenital to be 6% of neonatal deaths and the study reports 3%. As discussed before, VA tends 
to underestimate congenital cause-of-death, particularly cardiac abnormalities so these may 
have been undetected. The major difference is between the categories of preterm and asphyxia, 
where the study reported 10% higher in asphyxia and 6% lower in preterm compared to the 
model predictions. The case definition used in the study for birth asphyxia was “not breathing at  
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birth”. Although the specified hierarchy put preterm above birth asphyxia, the categorisation 
was undertaken by three experts, not a computer algorithm. Thus it is likely the proportion in 
the study may be inflated compared to a stricter intrapartum-related definition. 
 
The data from England, Wales and Northern Ireland comes from a CEMACH 2004 annual 
report.
137 The confidential enquiry data is drawn from a rapid reporting system in facilities, and 
are compiled by CEMACH offices. When the CEMACH  data is cross checked with registration 
data for stillbirths and neonatal deaths from the Office of National Statistics
137 the CEMACH 
data capture is currently higher than the VR capture especially for stillbirths.  The VR data are 
for 2000 so not are not exactly comparable with the CEMACH input data here for 2004, but the 
results are very close (Table 7.5c). The analysis of multiple VR codes and mapping onto the 
selected cause-of-death categories seems to match well the classification and the data collected 
through the confidential enquiry process. However the VR data does not included the richness 
possible in the CEMACH data where analysis by gestational age is possible, as well as multiple 
other variable of interest for programmatic action.
138 
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Table  ⑫7. 5a  Comparison of neonatal multi-cause model predictions with study neonatal cause-of-death data - India 
 
  Study description Comparison of study and model neonatal proportionate mortality results  
 Cause-of-
death 
Study 
result 
(%) 
Model 
result 
(2004) 
(%) 
Absolute 
diff %  diff  Comment 
India 
NMR  
(national NMR) 
57 
 (39) 
Intrapartum 
related 
(“birth 
asphyxia”) 19 22* 3 14
Lower asphyxia % in study may be 
explained by hierarchy used in the 
study with all preterm births placed 
above birth asphyxia, but not accurate 
measure of gestational age, so term 
IUGR or borderline preterm infants with 
intrapartum –related neonatal deaths 
could be misclassified into preterm 
cause-of-death category 
Population 
representativeness 
Poor, rural pop, 
higher than national 
NMR Preterm 35 35 0 0 No difference 
Population size  61,591 households  Infections 31 25 -6 -24
Expect infection % to be higher in study 
population as higher NMR 
Health system 
context 
Approx 30% births at 
home, no intensive 
care Tetanus 5 4 -1 -25
Expect tetanus % to be higher in study 
population as higher NMR than national 
Date 
Not specified - 
estimated to be 2002-
2004 Diarrhoea 2 2 0 0 No difference 
No. neonatal 
deaths 1048  Congenital 8 6 -2 -33
Expect congenital % to be higher in 
study population as high consanguinity 
Methods 
Retrospective survey 
and verbal autopsy, 
causes allocated by 
computer algorithm  Other NA  6 NA  NA 
138 deaths unallocated as no "specific 
other" category in hierarchy 
Study data source for India.
56 
Model predictions using the same multi-cause model as for 2000 but revised for Countdown 2004 with latest coverage data and used here as better time period match to the study data 
* The single cause model prediction for India is 21% 
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Table  ⑬7. 5b Comparison of neonatal multi-cause model predictions with study neonatal cause-of-death data - Ghana 
 
  Study description Comparison of study and model neonatal proportionate mortality results 
 Cause-of-
death 
Study 
result 
(%) 
Model 
result 
(2004) (%) 
Absolute 
diff %  diff  Comment 
Ghana 
NMR  
(national NMR) 
31  
(42) 
Intrapartum 
related 
(“birth 
asphyxia”) 33.5 23* -10.5 -46
Higher % in asphyxia may be 
explained by non-specific case 
definition (not breathing at birth)  
Population 
representativeness 
Rural population, 
lower than 
national NMR  Preterm 20 26 6 23
Probable misclassification from 
preterm to birth asphyxia 
Population size 
4 districts (out of 
110) Infections 38 32 -6 -19 Not major difference 
Health system 
context 
Approx 50% 
births and 
neonatal deaths 
at home, no 
intensive care  Tetanus 0.5 4 3.5 88
Expect tetanus % to be lower in 
study population as lower NMR 
than national 
Date 
Jan 2003-  June 
2004 Diarrhoea 2 3 1 33 Minimal absolute difference 
No. neonatal 
deaths 623  Congenital 3 6 3 50
Probable under-detection of 
congenital using verbal autopsy 
(especially cardiac) 
Methods 
Demographic 
surveillance and 
verbal autopsy, 
expert medical 
opinion for 
allocation Other 3 6 3 50
Low % attributed to specific other 
may reflect tool and expert focus 
on major causes 
Study data source for Ghana
99;141 
Model predictions using the same multi-cause model as for 2000 but revised for Countdown 2004 with latest coverage data and used here as better time period match to the study data 
* The single cause model prediction for Ghana is 23% 
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Table  ⑭7. 5c  Comparison of neonatal multi-cause VR analysis with real national neonatal cause-of-death data -  England, Wales and Northern Ireland  
 
 
Study description 
Comparison of study and VR analysis neonatal proportionate mortality results 
 Cause-of-
death 
National 
result 
(2004) 
(%) 
VR 
data 
(2000) 
(%) 
Absolute 
diff %  diff  Comment 
United 
King-
dom 
NMR  
(national NMR)  3.7 (same) 
Intrapartum 
related 
(“birth 
asphyxia”) 11 14 3 21
Minimal absolute difference, 
although percentage difference is 
large. Difference in year (2000, 
2004) may be a factor. 
Population 
representativeness  All of UK   Preterm 48 45 -3 -7 Minimal absolute difference 
Population size  60.5 million  Infections 7 6 -1 -17 Minimal absolute difference 
Health system 
context 
High income, full 
coverage  
including 
intensive care  Tetanus 0 0 0 0  Not estimated 
Date 2005  Diarrhoea 0 0 0 0  Not estimated 
No. neonatal 
deaths 2,380  Congenital 23 28 5 18
Model may not fully account for 
increasing termination of 
pregnancy  
Methods 
National reporting 
and surveillance  Other 7 7 0 0
Specific other the same, but 2.5% 
allocated to SIDS, 1.3% unknown 
or unclassified 
National data source for England, Wales and Northern Ireland, 2004
137 
VR data analysis, input data 2000 
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7. 4    Comparison of single cause and multi-cause results 
 
7.4.1 Comparison of results from the two modelling approaches 
Remarkably, despite the differing approaches for the multi-cause and single cause models, the 
global point estimates for intrapartum-related neonatal deaths are almost the same, at 0.904 and 
0.91 million respectively. Indeed, the uncertainty estimates are also very close (0.65–1.17 
million and 0.60-1.08 million), although also generated by different methodologies (Chapter 6).  
 
Given the close match of the input databases, apart from the additional unpublished datasets 
included for the multi-cause model, perhaps this is not surprising. However, it may be that the 
global agreement is a coincidence whilst regional or country estimates disagree. Table 7.6 
shows a regional comparison of the single and multi-cause results for the proportion of neonatal 
deaths that are intrapartum-related. There is very little difference in absolute terms. The percent 
variation ranges from 4% to 22%, with the biggest difference in the Americas and Europe. 
However, although the difference is apparently greatest in the low mortality regions, there is not 
a consistent direction in this difference – the single cause model predicts a higher proportion in 
the Americas and a lower proportion in Europe compared to the multi-cause model. 
 
Table  ⑮7.6  Comparison at regional level of the proportion of intrapartum-related neonatal 
deaths (“birth asphyxia”)  comparing estimates from single cause and multi-cause modelling 
 
 Region 
Numbers of 
neonatal 
deaths 
(1000s)
Proportion of neonatal deaths estimated 
to be due to asphyxia 
Single cause 
model results
Multi-cause model 
results
Africa 1128  21%  24% 
Southeast Asia  1443  24%  23% 
Eastern Mediterranean  603  23%  20% 
Western Pacific  512  25%  26% 
Europe 116  18%  20% 
Americas 195  22%  18% 
Global average 
 
 23%  23% 
Global total (1000s) 
 
 
3,997 
 
 
 
904 
(650 to 1170) 
 
910 
(600 to 1080)  
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A national level comparison of the two sets of estimates shows a wide scatter (figure 7.3). There 
appears to be a cluster of countries with lower proportions (> 15%) with some agreement and 
then a cloud of scatter. Then at higher proportions (20% to 30%) the multi-cause model seems 
to estimate a slightly higher proportion than the single cause model. Clearly the coincidence of 
the same point estimate at global level is just that – a coincidence based on a combination of 
higher and lower estimates in each set that happen to come to the same total. This emphasises 
the challenges involved in using estimates at national level, the need for more analytic work to 
advance model work and to include uncertainty limits on national estimates. The punch line 
remains the same - improved input data is the only real answer. Much of this uncertainty is due 
not just to lack of data but also to low quality or inconsistent cause attribution.  
 
 
Figure １５ 7.3   Comparison for 192 countries of the proportion of intrapartum-related neonatal 
deaths (“birth asphyxia”) comparing estimates from single cause and multi-cause modelling  
 
* The red line is a 45 degree line representing equality between the two sets of estimates 
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7. 5    Summary of the comparison of the two modelling 
approaches  
 
The objective of this chapter, and Objective 5 of the thesis, includes a comparison of the single 
and multi-cause modelling methods. Table 7.7 summarises the similarities and differences for 
each step of the estimation process. In both exercises the same case definitions for intrapartum-
related neonatal deaths was specified, although both remain at the mercy of the VR data death 
certificate certifier or the study investigators in terms of the details and application of the case 
definition in reality. The input data for the two exercises is very similar (Chapter 5). The results 
at global level are remarkably similar – both giving 23% of the global total of neonatal deaths 
and both falling well within each others uncertainty range. The regional results are not very 
different (Table 7.6) although at national level the predictions exhibit major variation (figure 
7.3). The main difference lies in the modelling methods.  
 
The limited available single comparisons of each model suggests they perform with an 
acceptable level of consistency compared to real local data, and that more marked variations in 
proportionate mortality results could be explained. However in order to make a definitive 
statement on which method (single or multi-cause) is performing better at national level a “gold 
standard” would be required to compare with national level predictions from both models. Such 
a reliable measure of intrapartum-related neonatal deaths in a number of countries, at national 
level does not currently exist. One more limited option is to compare the single cause model 
predictions against the two studies in high mortality settings used to validate the multi-cause 
model. In the Indian study (Table 7.6a) the reported intrapartum-related percentage was 19%, 
the multi-cause model predicted 22% and the single cause model predicted 21%. In the 
Ghanaian study (Table 7.6b) the reported percentage was 33.5%, the multi-cause model 
predicted 23% and the single cause model also predicted 23%. In these two examples the single 
and multi-cause model estimates were close to each other and the study comparison data for 
India was reasonably close but for Ghana was very different, possibly because of the use of an 
older case definition for “birth asphyxia”. However, the possibility remains that at national level 
both models may be sometime overestimating and sometimes underestimating, influenced by 
the weaknesses in the input data variation for proportionate cause. If a considerable proportion 
of the variation is measurement and misclassification issues, particularly with older case 
definitions of “birth asphyxia”, this may be more challenging to predict in a model.  
 
Overall multi-cause modelling holds a number of the advantages compared to single cause 
modelling as laid out in Chapter 3. The major advantage is the consistency and transparency by  
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which multiple cause estimates can be produced within a given time period (for example 
neonatal), avoiding expert opinion in combining multiple single cause estimates which are very 
unlikely to add up to 100% just by chance. On this basis the multi-cause estimates are the most 
likely to be used widely and to receive further investment in refining, unless the single cause 
estimates can be convincingly demonstrated to be superior for national level predictions. 
 
Table  ⑯7.7 Comparison of single and multi-cause models for estimation of intrapartum-related 
neonatal deaths 
 
Step in 
estimation 
process 
Single cause model Multi-cause model 
1.  Case definitions for 
intrapartum 
neonatal deaths  
Same definition sought 
Same limitation with input data in terms of consistent application  of the 
case definition or detailing of case definition and hierarchy 
 
2.  Input data for 
cause-of-death 
VR data – 48 countries 
 
Study data – 46 studies,         
                     12,335 deaths 
 
VR data – 45 countries (44 as model inputs) 
 
Study data – 56 studies,  
                      13,685 deaths 
 
3.  Methods and 
modelling 
 
Single cause  Multi-cause 
4.  Predictors in final 
equation for 
intrapartum-related 
neonatal deaths 
Regression model  equation 
including: 
-  Under five mortality rate 
-  Gross domestic  product 
per capita 
-  DPT3 immunisation 
coverage 
-  Skilled birth attendant 
coverage 
Multinomial model with log ratio equations 
for all the causes against one corner cause: 
-  Study-based model: Asphyxia estimated 
as the residual of all the other causes as 
asphyxia was the corner cause 
-  VR based model for log of ratio of 
asphyxia/preterm ratio the only 
significant predictor was low birth 
weight rate 
 
5.  Global results  904,400 
(0.65 – 1.17 million) 
 
910,000 
(0.60 – 1.08 million) 
6.  National results  Very poor agreement at national level and no obvious pattern 
 
7.  Uncertainty ranges  Provided at global level, but 
not at regional or national 
level 
 
Provided at global level by cause, but not at 
regional or national level 
8.  Review process  Expert review process at 
WHO and peer review 
 
Expert review through CHERG and UN and 
peer review process 
9.  Comparison of 
model predictions 
with local data 
Model predictions compared 
well with data from 4 
studies in high mortality 
settings and performed well 
Compared with data from 2 high mortality 
studies and VR data in one low mortality 
country. Performed well for VR data but for 
the studies the most variability was for the 
birth asphyxia category 
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Chapter 8                                                             
Implications for improving estimation methods                              
and data collection                                                     
(Objective 5) 
 
 
 
Objective 5 
Summarise actions to improve estimates and  
input data for neonatal cause-of-death,  
  listing research priorities 
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8.1  Overview of neonatal cause-of-death estimates and their application 
 
These are the first systematic global estimates of intrapartum-related neonatal deaths aiming to 
use a more specific case definition, shifting from previous use of “not breathing at birth” and 
attempting to exclude preterm infants and congenital abnormalities. However changing from the 
strongly held term “birth asphyxia” will take time. Using two different methods, an estimated 
23% of neonatal deaths globally are associated with acute intrapartum events, over 900,000 
deaths each year. Closely associated with this loss of almost one million live born infants, are an 
additional 1.02 (range 0.66-1.48) million intrapartum stillbirths,
51 accounting for 32% of 3.2 
million stillbirths.
51 This total burden of around 2 million intrapartum-related deaths is largely 
invisible in both safe motherhood and child survival programme priorities. Improving health 
systems at the time of childbirth potentially holds a triple benefit - reducing neonatal mortality 
and intrapartum stillbirths as well as many of the estimated 0.5 million maternal deaths a year. 
 
These are the first systematic, country-level estimates for multiple causes of neonatal death, 
detailing inputs and methods, as well as providing uncertainty estimates.
1;11 The WHO has used 
these estimates in the World Health Report 2005
1;11 and has now institutionalised the 
methodology in the United Nations process for national and global estimates. In addition, these 
results were incorporated in the World Bank Disease Control Priorities publication and Data 
volume,
199 and are used for the GBD for the year 2005 (www.globalburden.org).  
 
Improving the estimates and data is not an end in itself, but is a means of moving to more 
attention, investment and action especially for the poorest countries, and indeed also the poorest 
families in transitional and even in rich countries. While global estimates are helpful for 
visibility and increasing policy and programme imperative, the most important use for cause-
specific data is at national and programme level. The marked variation in cause proportionate 
mortality emphasises the need for local data for decision-making (Figure 8.1). At country level 
these estimates and an update for 2004 have been used for national data profiles for newborn 
health in 46 countries in Africa,
38 and an input for MDG profiles for the 68 priority countries
198 
in the Countdown to 2015 reports.
33 
 
Although the uncertainty around modelled estimates is considerable at global level, it is wider 
still at country level. The major mismatch at country between the single and multi-cause model 
results for intrapartum-related neonatal deaths underlines the many factors affecting estimation 
at this more specific level. However, the data being used for programmatic priority setting in 
low income countries may be so misleading that national estimates are seen as a useful input  
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particularly where current data are utterly lacking or are misleading for programmes. For 
example, in Ethiopia only 6% of births occur in hospital and less than 5% of the estimated 
120,000 neonatal deaths are in facilities. Yet the data for neonatal deaths in facilities was used 
as the basis for decision-making for the national child survival strategy in 2005. This pie chart 
reported very few neonatal deaths due to tetanus, a low proportion of neonatal infections and 
included a very high proportion of intrapartum deaths, probably because of referral bias. The 
multi-cause model estimates suggests that in Ethiopia tetanus accounts for 7% and 
sepsis/pneumonia for 36% of neonatal deaths. These are the most feasible causes to address in 
the local health system context. The Ethiopian Federal Ministry of Health and UN agencies are 
now using the new neonatal cause-of-death estimates as basis for planning.  
 
Even in South Africa there are no nationally representative, reliable cause-of-death data for 
neonates. Vital registration coverage is at about 80% of adult deaths, but lower for neonatal and 
child deaths. Facility based audit data for the national Perinatal Problem Identification 
Programme (PPIP), or “Saving Babies”, covers about 20% of births
200 and predominantly pre-
discharge deaths, selectively missing infections in the late neonatal period. Policy dialogue 
around the estimates from the multi-cause model has raised awareness of the “missing” 
infections in the national data and highlighted the need to address these programmatically, and 
also to improve data collection. 
 
Proportionate cause-of-death in the neonatal period is closely associated with the level of NMR 
(Figure 8.1). The higher the NMR is, the greater the proportion of deaths due to infections and 
tetanus. For example, at NMRs of over 45 per 1000 more than half of neonatal deaths are due to 
infections and tetanus, whereas at NMRs of less than 15 only 15% are due to infections and 
tetanus is a negligible proportion.
2  Hence if there are no useable data for neonatal cause-of-
death and no local estimates, the level of NMR can be used as an approximate guide, at least for 
programme priority setting.
27 This variation of cause proportionate mortality by NMR level has 
been used in some planning and prioritisation exercises to phase neonatal care strategies.
27  
  
These estimates advance the science of systematic cause-of-death estimates, particularly in 
terms of simultaneous estimation of multiple causes of death within a given time period. The 
uncertainty estimates provided are wide but still do not capture all the potential sources of 
uncertainty. The next section of the thesis discusses in more detail the estimation process and 
implications for future estimation. 
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Figure １６ 8.1  Estimated distribution of causes of neonatal death for 192 countries, according to 
the level of neonatal mortality rate 
 
Figure from Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? Lancet 2005; 
365: 891-900. 
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8.2   Improvements implemented for estimation of neonatal cause-of-
death, limitations and implications for improving future estimation 
 
In developing these neonatal cause-of-death estimates recent advances in global estimation 
science have been applied (Chapter 3). Further innovation introduced particularly for multi-
cause estimation which has many theoretical advances but in reality is challenging to undertake, 
particularly given the complex statistical approaches required.
12  Despite the wide uptake of the 
results by the UN,
1;11 Countdown
33 other global burden groups, and national level use, major 
limitations remain. The estimates for 95% of neonatal deaths (111 countries, 3.8 million deaths, 
study data model) were based on data on fewer than 14 000 neonatal deaths from 56 studies. 
The substantial uncertainty around these estimates is inevitable given the limited quantity and 
quality of data from the settings in which the great majority of neonatal deaths occur, and 
improving the input data will be discussed under section 8.3. In this section the focus is on 
further improvement of the estimation process. In order to systematically examine the strengths 
and weaknesses of this work and implications for future advances, the steps in the estimation 
process outlined in Chapter 3 will each be examined in turn and summarised in table 8.2. 
 
 
8.2.1  Case definitions for cause-of-death  
The lack of consistent case definitions and rules in hierarchical assignment of causes hinders 
comparisons across time and between studies, and particularly between VR and verbal autopsy 
(VA) data. There was substantial variation in the distributions of causes between individual data 
sources in both the VR and the study datasets, although highest for the study data (Chapter 5). 
The equations within the multi-cause model explain only some of this variability, and the R-
squared value is better for some causes, e.g. tetanus. Challenges in predicting ratios involving 
the “other neonatal” cause category are not surprising since this category is a combination of 
several specific causes of death such as jaundice and haemorrhagic disease of the newborn and 
hence hard to predict as one entity. Some of the variation in proportionate mortality by cause 
shown in the input data is likely to be due to true epidemiological variation. For example, in 
figure 2 the outlying studies with a higher proportion of tetanus deaths were from populations 
with extremely low (<10%) tetanus immunisation coverage.  
 
Inconsistencies in the attribution of cause-of-death also play an important role, however. 
Preferences were apparent for certain codes in certain countries and also probable 
misclassification between causes such as between preterm and infections in both VR and VA 
data (Chapter 5). Addressing this issue in input data is not possible through modelling alone but  
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modelling advances may contribute to some extent.  If datasets with significant misclassification 
could be identified consistently and objectively and if the direction of the effect is consistent 
then a dummy variable could be introduced into the cause specific equation to reflect this. 
Another more feasible option, at least for the study data, is the introduction of a dummy variable 
for quality of case definitions and hierarchy applied. We did test a number of data quality scores 
but none remained in the final model. Hence, the only real solution is improvement in the input 
data, which is discussed in Section 8.3.3. 
 
 
8.2.2  Input data and inclusion criteria 
There are challenges to overcome in developing estimates, not least of which is the lack of 
reliable data.
46 While inclusion criteria were explicit, in many cases authors’ descriptions of 
case definitions was limited or ambiguous and few gave detailed algorithms or information on 
the hierarchies applied. Extensive efforts have been made to systematically identify and use the 
best information available. Of the almost 7,000 abstracts screened, only 48 published studies 
(and 8 unpublished datasets) provided population-based, comparable cause-of-death data for 
enough causes of neonatal death to meet the inclusion criteria for the multi-cause modelling. 
There are large areas of the world, representing approximately one third of neonatal deaths, with 
no useable input data at all.  Most crucially, no useable data were identified for many of the 
world’s poorest countries which together account for about one third of neonatal deaths.
46  It is 
possible that some publications or unpublished data were missed due to language barriers, 
despite not limiting searches by language. Attempts were made to contact researchers in China, 
Latin America and Francophone West Africa. Approximately one third of the studies included 
are from India, which accounts for 28% of the world’s neonatal deaths. Data are particularly 
lacking from central and north western Africa, central Asia and much of China. This makes 
recent studies from Kintampo
6,7 and Navrongo
26 demographic surveillance sites in Ghana 
particularly welcome. The lack of available data from China is a wider issue than for neonatal 
death alone and indeed is a recurrent theme for all the expert groups in the GBD work. A 
sustainable and nationally used data source that can be shared outside the country is an 
important priority for global health estimates given the size of China population.  
 
In the data screening process the single largest group of studies excluded were those facility-
based studies that were not likely to be representative, in populations where less than 90% of 
women give birth in facilities. These studies were excluded because the distribution of causes of 
death in these studies may not reflect the distribution of causes of death in the general  
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population and the direction of selection bias is not predictable. For example, if obstetric referral 
is effective, then birth asphyxia will be over-represented in facility-based data.
73 Conversely, in 
isolated areas with low demand for facility-based care, facility-based data may under-estimate 
asphyxia as a cause-of-death.
74  
 
The data included in many regions are dependent on international research sites (Chapter 5 
figures 5.2 and 5.3). It is possible that the populations in these long-term study sites are 
systematically different from the national populations of their host countries. Local data 
regarding immunisation coverage and other characteristics that may differ from the national 
level may be important to avoid introducing systematic biases into estimates. While the use of 
local covariate data (for example, high tetanus toxoid coverage data) may account for some of 
this population unrepresentativeness through modelling, there may well be other variables 
unaccounted for that result in biases. Some of these biases may be in the direction of worse 
health outcomes (e.g. study sites selecting higher mortality populations) and some may be in the 
direction of better health outcomes (e.g. study sites with lower mortality because they are easier 
to study or have already benefited from health intervention trials). It cannot be assumed that 
these two biases would cancel each other out. In order to avoid future heavy dependence on 
opportunistic data not originally collected for this purpose, investment is needed in larger scale 
data collection that is regular and consistent over time. Examples include a VA follow up study 
after national DHS, and establishing a Sample Surveillance site such as in India and China. 
 
Other exclusions were for the specific quality criteria set. For example, studies with few deaths 
of known cause (<20) which were mostly small studies in rural India. Such a small number of 
deaths are too unstable for proportionate mortality evaluation. A number of studies were 
excluded due to reporting less than 5 causes of neonatal deaths. Very few studies (3) had 25% 
or more unknown neonatal cause-of-death and were excluded on this basis. Similarly, a few 
studies were excluded because they covered a period of less than a year. Most causes of 
neonatal death are not strongly seasonal, apart from the small proportion due to diarrhoea, and 
possibly pneumonia. However, in most countries birth rates show seasonality. This may result 
in bias if a short period of data collection coincided with a peak in deaths just because of 
variation in the overall birth prevalence, or for example in a peak in preterm births such as may 
occur 6 or 7 months after a major holiday. 
 
These exclusions all carry lessons learned for design of future studies. Publication of a set of 
guidelines for study quality for cause-of-death studies in general, with specific guides for  
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various causes including neonatal cause-of-death, may help improve the design of future 
studies. In addition, it could be argued that VR data with coverage of 80% or 85% are better 
than one or two small studies or no national data at all, and future estimation processes should 
consider sensitivity analysis looking at inclusion of varying VR quality cut-offs.  
 
 
8.2.3  Methods and modelling 
Given the lack of population-based cause-of-death data for most of the high burden countries, 
modelling is the only option for cause-of-death information for the near future, not just for 
neonatal deaths or child deaths, but also in many countries for adult deaths. If modelled results 
are presented as if they are “real data” this creates a false impression that more data are 
adequate. Hence transparency in modelling methods is not just good practice but is important in 
highlighting data gaps. In both the single and multi-cause neonatal mortality models, every 
attempt has been made to explicitly detail inputs, modelling equations and key assumptions.   
  
In addition to other limitations on input data and modelling methods, a further constraint is the 
lack of local input predictor data to account for atypical study populations. Sourcing predictor 
data as close as possible in time and place to the study population was very time consuming but 
considered worth the investment given the atypical nature of many of these populations 
particularly in long standing research sites such as the Gambia MRC site. Other indicators 
which may be more closely linked to addressing intrapartum complications such as emergency 
obstetric care coverage could not be tested for fit due to lack of comparable national data for 
coverage affecting both the input dataset for modelling and the generation  the output national 
estimates which require recent national level data. 
 
 
8.2.4  Single versus multiple proportionate cause-of-death modelling  
For estimation of proportionate cause within a given period, a multi-cause model is more 
challenging but preferable, as discussed in Chapter 3. For estimating one cause-of-death   
consistently over time, for example neonatal tetanus or measles, a single cause model may be 
appropriate, but should follow similar steps and where possible avoid input of studies designed 
to measure only one cause because of the inherent biases. 
 
The multi-cause modelling approach used here builds on that used previously for child deaths, 
based on Seemingly Unrelated Regression applied to log ratios of causes.
12 For this exercise  
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multinomial regression models were used and these offer a number of advantages. First, this 
approach can handle studies which do not provide information on all the causes of death being 
modelled by applying assumptions about the category into which unreported causes have been 
assigned. Using the log ratio approach, such studies were excluded.
12 Second, the log ratio 
approach faces a problem with rarer causes which result in zero deaths in a proportion of data 
sources. A non-zero value must be introduced, but the choice of which non-zero value to use 
may affect the results obtained from the model and this contributed to the low proportion of 
deaths assigned to measles in the under five child mortality multi-cause model developed by 
Morris et al.
4812 Using the multinomial model, zeros are modelled naturally this challenge is 
avoided.  Further advances are possible and a range of models for first day, first week and late 
neonatal periods is of use for policy and programmes. A key input would be improved predictor 
variables that explained more of the variability between causes, which is complicated by the 
need for covariates that are able to predict a difference in the ratio to the corner cause. For 
example, the coverage of skilled attendants at birth may correlate with the proportion of 
neonatal deaths that are intrapartum-related, but may not be predictive for differences in the 
ratio of preterm birth to intrapartum-related neonatal deaths as the predictor may have a similar 
effect on both causes. Hence the range of predictors is restricted to those available for all 
countries and able to predict the relationship between changes in proportionate mortality as a 
ratio. 
 
 
8.2.5  Uncertainty ranges 
In the past, uncertainty around estimates has been portrayed as the 95% Confidence Interval of 
the input data. However this is a very limited part of the considerable uncertainty inherent in an 
estimation process where data are limited, of variable quality and multiple sequential 
assumptions may be multiplicative not just additive for the uncertainty. The approaches used to 
estimate uncertainty in these two models do take account of uncertainty in the modelling and to 
some extent in the input cause-proportionate mortality data, particularly the jackknife approach 
used for the multi-cause model. The uncertainty around neonatal death estimates is expected to 
be considerable but is not included as WHO did not provide this information.  
 
For the multi-cause model it is clear that the uncertainty varies by cause and in most cases is 
asymmetric (Table 7.2). For example, for the category of “other neonatal” causes of neonatal 
deaths the uncertainty range is from 0.19 to 0.62 million, which is almost 30% below but 134% 
above the point estimate. This makes sense. For large causes, the upper limit is set by the total  
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number of deaths so expect more uncertainty below. For rare causes which have a low 
proportion, the minimum is zero so more uncertainty is expected above the point estimate 
giving an asymmetrical distribution of uncertainty. 
 
There are no clear guidelines on estimation of uncertainty in national and global estimates and if 
left to individuals it may be highly misleading. The WHO World Health Report 2005 was 
unable to give uncertainty around the child cause-of-death estimates as the approaches used for 
different estimates were non-comparable. These differences probably reflect the assumptions 
applied in estimating uncertainty more than they reflect real differences in the uncertainty of 
different estimates.
44 For example, the uncertainty bounds for the CHERG estimates for child 
health varied from around 10% above and below the point estimate for malaria mortality
201 to 
the much wider uncertainty shown around the neonatal results. The malaria estimates also have 
major inherent uncertainty since there are limited input data, mostly from malaria study sites, 
and the data are based on fever symptoms reported through VA rather than screening blood for 
parasites. Assumptions were also applied at a number of key points in the malaria estimates 
process but were not reflected in the uncertainty estimates provided.
46 Standard guides and 
advances in the uncertainty estimation methods would help to promote a conservative and 
comparable approach. Presenting wide uncertainty ranges underlines the lack of input data and 
many other sources of uncertainty in global estimates. 
 
 
8.2.6  Review process 
These neonatal cause-of-death estimates, and particularly the multi-cause model, benefited from 
a rigorous built in peer review process though the CHERG meetings every 6 months, hosted 
alternately by WHO and UNICEF. Many of the challenges experienced in cause-of-death 
estimation are not unique to the neonatal period. Cross group dialogue, for example with the 
pneumonia, malaria and diarrhoea groups resulted in new insights around key assumptions. 
Expert review is time consuming and takes a high level of expertise. Currently this expertise is 
limited in most of the countries with the highest burden of newborn deaths. Capacity building in 
perinatal epidemiology is key both for review and revision of estimates, but also to critique and 
improve current data.  
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Table  ⑰8.1  Advances implemented in neonatal cause-of-death estimation and implications for further improvements in estimation 
 
Step in 
estimation process 
ADVANCES IN IMPROVING ESTIMATION  IMPLICATIONS FOR FURTHER ADVANCES 
1.  Case definitions 
for cause-of-death  
-  Shift from perinatal causes to programmatically relevant categories 
of cause-of-death 
-  A minimum list of cause-of-death categories that can be used in low 
income countries, and mapped onto more complex specific causes 
used in high income countries i.e. VR codes from ICD 9 and ICD10 
requiring examination of the ICD codes in the neonatal period to set 
up this mapping process 
-  Consensus case definitions and increased detail for causes 
if desired – e.g. split ’other’ category to show jaundice, 
split infections into specific infection syndromes 
(pneumonia, sepsis, meningitis) 
-  Consensus on classification and hierarchies and standard 
application in Verbal Autopsy use 
-  Simplifying ICD, minimum list of ICD 10 codes that links 
with VA tool 
2.  Input data  -  All data sources examined including a new analysis of VR data from 
countries with high coverage of registration, systematic searches of 
published literature and attempts to identify unpublished literature 
-  Explicit inclusion criteria for data regarding population 
representativeness and regarding comparability for causes of death 
-  Methods to increase coverage of neonatal/child cause-of-
death data through existing data collection e.g. VA after 
DHS, DSS, Sample SS 
-  Explicit quality criteria to guide design of future studies 
e.g. data reported by year  
-  Exploratory analysis regarding  use of facility data  
3.  Methods and 
modelling 
 
-  VR data to be used for the country of origin or for modelling for 
countries with similar NMR, or as an input to a model with other 
data covering high NMR countries. VR data from low NMR 
countries should not be used as the sole data to predict proportionate 
mortality in high NMR countries 
-  Explain the models, assumptions made and publish the equation(s) 
-  Potential use of historical VR data to predict proportionate 
mortality for countries with a similar NMR 
4.  Single 
proportionate 
cause-of-death 
modelling versus 
multi-cause 
-  For estimation of proportionate cause within a given time period a 
multi cause model is preferable 
-  If estimating one cause-of-death, single cause model may be 
appropriate, but should follow similar steps and where possible 
avoid input of studies designed to measure only one cause because 
of the inherent biases 
-  Simplification of multi-cause modelling 
-  Increased detail for causal categories if desired 
-  Model for multi-cause neonatal deaths in first week and 
first day of life 
5.  Uncertainty ranges  -  Uncertainty estimates should be provided and should not be based on 
95% CI, but should take account of as many sources of uncertainty 
in the inputs as possible  
 
-  Better delineation of sources of uncertainty and methods to 
account for these in a comparable way across varying 
estimates 
6.  Review process  -  External expert group process should review the inputs, methods and 
results  
 
-  Expert review is time consuming and takes a high level of 
expertise – capacity building in perinatal epidemiology and 
especially in the high burden countries is key 
7.  Compare model 
predictions with 
local data 
-  Both single and multi-cause model estimates compared with local 
data for a range of NMR levels and meeting the criteria set for  
inclusion in the study database 
-  In addition to statistical comparison, review by country 
level policymakers increases ownership and use of the data 
in country and awareness of need for better data collection   
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8.2.7  Validation of model predictions by comparing with real data 
 
For both the neonatal intrapartum single cause and the neonatal multi-cause models a validation 
exercise was undertaken. The single cause model validation was undertaken at the time and 
included in the publication. For the multi-cause model all data meeting inclusion criteria had 
been used as inputs to the model and hence the validation awaited new high quality data for 
comparison. These validation exercises suggest the models are performing well with remarkably 
close agreement to real data. There are a few variations which are small in absolute terms and 
would be expected given selection biases in the study datasets used for validation key causes for 
the multi-cause model. For example, the India study was in a poor rural population with NMR 
almost 50% higher than the national average, and so would be expected to have a higher 
proportion of neonatal deaths due to tetanus than in the model which is predicted at national 
level.  However, the variation between model and study data for birth asphyxia and preterm is 
high both for the India study and the Ghana study, and is in the opposite direction– for India 
where the study reports the preterm proportion as higher than the model prediction.  In contrast 
in the Ghana study data ‘birth asphyxia’ is higher than the model prediction. This is a recurrent 
issue in data quality, with misclassification between preterm and birth asphyxia, particularly 
where the case definitions are the older clinical case definitions based on condition at birth and 
low Apgar score (Chapter 4).  Section 8.3.3 discusses advancing the case definitions, tools and 
hierarchies to address this challenge.  
 
Conclusions regarding advancing the modelling 
The neonatal multi-cause modelling process has been established as a regular exercise every 
five years by the CHERG to revise input data and reconstruct the model. The 2005 estimates 
will also feed into the GBD.  In the intervening years incremental updates are possible with a 
much faster exercise applying the same multi-cause model but using the latest national predictor 
variables and the annual estimates of neonatal deaths.  
 
There is interest from policymakers in models for cause-of-death by time blocks within the 
neonatal period, notably early and late, and ideally also for the first day of life. There is a 
tension between the demand for increased granularity in the causal categories, which increases 
the complexity of the dataset construction and the modelling, and on the other hand the desire 
for simpler modelling processes and wariness of spurious results especially once the estimates 
are being published and used at country level. The only real solution is to improve the input 
data.  
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8.3 Improving the input data for neonatal deaths now and the research 
agenda 
 
8.3.1 Overview of improving the data 
 
Despite a large number of neonatal deaths, reliable information is lacking on the numbers of 
these deaths,
4 even more so for cause-of-death.  This exercise has highlighted the paucity of 
reliable, representative data on the causes of neonatal death from settings in which most 
neonatal deaths occur (Chapter 5).
46 While improved and transparent estimation methods are 
important, the quantity and quality of input data must be improved. If not, then at the time of the 
next cause-of-death estimates in five years or even after the target of the MDGs in 2015, we will 
still be basing decisions on estimates with inevitably wide uncertainty due to the lack of useable 
data. 
 
Data collection for intrapartum-related neonatal deaths, or generally for neonatal cause-of-death, 
cannot be separated from other streams of national data collection. Improving national data 
collection systems in low income countries is a global priority given the focus of the 
international community on tracking the MDGs and increasing investment in health and 
development.
46 Significant funding and several new global initiates have been launched to 
improve health metrics.
202 Pregnancy outcome data are crucial for MDG tracking and especially 
for the goals 4 (child survival) and 5 (maternal health). For many of the priority indicators for 
MDGs 4 and 5, the numerators depend on pregnancy outcome data and for almost all the 
indicators the denominator is live births.  
 
While the biggest data gaps are in the poorest countries with the highest burdens, there are also 
missing data in high-income and especially transitional countries. In addition, as mortality falls, 
the risk of disabled survivors becomes more of a public health issue and the countries with the 
least data on morbidity outcomes are transitional countries where the problem is likely to be 
greatest, including large countries such as China.  
 
Table 8.2 summarises actions possible now to improve the data, and research questions with a 
focus on low income countries. Then the following key data areas will be discussed in detail: 
1. Counting neonatal deaths, all births and other pregnancy outcomes 
2. Case definitions and hierarchical cause-of-death attribution  
3. Neonatal morbidity and risk factors  
4. Counting avoidable factors and sub optimal care 
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Table  ⑱ 8.2  Improving country level data for neonatal deaths– what can be done now and what are the key research questions? 
 
  ACTIONS TO IMPROVE DATA   RESEARCH QUESTIONS  
(low income country focus)  High income Low income countries
1. Counting 
pregnancy 
outcomes 
including 
all births, 
maternal 
deaths  
neonatal 
deaths 
stillbirths  
VR and use of specific death 
certificates for stillbirth and neonatal 
deaths.  
Crosslink civil registration system and 
health system databases  
Household surveys (retrospective): use of pregnancy history not 
birth history in DHS to better capture early neonatal deaths and 
stillbirths, promote inclusion of key modules in UNICEF MICS 
 
Demographic surveillance sites (prospective): Consider Sentinel 
Surveillance sites especially in large countries (e.g. India and 
China), or network or study sites (e.g. INDEPTH) 
 
Improve VR: Increase coverage and quality of births and deaths 
registration, crosslink civil registration system and health 
system databases 
-  Improving measurement of pregnancy 
outcomes in surveys – e.g. comparing 
pregnancy history and birth history for 
validity and  additional time taken during 
survey 
-  Developing a “quality score” to assess 
neonatal mortality data for 
representativeness, age heaping etc 
-  Novel use of facility data – can 
recognised biases in facility data be 
adjusted for using modelling? 
2. Case 
definitions 
and 
hierarchical 
cause-of-
death 
attribution  
Consensus on consistent list of 
programmatically relevant, comparable 
categories, case definitions, and explicit 
hierarchy 
 
 
Data collected through: 
-  VR  
-  Confidential enquiry systems 
-  Special studies 
Consensus on consistent list of programmatically relevant, 
comparable categories, case definitions, and explicit hierarchy 
 
Verbal autopsy studies with standard data collection  tool, and 
hierarchical attribution  
 
Data collected through: 
-  Follow up study after household surveys (e.g. DHS) 
-  Demographic Surveillance Sites (e.g., sentinel sites) 
-  Improved VR 
-  Special studies 
-  Evaluation of standard verbal autopsy 
tool, case definitions and hierarchy, 
mapping more complex sub categories 
from ICD onto the basic list of 
programmatically relevant causes.  
-  Effect of varying hierarchies on 
proportionate mortality  
-  Comparison of cause-of-death allocation 
by experts or by computer algorithm 
-  Inclusion of a standard social autopsy 
module. 
3. Neonatal 
morbidity 
and risk 
factors  
Standardise case definitions for 
tracking morbidity e.g. neonatal 
encephalopathy 
 
Crosslink existing databases (e.g. 
perinatal follow up and cerebral palsy 
registers) 
Standardise case definitions for tracking morbidity e.g. neonatal 
encephalopathy. Data collected through: 
-  Demographic Surveillance Sites (e.g., sentinel sites) 
-  Special studies 
 
-  Improving gestational age data – e.g. 
weight as a surrogate, simplified clinical 
assessment  
-  Developing disability assessment 
standards, simpler tools across cultures 
(e.g. motor, IQ) and set  protocol for 
what to measure at what age  
4. Counting 
avoidable 
factors,  and 
sub optimal 
care 
National audit systems with regular 
reports on data and trends, as well as 
specific themes e.g. intrapartum 
stillbirths 
 
Consider confidential enquiry for 
maternal, infant deaths and stillbirths 
Audit system for maternal, neonatal deaths and stillbirths. 
Collate data nationally and promote sentinel sites in varying 
regions and health systems contexts so information can be 
useful for policy prioritisation whilst not representative. 
Consider focus on few indicators initially e.g.  intrapartum 
stillbirths and pre-discharge neonatal deaths in babies >2000 g 
-  Evaluation of simplified audit tools and 
mechanism to maximise resultant change 
in policy and programmes  
 
 
For more details on INDEPTH network of surveillance sites please see Definitions section of this thesis, page 16 
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8.3.2 Counting pregnancy outcomes  
 
What to count? 
For most of the history of global health the focus has been on measuring fertility and child 
deaths, particularly in large scale surveys. Maternal mortality has also become a programme 
priority and a measurement challenge.
203;204 Global attention on the time of birth has recently 
increased with recognition that almost 40% of child deaths under the age of 5 years occur in the 
first month of life, indeed 30% in the first week of life.
4 However, one large group of deaths yet 
to count or to be counted are stillbirths, here defined as babies dying during the last trimester of 
pregnancy. A baby who dies five minutes after birth, or indeed who has a detectable heart rate at 
birth, counts in the global estimates of child deaths. A baby who dies even in the process of 
birth does not count.
51 Stillbirths are not reported in WHO routine mortality data, or included in 
the MDGs or the GBD, although novel work is in progress to develop methods to achieve 
this.
199 The epidemiological, programmatic, and rights-based arguments for improved 
measurement of stillbirths have already been summarised (Chapter 5).  In moving forward the 
key pregnancy outcomes to capture are all births, stillbirths, neonatal deaths and maternal 
deaths. In addition low birth weight, prematurity and NE are important intermediary outcomes 
to measure.  
 
How to collect the data?  
In high income countries VR provides a good source of data for most pregnancy outcomes, 
although stillbirths may continue to be under-reported. Currently national stillbirth data is not 
included in many population-based surveys or collated annually by any international 
organisation, in contrast to annual reporting to WHO of deaths among live born infants. The use 
of specific death certificates for stillbirths and neonatal deaths improves capture of specific data 
such as intrapartum complications and gestational age. Most European countries have specific 
perinatal certificates, but few low and middle income countries do. 
 
In the short time left until 2015 it is unlikely that VR will reach the benchmark of 90% coverage 
of adult deaths in most South Asian and Sub Saharan African countries where fertility and 
mortality are highest (Chapter 5). For some countries – notably India and China – the strategy is 
to develop Sample Registration Sites which are spread across the country and designed to be 
nationally representative. However, these sites take some time to “mature” and valid assessment 
of pregnancy outcomes and especially reliable neonatal cause-of-death data is not expected in 
the next few years.
205 Hence for most low income countries the only nationally representative 
mechanism for pregnancy outcome data are intermittent household surveys, principally the DHS 
which takes place every 5 years in around 50 countries and whose core questionnaire uses a 
birth history module. To date UNICEF’s MICS includes minimal data around the time of birth  
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and relies on indirect mortality estimation for child mortality outcomes, not even a basic birth 
history. Increased investment in MICS means these surveys are being run in more countries and 
more often so inclusion of a pregnancy history could result in a major increase in availability 
and frequency of data.
206   
 
Is under-reporting an inevitable failing of retrospective data collection compared to prospective, 
or can retrospective surveys such as DHS improve stillbirth reporting, for example by using 
pregnancy history instead of birth history? Use of a pregnancy history in surveys would enable 
collection of regular, national stillbirth data and would likely to increase capture of early 
neonatal deaths. During the 1960s, ‘70s and ‘80s when data collection in low and middle 
income countries was expanding, there was tremendous experimentation in demographic 
methods for the collection of fertility and mortality data. The World Fertility Surveys applied 
both backwards and forwards questioning for pregnancy histories. Casterline analysed 
pregnancy loss data in 41 of these retrospective surveys,
207 concluding that various formats of 
pregnancy history compared to results from prospective, clinical studies in Western countries 
detected 50-85 percent of all recognisable pregnancy losses, with stillbirths after 28 weeks 
better captured than earlier pregnancy losses.
207  There is a trade-off in terms of length of 
questioning, and receiving valid answers, that has not been well studied, and this is a general 
concern given the hundreds of questions (>700) in the current DHS core questionnaire. 
(www.measuredhs.com)  
 
Advancing the tools and key research gaps 
Thus, many questions remain unanswered regarding the most valid, reliable, feasible and 
affordable means of collecting nationally representative pregnancy and vital events data in 
different settings. Key questions include: comparing the validity and time taken for pregnancy 
history compared to birth history; comparison of complete live birth or pregnancy histories with 
histories truncated in time (e.g. the last 5 years). The goal of such research efforts should not be 
restricted to identification of the methods to achieve the highest quality, but to identify feasible 
ways to collect affordable, comparable data at scale – for example quantifying the loss of data 
quality for a truncated versus a complete live birth or pregnancy history, or a survey covering 
wide-ranging issues versus a highly focused questionnaire, balanced with time or cost savings.  
The expanded number of demographic surveillance sites in various low and middle income 
world regions offer opportunities for examining these questions regarding retrospective 
reporting of pregnancy outcomes in a site with prospective data to use as a “gold standard.”  
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8.3.3 Cause-of-death data 
 
What to count? 
There has been a shift from the group category of “perinatal causes” based on the Perinatal 
chapter of ICD
2, to programmatic categories for causes of neonatal deaths (Chapter 4). Six 
selected categories, with a residual group of ‘neonatal other’ were outlined in Table 4.1 and 
have been used for the multi-cause modelling. While a few are single causes, such as neonatal 
tetanus, most are causal categories and some such as congenital include hundreds of specific 
diagnoses. Where the health information system capacity allows this, analysing more detail 
within these causal categories may be useful for programmatic planning and tracking. Table 8.3 
proposes relevant sub groups possible through facility data, and VR data which can map onto 
the basic 7 categories which are possible in VA data.  This layered approach allows comparison 
across different countries and levels of data capacity, but still enables high income, high data 
capacity settings to have more complex and detailed information. 
 
Table  ⑲8.3  Case definitions for neonatal cause-of-death showing mapping of seven programmatic 
categories which are possible in Verbal Autopsy onto more detailed categories possible where 
complex data collection is at high coverage  
 
Cause-of-death 
category  
(possible through VA) 
More detailed cause-of-death 
sub-category (possible through 
clinical audit data or VR)
Finer level of 
detail (with ICD 
codes from VR)
Congenital abnormalities  Chromosomal abnormalities 
Cardiac defects 
Neural tube defects 
Other major structural abnormalities (e.g. 
abdominal wall, gastro-intestinal, genitor 
urinary) 
Other congenital (residual) 
  
Specific e.g. which 
chromosomal 
abnormality, defined 
cardiac defect e.g. 
Fallot’s  tetralogy 
Neonatal tetanus  Neonatal death due to tetanus 
 
- 
Preterm birth  Surfactant deficiency (Respiratory distress 
syndrome),  
Intraventricular haemorrhage, 
Necrotizing enterocolitis  
 
Specific 
complications or other 
more detailed codes 
Intrapartum 
(Birth asphyxia) 
Neonatal encephalopathy  
Birth injury 
 
More details eg type 
of birth injury 
Sepsis/ pneumonia  Sepsis/septicaemia 
Meningitis 
Pneumonia/ acute respiratory tract infection 
 Other neonatal infection 
 
Specific organisms 
Specific 
complications  
Diarrhoea  Neonatal death due to diarrhoea  
 
Specific organisms 
Other   Neonatal jaundice  
Haemorrhagic disease of the newborn 
Term baby dying due to in-utero growth 
restriction 
Sudden Infant Death Syndrome 
Injury (deliberate and accidental) 
 
Multiple codes 
possible in ICD   
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Case definitions do have an effect on proportionate outcome, particularly for “birth asphyxia” 
(Chapter 4), but the major effect on proportionate mortality comes from varying the 
hierarchy.
130 For example the WHO and London School of Hygiene and Tropical Medicine 
child survival VA tool which categorised all deaths in the first 3 days of life as “early 
perinatal”.
52 In addition, since diarrhoea was the first category in the hierarchy and congenital 
was far down the hierarchy, a baby with a neural tube defect and incontinence would be coded 
as dying from diarrhoea. The next generation of VA tools in the late 1990s followed two 
different approaches in attributed cause-of-death amongst preterm babies. One extreme is to 
assume that for all preterm babies who die, preterm is assigned as the cause. This does not 
follow ICD rules, and also results in the vast majority of deaths in one large category (60 to 
95%) which reduces the value for public health prioritisation. At the other extreme, preterm 
birth is the last on the hierarchy and so it is only considered a cause if the baby did not die of 
anything else. It also classifies all babies not breathing at birth as being due to “birth asphyxia”, 
which is an over-estimate for intrapartum neonatal deaths in term babies and an underestimate 
for preterm birth complications.
208 Adapting from NICE,
65 the CHERG expert group developed 
a hierarchy (Figure 8.2) which has since been used by several large VA studies, including in 
India
56 and Ghana.
99;141   
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Figure １７ 8.2  Hierarchical classification system for causes of neonatal death used by the Child 
health Epidemiology Reference Group 
 
Unexplained cause of death in the neonatal period
Other specific cause in the neonatal period 
(eg, jaundice, haemorhagic disease of the newborn, injuries) 
Diarrhoea
Neonatal infections                                                                  
(sepsis, pneumonia, meningitis)
Intrapartum‐related
Preterm direct complications or gestational age <34 
weeks (approx  equivalent of < 2000 gms birthweight)
Neonatal Tetanus
Congenital abnormality
Neonatal deaths
 
 
Note: the hierarchy is consistent with table 4.1. If congenital abnormality and neonatal tetanus are both 
present then expert opinion may be required to determine the primary underlying cause. Congenital 
abnormalities are markedly underestimated in verbal autopsy data as only obvious external abnormalities 
will be detected and congenital heart disease is commonly misclassified as infection.  
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How to collect the data? 
As with counting pregnancy outcomes, the potential data mechanisms for cause-of-death will 
vary by country. For high income countries, VR data are high coverage but not always high 
quality. There are multiple codes used for causes of death in the neonatal period – in this 
analysis we identified around 12 000 codes across the 83 countries. WHO have proposed a 
marker of quality for VR based on the proportion of cause-of-death codes that are considered to 
be “garbage” codes.
133   
 
For low and middle income countries, while increasing coverage and quality of VR is important, 
in the short to medium term other larger scale data collection mechanisms are urgently required, 
not just for neonatal cause-of-death but also for child and potentially stillbirths and maternal 
deaths. The main options were outlined in Chapter 5 and include Sample Registration sites, 
networks of DSS such as the INDEPTH network (see page 16 for more detail), follow-up 
studies after national DHS and special research studies. Follow-up studies after nationally 
representative DHS are especially promising, for example in Bangladesh,
209 Egypt
168 and a 
recent one in Pakistan which is the first to include stillbirths and maternal, neonatal and child 
deaths (Prof ZA Bhutta, personal communication). If investing in these or other special studies 
for cause-of-death or morbidity data, it would be crucial to consider quality criteria in designing 
sample size, seasonality issues and use of standard tools so that the data will be comparable and 
useful for policy and programmes. 
  
One recently suggested option is that of using data collected at health facilities and correcting 
for known biases with modelling. Facility data may differ systematically from population based 
data in a predictable manner - the case mix, for example, might show a higher proportion of 
intrapartum-related neonatal deaths in high-risk and referred infants. Such modelling could 
provide a useful, and inexpensive, tracking method.  
 
Advancing the tools and key research gaps 
Recently the Health Metrics Network have facilitated a process to develop standard VA data 
collection forms  for neonatal deaths, child deaths aged 1 month to 5 years and all deaths from 5 
years to old age.
131 The neonatal VA form is only 8 pages long and takes around 30 minutes to 
administer.
27 The variables provide enough information to categorise a stillbirth into intrapartum 
or antenatal as well as attribute a neonatal death to any of the 6 specific categories and also to 
jaundice and haemorrhagic disease of the newborn. This allows comparable cause-of-death with 
high income countries, mapping with ICD codes.  
 
A standard VA questionnaire is an important step, but will not necessarily prevent questionable 
variation in cause-proportionate mortality patterns if subsequent steps remain unstandardised.  
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However there is as yet no specific algorithm or guide for attributing causes of death. More 
research is required to compare expert opinion as used in most VA studies, with expert option 
using an algorithm (as per the recent Ghana Kintampo VA study),
99 with computer algorithms. 
The Bill & Melinda Gates Foundation Grand Challenges VA research group based at Johns 
Hopkins are attempting to develop computer algorithms (Baqui, personal communication). 
Another important area of research for VA is to detail the implications of varying algorithms. 
Recent analysis by Lee and colleagues
130 using a dataset from Nepal has examined various 
hierarchies for birth asphyxia and shows major differences in the proportionate mortality 
attributed to birth asphyxia depending if it is put above or below preterm birth in the hierarchy. 
Through another Gates Grand Challenges grant Murray and colleagues are using probabilistic 
approaches to allocate cause-of-death.
30 All of these hold potential to make verbal autopsy both 
more standardised and also less reliant on time-intensive expert input which may extend the use 
of the tools beyond research teams. 
 
 
8.3.3 Neonatal morbidity and risk factors 
What to count? 
As neonatal mortality falls, the risk of disabled survivors becomes a significant public health 
issue. The countries with the least data on morbidity outcomes are transitional countries where 
the problem is likely to be greatest, including huge countries such as China. A major discussion 
of neonatal morbidity outcomes is beyond the scope of this thesis, but comparable, high quality, 
population-based neonatal morbidity data are almost entirely lacking in low income countries.
210 
Without more systematic attention now to embedding morbidity measures in studies and in 
health information systems in low and middle income countries, there will be little or no useable 
data for public health planning on major issues from multi-domain disability (cerebral palsy) to 
specific impairments such as retinopathy of prematurity.  
 
Specifically for intrapartum-related outcomes, the key is to track the incidence of NE. In 
settings with higher coverage of skilled institutional delivery use of simplified scoring systems 
is feasible but at community level assessment of NE is only potentially feasible in research 
studies and even then proves challenging (personal communication Dr Anne CC Lee). 
 
Preterm birth is an important morbidity outcome to track in terms of an adverse pregnancy 
outcome, but also to allow more useful cross tabulations of data, for example to identify what 
proportion of neonatal deaths attributed to infection are in preterm infants. Given the almost 
total lack of nationally representative data on gestational age in many low and transitional 
income countries, birthweight is often used as a surrogate. However, birthweight data are also 
missing for more than two-thirds of newborns in the least developed countries which account  
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for around two-thirds of the burden (Table 8.5). Other measurement options are simplified 
gestational age assessment and the possibility of asking maternal perception of gestational age 
or last menstrual period in DHS-type surveys. The “gold standard” of first trimester ultrasound 
gestational age assessment is increasingly the norm in transitional countries and in many urban 
settings in South Asia, but even when undertaken does not necessarily connect through to the 
neonatal records. 
 
Advancing the tools and key research gaps 
An important priority to ensure comparability is to develop feasible case definitions for tracking 
neonatal morbidities, especially NE, severe infection and jaundice. Increasing the national 
availability of gestational age data and the quality of birthweight data require innovation such as 
simplified gestational age assessment scores and birthweight scales or birthweight surrogate 
measures(e.g. chest circumference)
211 for low literacy CHWs.
212 Standardised but simpler 
disability assessment tools are required for use across varying cultures to assess IQ, but also 
motor skills. Assessment of behavioural abnormalities is a quagmire of non-standard terms. 
Consensus protocols for what to measure at what age are necessary to increase comparability 
across studies, particularly to develop summary estimates for exercises such as the GBD. 
 
 
Table  ⑳8.4  Regional variation of the percentage of babies weighed at birth around the year 2000 
 
Region  Percent of births  
weighed at birth 
South Asia  26 
Sub-Saharan Africa  35 
Middle East and North Africa  40 
East Asia and Pacific  70 
CEE/CIS 79 
Latin America and Caribbean  83 
“Developing” countries  42 
“Least developed” countries  32 
Source: Using data from
213 
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8.3.4 Counting avoidable factors and improving care 
 
What to count? 
Improving case definitions, while of relevance to estimation of burden of disease, may not 
directly link to the specific programme actions to reduce the burden. To reduce intrapartum-
related deaths the key information required for programmes is the proportion of intrapartum 
stillbirths and intrapartum neonatal deaths due to avoidable factors so that health system and 
community delays are identified and addressed, for example through perinatal audit. There are 
many examples of effective audit from high income countries – for example the UK 
CEMACH.
93 There are fewer examples from low income countries, particularly of audit at 
national scale – one example is from South Africa where the maternal audit is a national 
confidential enquiry.
200 Stillbirth and neonatal audit are voluntary, facility-based and currently 
cover about 20% of the country’s births. National reports are produced every 3 years, called 
Saving Mothers and Saving Babies. A new audit for children has started more recently. Most 
audits apply a common process that includes the following steps: 1) recording every death with 
underlying medical, administrative and social causes and discussing in a non-condemnatory 
way; 2) synthesis of data and identification of local priorities for action to reduce death, and 
implementation of these at local level; 3) Intermittent collation of national data to make national 
recommendations; and 4) implementation of these actions, then assessment of whether the 
recommendations have been undertaken. This last step in the process is the most critical and 
often lacking in most examples, especially at national scale. 
 
Advancing the tools and key research gaps 
Audit tools for use at scale in Sub Saharan Africa and South Asian facility settings may need to 
be simplified and adapted given the human resource crisis, especially in many African 
countries.  
Selecting a few limited indicators and using these to leverage change may be more realistic than 
comprehensive databases. One proposed indicator of particular relevance to intrapartum care 
tracking is the Intrapartum Case Fatality Rate – a composite of intrapartum stillbirths and 
predischarge neonatal deaths in term babies. This indicator has been proposed by United 
Nations Population Fund (UNFPA) as an addition to United Nations core indicators for tracking 
Emergency Obstetric Care.
214  Evaluation of the indicator and feasibility of use is required.  
Implementation research into mechanisms to maximise resultant change in policy and 
programmes using audit process could help to maximise the effectiveness of audit. Community 
level death audits or community and facility partner audit have been tested in small scale 
projects, but may be a useful tool for increasing facility quality of care and community trust.
23  
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8. 4    Summary for improving the estimates and improving the 
data 
 
The fifth and final objective  of the thesis was to summarise actions to improve estimates and 
input data for neonatal cause-of-death, particularly related to birth asphyxia, listing research 
priorities. Chapter 8 has detailed the steps involved in the estimation process, based on the 
review of methods in Chapter 3. The advances achieved, the challenges and suggestions for 
further improvements have been described. 
 
However the key issue in improving the estimates remains the quantity and quality of the input 
data. While the focus of the thesis is on cause-of-death proportionate data, the estimates for 
numbers of deaths by cause are dependent on the reliability of data regarding numbers and rates 
of neonatal deaths. Counting pregnancy outcomes is an essential step in capturing the numerator 
and the denominator for NMRs. Increasing VR coverage is the most comprehensive and also 
estimated to be the most cost-effective approach in the long term,
215 and would also advance the 
available cause-of-death data. In the interim other data collection systems hold promise such as 
Sample Registration and DSS with linked VA, or with DHS and subsequent VA studies. Data 
regarding neonatal morbidity and comparable assessment of long term impairment following 
neonatal complications are almost entirely lacking even at facility level in low income countries. 
This gap will become increasing important as care improves and more babies survive.   
 
The underlying purpose of perinatal epidemiology is not merely to improve the numbers and 
validity but to reduce deaths and disability - counting avoidable factors and improving care. 
Many research questions remain regarding improving both the process of data collection, 
refining the data collection tools and analysis, and the process of linking the data to action. 
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Chapter 9                                                             
Conclusions 
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Two clear messages resound. Firstly, while the data have uncertainties, there are now more than 
enough data to be certain that action is required to reduce around four million annual neonatal 
deaths, and around 910 000 intrapartum-related deaths. Secondly, while there are enough data to 
drive action, there are important data gaps and the poorest and highest risk families and 
countries have the least data and receive the least attention.  
 
Neonatal deaths are now on policy priority lists, but investment and implementation action are 
still not proportionate to the size of the burden. There is more progress in reducing neonatal 
deaths from infections and tetanus, than for intrapartum-related and preterm birth complications. 
Intrapartum-related deaths are a major contributor to the global burden of disease, accounting 
for almost one million neonatal deaths and are closely associated with over one million 
intrapartum stillbirths, maternal deaths due to direct obstetric causes and an unknown burden of 
NE and subsequent disability (Figure 9.1). The 910 000 intrapartum-related child deaths exceed 
the estimated 840 000 child deaths due to malaria.
5 Attention and investment in malaria is much 
greater and is increasing exponentially. The UN Summit in September 2008 committed $3 
billion of extra funding for malaria bednets, drugs and a vaccine – already more than the total  
invested in all of maternal newborn and child health in the 68 priority countries in 2006.
36 
Malaria deaths justify action, but in a data-based world, neonatal deaths and intrapartum-deaths 
should also be linked to investment and action. Panel 9.1 summarises priority actions for 
reducing neonatal deaths based on current data. 
 
Figure １８ 9. 1  The burden of intrapartum-related neonatal deaths, intrapartum stillbirths, 
maternal deaths and the unknown associated burden of neonatal morbidity and disability  
 
 
0.5 million  
maternal 
deaths
1.02 million  
intrapartum 
stillbirths
?? babies with 
Neonatal encephalopathy
910,000
(0.6 – 1.1 million)
neonatal deaths 
related to 
intrapartum events
?? Children and adults with poor 
development or disability
due to fetal/neonatal ill-health
50 million births at home each year
Inadequate coverage and quality of intrapartum care 
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Table  21 9.1  Applying the information to improve neonatal survival 
 
How many? 
  Reducing 4 million neonatal deaths is a moral imperative and essential for 
achievement of MDG-4 for child survival. 
 
When? 
42% of child deaths occur in the first month of life, up from 37% in the year 2000. 
 
Between quarter and half of all neonatal deaths occur within 24 hours of birth—the 
riskiest day of life. Yet 50 million births occur at home. 
 
Three-quarters of neonatal deaths occur in the first week of life, and yet postnatal 
care coverage within 2 days of birth is a median of 22% for the 14 of 68 Countdown 
countries with comparable data. 
 
Where? 
  99% die in low- and middle-income countries, where data are limited. 
< 3% die in countries with full coverage VR systems. 
 
Three-quarters of neonatal deaths are in South Asia (2 million) and Sub Saharan 
Africa (1.2 million) with two-thirds dying in just 10 countries. 
 
Approximately half of neonatal deaths occur after home births and without contact 
with the health system, and rural populations and families with the lowest incomes 
have the highest risk of neonatal death. 
 
Why? 
Intrapartum-related neonatal deaths account for an estimated 23% of neonatal 
deaths, the third largest cause after infections (34%) and direct complications of 
preterm birth (28%). 
 
Neonatal proportionate mortality varies with the level of neonatal mortality and 
across regions, with infections accounting for almost half of deaths in settings with 
high mortality. 
  
Maternal complications, especially during childbirth, carry a high risk of neonatal 
death.  
 
  Approximately 60-80% of neonatal deaths occur in low birthweight babies. 
Reducing case fatality rates for moderately preterm and term in-utero growth 
restriction infants is feasible without complex technology. 
  
Eliminating the equity gap for neonatal mortality risk between the richest and 
poorest families within countries in sub-Saharan Africa and South Asia could avert 
almost three-quarters of a million deaths. 
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The second clear message is that although there is ample evidence here to show that action is 
required now to reduce this burden, current neonatal mortality data are far from adequate, and 
morbidity data are virtually totally lacking. Stillbirths, which are a closely linked outcome, 
remain invisible and uncounted in most low income countries.
214 Systematic, programmatically 
relevant estimates for neonatal cause-of-death as presented in this thesis have been a crucial 
short term step. These methods are now institutionalised in United Nations estimation processes 
for neonatal cause-of death and will become an annual estimation output. However the wide 
uncertainty ranges, especially at national level, could result in low prioritisation for policy and 
programme investment. 
 
This exercise has highlighted the paucity of reliable, representative data on the causes of 
neonatal death from settings in which most neonatal deaths occur.
46 While improved and 
transparent estimation methods are important, these are no panacea. The quantity and quality of 
input data must be improved or by 2015, the target year of the MDGs, we will still be relying on 
inherently uncertain estimates – stumbling in the dark.
196  
 
Specific recommendations to improve the data quality will depend on the setting and the local 
capacity for information tracking, but some generic principles can be stated: 
 
1.  Counting pregnancy outcomes including neonatal deaths requires investment in 
information systems 
The focus in all data collection systems (vital registration, surveys, sample registration) 
should be on capturing all births and all deaths around the time of birth in order to evaluate 
the effectiveness of programmatic interventions and to improve the capture of fatal and non 
fatal outcomes for mothers, babies and children. Neonatal outcomes are integral to the 
tracking system that is the foundation of any effective national health management 
information system. Not counting stillbirths, and especially the one million occurring at the 
time of labour, may result in misinterpretation of progress.
51 Registration systems are a key 
component of development infrastructure, but remain underfunded by governments and 
development partners.
6 Counting births has a human rights dimension as well as a statistical 
function – a birth certificate confers legal citizenship. Some low income countries have 
shown rapid jumps in the proportion of children with birth certificates.
9 Interim measures 
such as household surveys and demographic surveillance could be improved in a short 
period to provide more reliable pregnancy outcome data. Progress is possible and is 
necessary to track the increasing investments in global health and MNCH care services. 
 
2.  Counting neonatal cause-of–death and outcomes related to acute intrapartum events 
requires innovation in tools and methods for verbal autopsy and for morbidity tracking   
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Outcomes related to acute intrapartum events must be actively sought and counted, or they 
will be easily missed. This will require innovation in both rich and poor countries. In high 
income countries capture of intrapartum-related mortality outcomes is generally good, 
although potentially subject to systematic misclassification in litigious societies. Tracking 
NE incidence and linking databases for long term morbidity information remains a 
challenge, and is urgently required in transitional/middle income countries.  
 
In low income countries the priority is for feasible methods to enable the health system and 
existing survey tools to count deaths and to attribute causes for stillbirths, and neonatal 
deaths.  Table 8.2 has summarised some immediate opportunities to improve the data, as 
well as research priorities. Wide consensus on a standard VA tool and use of a consistent 
hierarchy is an urgent need. Practical, but simple classification systems for cause of fetal 
and neonatal deaths can help to identify preventable deaths, prioritise interventions and 
facilitate the monitoring of impact of interventions. Neonatal morbidity measurement in low 
income settings should not be left until after mortality has been addressed. There are only 
three cohort studies following cases of NE from low income countries and all start from 
hospital populations. Well designed cohort studies are an important gap and these will 
require consistent case definitions and standard protocols and tools for disability assessment 
which are currently lacking for low income settings. 
 
3.  Counting and addressing avoidable factors requires wider scale implementation of  audit 
systems 
To reduce intrapartum-related deaths data on avoidable factors are essential so that health 
system and community delays are identified and addressed. 
93 There are fewer examples of 
wide scale audit from low income countries, 
200 and a systematic analysis is required of the 
process of how to reach wider scale in such settings and how to maximise and sustain 
change. In the meantime an indicator combining fresh stillbirths and predischarge neonatal 
deaths amongst babies weighing over 2500g and without major congenital abnormalities 
may be useful, and possible to collect from existing information in facility birth registers.
214  
 
4.   Community and civil society ownership are important for sustainable change 
Promoting community accountability for maternal and fetal/neonatal survival in each 
pregnancy will enable community ownership of the problem and joint action as well as 
better data collection.
137;216 Successful models of such community participation and 
ownership for addressing maternal and fetal/neonatal outcomes in various low and middle 
income countries are scarce but suggest that community power has been under-rated.
24;217   
In high income countries the power of bereaved parents in gaining attention for stillbirth  
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and neonatal deaths and in effecting change has been crucial. As yet, the bereaved parents in 
low income countries are largely silent and also unsupported. 
 
Improving estimates, data and visibility is one step but does not automatically result in 
investment. Another key factor is consensus on feasible solutions and communicating these 
effectively for both national governments and donors to see achievable solutions within their 
political time frames.
16  Each year 50 million women give birth at home
27 and in sub Saharan 
Africa the average coverage of skilled attendance has not increased significantly in a decade.
38 
Moving forward to effective partnerships between obstetric and neonatal/child survival groups 
has potential to clarify the problem of acute intrapartum events, measure the outcomes better 
and reduce the huge burden of deaths and disability. The need could not be clearer - both for 
better counting but also for action to make neonatal and stillbirth outcomes count. Innovative 
approaches are required to increase information for decision-making and improve care at birth 
in settings where far too many babies do not cry at birth. Continued invisibility and inaction will 
ensure their cries remain unheard.  
162 
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Appendix A: Publications and presentations related to the thesis 
 
Table A. 1: Publications so far of relevance to the PhD subject of neonatal cause-
of-death estimates 
 
Publication 
type 
Title, journal and authors
Journal 
articles 
1.  Lawn JE, Shibuya K, Stein C. No cry: Global estimates of intrapartum-related 
stillbirths and neonatal deaths. Bull.World Health Organ 2005; 83: 409-17. 
 
2.  Rudan I, Lawn J, Cousens S et al. Gaps in policy-relevant information on 
burden of disease in children: a systematic review. Lancet 2005; 365: 2031-40. 
 
3.  Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 
million neonatal deaths in the year 2000. Int J Epidemiol 2006; 35(3):706-718. 
 
4.  Lawn JE, Cousens S, Bhutta ZA, Darmstadt GL, Martines J, Paul V et al. Why 
are 4 million newborn babies dying each year? Lancet 2004; 364:399-401. 
 
5.  Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? Where? Why? 
Lancet 2005; 365: 891-900. 
 
6.  Knippenberg R, Lawn JE, Darmstadt GL, Begkoyian G, Fogstad H, Walelign N 
et al. Systematic scaling up of neonatal care in countries. Lancet 2005; 
365:1087-1098. 
 
7.  Lawn JE, Cousens SN, Darmstadt GL, Bhutta ZA, Martines J, Paul V et al. 1 
year after The Lancet Neonatal Survival Series--was the call for action heard? 
Lancet 2006; 367:1541-1547. 
 
8.  Lawn JE, Osrin D, Adler A, Cousens S. Four million neonatal deaths: counting 
and attribution of cause-of-death. Paed Perinatal Epi. 2008 22: 410-416. 
 
9.  Lawn JE, Rudan I, Rubens C. Four million newborn deaths: Is the global 
research agenda evidence-based? Early Hum Dev 2008. in press 
 
10.  Lawn JE, Costello A, Mwansambo C, Osrin D. Countdown to 2015: will the 
Millennium Development Goal for child survival be met? Arch Dis Child 2007; 
92(6):551-556. 
 
11.  Lawn JE, Manandhar A, Haws RA, Darmstadt GL. Reducing one million child 
deaths from birth asphyxia--a survey of health systems gaps and priorities. 
Health Res Policy Syst 2007; 5:4.:4. 
 
12.  Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K. Stillbirth rates: 
delivering estimates in 190 countries. Lancet 2006; 367:1487-1494. 
 
13.  Darmstadt GL, Walker N, Lawn JE, Bhutta ZA, Haws RA, Cousens S. Saving 
newborn lives in Asia and Africa: cost and impact of phased scale-up of 
interventions within the continuum of care. Health Policy Plan 2008; 23(2):101-
117. 
 
14.  Bryce J, Daelmans B, Dwivedi A, Fauveau V, Lawn JE, Mason E et al. 
Countdown to 2015 for maternal, newborn, and child survival: the 2008 report 
on tracking coverage of interventions. Lancet 2008; 371(9620):1247-1258. 
 
15.  Darmstadt GL, Walker N, Lawn JE, Bhutta ZA, Haws RA, Cousens S. Saving 
newborn lives in Asia and Africa: cost and impact of phased scale-up of 
interventions within the continuum of care. Health Policy Plan 2008; 23(2):101-
117. 
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Chapters and 
books 
1.  Lawn JE, Cousens SN. Newborn Survival: Background paper for the World 
Health Report 2005, Neonatal chapter and the statistical annex. 
 
2.  Lawn JE, Zupan J, Begkoyian G, Knippenberg R. Newborn Survival. In: 
Jamison D, Measham A, editors. Disease Control Priorities. 2 ed. The World 
Bank and the National Institutes of Health; 2006. 
 
3.  Jamison D, Shahid-Salles S, Jamison J, Lawn JE, Zupan J. Incorporating Deaths 
near the Time of Birth into Estimates of the Global Burden of Disease. In: 
Lopez AD, Mathers CD, Ezzati M, Jamison D, Murray CJ, editors. Global 
Burden of Disease and Risk Factors. 2 ed. The World Bank and the National 
Institutes of Health; 2006. 
 
4.  Joy Lawn, Pyande Mongi, Simon Cousens. Africa’s newborns – counting them 
and making them count. In Opportunities for Africa’s Newborns. Eds Lawn JE, 
Kerber KJ. PMNCH, Cape Town, 2006. ISBN ISBN-13:  978-0-620-37695-2. 
ISBN-10:  0-620-37695-3 
 
5.  Countdown working group. Countdown to 2015. Maternal Newborn and Child 
Survival: Tracking progress in Maternal Newborn and Child Survival. The 2008 
report. UNICEF, New York 2008. 
 
6.  Situation Analysis of newborn health in Uganda. Uganda Ministry of Health, 
Government of Uganda, September 2008. 
 
7.  Situation analysis of newborn health in Tanzania. Tanzania Ministry of Health, 
Tanzania, 2009. 
 
8.  Situation analysis and action plan for newborn health in Nigeria. Nigeria 
Federal Ministry of Health, in preparation, publication due early 2009  
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Table A.2  Presentations related to the thesis  
 
Table A. 2: Selected presentations so far of relevance to the PhD subject of neonatal cause-of-death estimates, and experience gained 
Event  When   Where  Presentation/role or experience gained 
Child Health Epidemiology Reference 
Group hosted by WHO 
June 2004  Geneva, Switzerland  Presentation of work in progress regarding neonatal cause-of-death 
estimates 
United Nations Expert meeting to 
review child cause-of-death numbers 
for the World Health Report 2005 
October 
2004 
UNICEF, New York  Presentation of work on neonatal cause-of-death estimates and 
discussant on incorporation of these numbers in to WHO national 
estimates for use in World Health Report 2005 
Review meeting for The Lancet 
Neonatal Series 
November 
2004 
Geneva, Switzerland 
(approximately 60 people) 
Presenter for paper 1 of the series regarding  
“Four million neonatal deaths: When? Where? Why?” 
Media launch of The Lancet Neonatal 
series 
March 2005  London, England  Part of media panel 
WHO High Level Meeting to review 
policy briefs for the World health 
Report 2005 
March 2005  Geneva, Switzerland  Participant in high level meeting with 5 Ministers of Health  
Pediatric Academic Societies of 
America 
May 2005  Washington DC 
(about 400 in the audience, 
conference registration ~5000) 
Plenary presentation 
“No cry at birth: Counting intrapartum stillbirths and neonatal deaths 
related to intrapartum complications and making them count” 
(Also 2 posters) 
African Maternal, Newborn and Child 
Health Task Force 
October 
2005 
Addis Ababa, Ethiopia 
(approximately 100 people) 
Plenary presentation 
“1 million newborn deaths in Africa- when? Where? Why?” 
Experience in applying data regarding newborn deaths for 
policy/programmes  in varied African settings 
Tri-annual conference of the Union of 
African Paediatric Societies and 
Associations/ International Paediatric 
Association 
November 
2005 
Cotonou, Benin 
(several hundred participants) 
Keynote presentation on the State of newborn health in Africa and 
running a one day workshop for African Paediatricians from 27 
countries on newborn health status, policy and programmes.  
Experience in policy and programme application of data and in running 
a workshop with a varied audience 
WHO Inter–regional capacity building 
workshop for Integrating newborn care 
into Maternal and Child Health 
Programmes 
December 
2005 
WHO South East Asian 
Regional Office, New Delhi 
(approximately 30 people) 
Co-leading the technical inputs for a one week workshop for WHO 
staff from all 6 WHO regions to build capacity for WHO staff to use 
data and examine existing policy and programmes to accelerate 
progress to integrate newborn care into exiting programmes and to 
address gaps in care. 
Experience in simplifying the process of examining national data, 
evaluating this data and developing a step by guide to be followed in 
countries which has now been used in 2 large inter country workshops, 
translated into French and will be part of a guide to be published by 
WHO and partners. 
Child Survival Countdown to 2015   December  University College of London/  Participated in the Planning team for the conference, particularly  
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Conference (biannual)  2005  LSHTM 
(several hundred participants) 
working with country teams on their data regarding child survival 
progress. 
Made a plenary presentation on Costing interventions to reduce 
newborn impact modelling was based on The Lancet Neonatal Series 
model applied to cause specific estimates of neonatal deaths by 
country. 
UNICEF East and Southern African 
region (24 countries). Annual health 
Network Update Meeting for Senior 
health personnel 
February 
2006 
Held in a conference hall in 
Cape Town 
(approximately 50 people) 
Keynote presentation and discussions regarding newborn health status 
in Africa and priorities to improve newborn survival and health in very 
different countries. 
Experience in applying data regarding newborn deaths for 
policy/programmes  in varied African settings 
National Stakeholder meetings for 
newborn health in Malawi, Ethiopia, 
Uganda 
 
 
March, 
April 2006 
Malawi, Ethiopia, Uganda 
(approximately 40 -100 people 
present at each meeting) 
Presentations using data (including cause-of-death estimates) regarding 
the State of Newborn health in Malawi, Ethiopia, Uganda 
Experience in interpreting and evaluating data regarding newborn 
deaths for policy/programmes  in varied African countries and 
discussing the implications and crucial gaps in knowledge that affect 
scaling up of care 
Child Health and Nutrition Research 
Initiative, workshop in research priority 
setting 
May 2006  Bloomberg School of Public 
Health, John Hopkins School of 
Public health, Baltimore 
(approximately 40 people) 
Leading a Technical Working Group on Research Priority Setting for 
Birth Asphyxia as part of a team developing and testing a new method 
for systematic research priority setting. 
Experience in testing and refining a new systematic method for 
research priority setting being developed by Child Health and Nutrition 
Research Initiative and the Global Forum for Health Research  
African Inter–country workshop for 
Integrating newborn care into Maternal 
and Child Health Programmes (7 
country teams with high level Ministry 
of Health participation) 
June 2006  Harare, Zimbabwe 
(approximately 60 people) 
Co-organizing with WHO and partners a workshop to support Ministry 
of health teams from 7 countries to use data and examine existing 
policy and programmes to accelerate progress to integrate newborn 
care into exiting programmes and to address gaps in care. 
Experience in simplifying the process of examining national data for 
policy and programmes. 
Africa Newborn Regional Research 
network meeting  
October 
2006 
Addis Ababa, Ethiopia 
(approximately 50 people) 
Organizing and facilitating a workshop for 5 country teams  of 
researchers, policymakers and programme managers in to develop 
research study designs and protocols to test key questions related to 
scale up of newborn care in their countries 
Experience gained in assisting teams in research design, sample size 
calculation, data collection tools etc 
International Paediatric Association 
global meeting linked to Nigerian 
Paediatric Association meeting 
October 
2006 
Abuja, Nigeria 
(approximately 200 people) 
Keynote presentation on Integrating newborn care into existing 
programmes in Africa, with a focus on Nigeria, and  
using Nigeria specific data and analysis 
Global Forum Health Research  October 
2006 
Cairo, Egypt 
(approximately 100 people) 
Presenting the preliminary findings of Technical Working Group for 
Birth Asphyxia for the systematic research priority setting methods for 
the Child Health and Nutrition Research Initiative  
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This meeting and session provided an opportunity to examine research 
priority setting for birth asphyxia in the context of other major child 
health challenges 
Pan African Parliament special session  November 
2006 
Pretoria, South Africa  Plenary overview of the publication – Opportunities for Africa’s 
Newborns 
Special session of Pan African Parliament to launch the publication, 
plus media conference, TV and news coverage 
Priorities in Perinatal Care Meeting in 
South Africa 
March 2007  South Africa 
(approximately 300 people) 
Invited guest plenary 
1. State of Africa’s newborns, with a focus on South Africa 
2. No Cry at birth: counting intrapartum stillbirths and neonatal deaths 
related to acute intrapartum events, and making them count 
World Bank Newborn Health 
Symposium 
March 2007  World Bank, Washington DC 
(approximately 300 people) 
Plenary opening talk: 
“Newborn survival – what is progressing, what is not and where are 
the gaps?” 
PMNCH The Partners Forum  April 2007  Dar es Salaam, Tanzania 
(approximately 400 people) 
Talk in the opening plenary 
“Opportunities for Africa’s Newborns” 
 
Pediatric Academic Societies Meeting - 
special session on Child health 
Priorities (DCP) 
May 2007  Toronto, Canada (about 400 in 
the audience, conference 
registration ~5000) 
Newborn Survival - delivering the future (Plenary), 
Special session organised by PGPR and Gates Foundation 
Child Health Epidemiology Reference 
Group hosted by WHO 
June 2006  Geneva, Switzerland 
(approximately 30people) 
Presentation on neonatal cause-of-death work and next steps needed to 
advance this. 
International Paediatric Association 
Congress (every 3 years) 
July 2007  Athens Olympic Convention 
Center 
(about 4000 in the audience, 
conference registration ~8000) 
Plenary talk in special session on MDGs 
Newborn survival and the Millennium Development Goals 
Royal Society of Tropical Medicine of 
Hygiene, Centenary celebration 
Sept 2007  Queen Elizabeth Conf Center, 
London (approximately 1000 
people) 
Plenary talk in opening session 
Newborn survival and  Millennium Development Goal 4 
Global Burden of Disease 2 – Launch 
meeting 
Sept 2007  Seattle, USA 
(approximately 100 people) 
Lead for the Global Burden of Disease Group for Neonatal, Stillbirths 
and Congenital conditions 
Women Deliver  Oct 2007  Excel Conf Center, London 
(approximately 100 in audience) 
Symposium talk  
Stillbirths – delivering systematic estimates 
Africa Newborn Regional Research 
network meeting 
Nov 2007  Blantyre, Malawi 
(60 participants) 
Lead technical organiser for a workshop to assist 7 country teams 
(Ministry of health, Save the Children and academics) in practicalities 
of implementing research and ensuring comparable measurement 
across sites 
Child Health Epidemiology Reference 
Group hosted by UNICEF 
Dec 2007  UNICEF, New York 
(approximately 60 participants) 
Presentation of work in progress to update neonatal cause-of-death 
estimates, with new analysis of Vital Registration data and updating 
and advancing the study-based dataset 
Countdown to 2015 Core group and  February  Geneva, Switzerland  Teamwork on data and publications review regarding death, cause-of- 
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editorial meeting to review Lancet 
special edition papers and data for 
Countdown report 
2008  (small working meeting)  death and coverage data 
Countdown to 2015  April 2008  Cape Town, South Africa 
(approximately 400 participants 
including 14 Ministers of 
Health) 
Organising committee member 
Plenary speaker on “Research Advance for Maternal, Newborn and 
Child Health” 
 
Norway expert roundtable on MNCH 
evaluation 
April 2008  Cape Town, South Africa 
Small expert meeting 
approximately 50 people 
Presentation on 
Implementation research to inform the scale up of integrated newborn 
care 
Global Alliance for Prevention of 
Preterm birth and Stillbirths (GAPPS) 
May 2008  Seattle, USA  Presentation on 
Measurement gaps for stillbirths and preterm birth 
Union of African Paediatric Societies 
and Associations (UNAPSA) 3 yearly 
Congress 
May 2008  Sun City, South Africa, 
Approximately 500 people 
Plenary talks 
1.  Saving Africa’s Newborns 
2.  Appropriate technology for Child health 
Also organised a 7 country panel on Saving Newborn Lives around 
Africa 
Global Burden of Disease Neonatal 
Morbidity expert group meeting 
June 2008  Geneva, Switzerland, small 
working meeting of 27 people 
Organiser of meeting, and technical support for the 7 working groups 
Child Health Epidemiology Reference 
Group hosted by WHO 
June 2008  Montreux, Switzerland 
Approximately 40 people 
Presentation on work in progress to update and advance the neonatal 
cause-of-death estimates and develop stillbirth cause-of-death 
estimates and neonatal morbidity estimates 
Annual programme Review Meeting, 
Saving Newborn Lives 
July 2008  Bangkok, Thailand 
Approximately 60 people 
Presentations on  
1.  Measuring progress, counting deaths in newborn health 
programmes 
2.  Updates on birth asphyxia interventions  
Global Alliance for Prevention of 
Prematurity and Stillbirths (GAPPS) 
August 2008  Seattle, USA  Overview of the epidemiology and research gaps for measuring 
preterm birth and stillbirths 
David Harvey Lecture, Neonatal 
Update 
November 
2008 
Imperial College, London, UK  Invited keynote (David Harvey lecture)  
Delivering a global research agenda for 4 million newborn deaths 
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Appendix B: Supplemental tables summarising study datasets 
 
Table B.1 WHO Regions and Global Burden of Disease Subregions  
GBD region  Reporting 
subregion 
 
WHO Member States 
AFRO 
 
AFRO D  Algeria, Angola, Benin, Burkina Faso, Cameroon, Cape Verde, Chad, Comoros, Equatorial Guinea, 
Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Madagascar, Mali, Mauritania, Mauritius, 
Niger, Nigeria, Sao Tome And Principe, Senegal, Seychelles, Sierra Leone, Togo  
EMRO D  Djibouti, Somalia, Sudan 
AFRO E  Botswana, Burundi, Central African Republic, Congo, Côte d'Ivoire, Democratic Republic of the 
Congo, Eritrea, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, Rwanda, South Africa, 
Swaziland, Uganda, United Republic of Tanzania, Zambia, Zimbabwe 
AMRO 
 
AMRO A  Canada, United States of America 
AMRO B  Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Brazil, Chile, Colombia, Costa Rica, 
Dominica, Dominican Republic, El Salvador, Grenada, Guyana, Honduras, Jamaica, Mexico, 
Panama, Paraguay, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, 
Trinidad and Tobago, Uruguay, Venezuela 
AMRO A  Cuba 
AMRO D  Bolivia, Ecuador, Guatemala, Haiti, Nicaragua, Peru 
EMRO 
 
EMRO B  Bahrain, Cyprus, Iran (Islamic Republic Of), Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, 
Oman, Qatar, Saudi Arabia, Syrian Arab Republic, Tunisia, United Arab Emirates 
EMRO D  Egypt, Iraq, Morocco, Yemen 
EURO 
 
EURO A  Andorra, Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, 
Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San 
Marino,  Slovenia, Spain, Sweden, Switzerland, United Kingdom 
EURO B  Albania, Bosnia and Herzegovina, Bulgaria, Georgia, Poland, Romania, Slovakia, the Former 
Yugoslav Republic of Macedonia, Turkey, Yugoslavia 
EURO B  Armenia, Azerbaijan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan 
EURO C  Belarus, Estonia, Hungary, Kazakhstan, Latvia, Lithuania,  
Republic of Moldova, Russian Federation, Ukraine 
SEARO 
 
SEARO B  Indonesia, Sri Lanka, Thailand 
WPRO B  Malaysia, Philippines 
WPRO A  Brunei Darussalam, Singapore 
SEARO D  Bangladesh, Bhutan, India, Maldives, Nepal 
EMRO D  Afghanistan, Pakistan 
WPRO 
 
WPRO A  Australia, Japan, New Zealand 
WPRO B  China, Mongolia, Republic Of Korea 
SEARO D  Democratic Republic of Korea 
WPRO B  Cambodia, Lao People's Democratic Republic, Viet Nam 
SEARO D  Myanmar 
WPRO B  Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia (Federated States Of), Nauru, Niue, 
Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu 
 
AFRO, WHO African Region; AMRO, WHO Region of the Americas; EMRO, WHO Eastern 
Mediterranean Region; EURO, WHO European Region; SEARO, WHO South-East Asia Region; 
WPRO, WHO Western Pacific Region. 
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Table B.2  Summary of vital registration and study data inputs by WHO sub-regions 
 
Sub-region 
1  Number of 
countries 
Regional average 
NMR per 1000 live 
births 
2 
Number of countries with high 
coverage Vital Registration 
data 
Number of countries 
with study data 
(number of studies) 
Afro D  26  43  0 (1)
 3  4 (6)
  
Afro E  20  42  0  3 (6) 
Amro A  3  5  3  NA
4 
Amro B  26  14  6  4 (4) 
Amro D  6  21  0  3 (3) 
Emro B  13  17  2  4 (6) 
Emro D  9  46  0  2 (5) 
Euro A  27  3  21  NA
4 
Euro B  16  17  5  NA
4 
Euro C  9  10  4  NA
4 
Searo B  4  17  0  3 (6) 
Searo D  7  42  0  2 (19) 
Wpro A  5  2  3  NA
4 
Wpro B  22  19  0  1 (1) 
Total 
(Median yr)  
193 30  44  countries,   
96,797 deaths 
(2000) 
26 countries, 56 studies, 
13,685 deaths 
(1992) 
 
Wpr, WHO Western Pacific Region; Euro, WHO European Region; Amr, WHO Region of the Americas; Emr, 
WHO Eastern Mediterranean Region; Sear, WHO South-East Asia Region; Afr, WHO African Region. 
1 Countries in the 14 subregions of the Global Burden of Disease [Supplementary table 1 on website] 
2 NMR based on WHO estimates (WHO 2004) 
3 Vital registration data were available for Mauritius but were not used as inputs in the modelling exercise 
4 NA = not applicable. Studies from these sub-regions were excluded due to high VR coverage 
Details of the 56 studies included are given in Supplementary table B.2 
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Table B.3: Studies meeting inclusion criteria for assessment of multiple causes of neonatal cause-of-death. (56 studies, 26 countries, N=13,685) 
 
Author or Principal 
investigator 
Country  ￿￿￿￿￿￿
gion 
Year 
pub 
Median 
year data 
collection 
 Study 
population 
NMR 
Number of 
live births 
in study 
No of 
neonatal 
deaths 
% 
unknown 
cause-of-
death 
No of causes of 
death with available 
data after author 
communication 
Greenwood 
1 Gambia  AFRO  D  1987  1982  65  630  41  22  7 
Leach 
2 Gambia  AFRO  D  1999  1992  39  32164  1254  18 7 
Walraven 
3  Gambia  AFRO D  not pub  2000  24.6  3167  78  10  6 
Schumacher 
4 Guinea  AFRO  D  2002  1998  50  -  97  3  7 
Ekanem 
5 Nigeria  AFRO  D  1994  1991  37.3  -  24  0  7 
Pison 
6 Senegal  AFRO  D  1993  1987  36  809  33  4 6 
Fantahun 
7 Ethiopia  AFRO  E  1998 1992  52.8  909  48  2  6 
Dommisse 
8  South Africa  AFRO E  1991  1988  10.45  26887  281  2  7 
Woods 
9  South Africa  AFRO E  2001  2001  12  27462  253  0  7 
Setel (AMMP) 
10  
(Dar es Salaam)  Tanzania  AFRO E  not pub  2000  53.2  21,769  87  14  7 
Tanzania a (AMMP) 
10  
(Hai district)  Tanzania  AFRO E  not pub  2000  43.5  39618  142  16  7 
Tanzania (AMMP) 
10 
(Morogoro district)   Tanzania   AFRO E  not pub  2000  52.1  27,927  147  16  7 
Barros 
11 Brazil  AMRO  B  1987  1982  19.2  7270  127  11  7 
De O Gomes 
12 Brazil  AMRO  B  1997  1991  16.53  8348  138 0  6 
Samms-vaughn 
13   Jamaica  AMRO B  1990  1986  17.9  10249  950  0  6 
Mendieta 
14 Paraguay  AMRO  B  1999  1996  10.7  343047  3638  0  6 
Aguilar 
15 Bolivia  AMRO  D  1998  1995  47  -  85  7  7 
Perry  
16 Haiti  AMRO  D  not  pub  1997  28.5  2390  68  18  7 
Aleman 
17 Nicaragua  AMRO  D  1998 1993  11.59  6229  72  0  6 
El-Shafei 
18 Bahrain  EMRO  B  1988  1986  7.8  27644  228  0  7 
Ebrahim 
19   Bahrain  EMRO B  1998  1996  6.4  9531  61  0  6 
Kishan 
20 Libya  EMRO  B  1988  1984  20  16277  245  0  6 
El-Zibdeh 
21  Saudi Arabia  EMRO B  1988  1983  12  8111  80  3  6 
Asindi 
22  Saudi Arabia  EMRO B  1998  1994  9.6  92088  184  0  6 
Dawodu 
23 UAE  EMRO  B  2000 1991  6.7  8083  54  2  7 
Yassin 
24 Egypt  EMRO  D  2000  1995  49.3  1636  41  5  7 
Campbell
25 Egypt  EMRO  D  2004  2000  25.2  5406  117  12  7 
 Jalil
26;27 Pakistan  EMRO  D  1993  1984  54  1476  80  0  6 
Fikree 
28 Pakistan  EMRO  D  2002  1992  56.6  15360  649  23  7 
Bhutta 
29  Pakistan  EMRO D  not pub  2001  39.3  3917  154  1  7 
Djaja 
30  Indonesia  SEARO B  not pub  2001  25  -  180  2  7 
Sivagnanasundrum 
31  Sri Lanka  SEARO B  1985  1982  18.5  2738  51  10  7 
Fonseka 
32  Sri Lanka  SEARO B  1994  1987  23.2  -  267  5  5  
184 
Lucas 
33  Sri Lanka  SEARO B  1996  1993  14.6  407  120  0  6 
Khanjanasthiti  
34 Thailand  SEARO  B  1984  1984  31.28  1119  35  0  7 
Horpaopan 
35 Thailand  SEARO  B  1989  1985  8.02  100193  804  1  6 
Islam
36 Bangladesh  SEARO  D  1982  1976  89  1351  120  13 7 
Rahman 
37 Bangladesh  SEARO  D  1989 1986  70.12  984  69  0  6 
Bhatia 
38 Bangladesh  SEARO  D  1989  1982  67  926  549  6  6 
 Fauveau 
39 Bangladesh  SEARO  D  1990  1982  55  57837  2273  4  7 
Chowdhury 
40 Bangladesh  SEARO  D  1996  1983  64.9  7304  474  0  5 
Perry 
16 Bangladesh  SEARO  D  not  pub  1997  35.2  3518  124  11 7 
Gupta 
41 India  SEARO  D  1981  1977  56  -  31  0  5 
Damodar 
42 India  SEARO  D  1983  1979  70  579  30  23  6 
Shah 
43 India  SEARO  D  1984  1978  39.2  3083  121  0 7 
Pratinidhi 
44 India  SEARO  D  1986  1982  52  2990  135  0  6 
Datta 
45 India  SEARO  D  1988  1988  50.5  -  168  3  7 
Singhal 
46 India  SEARO  D  1990  1984  54.3  920  50  0  7 
Khalique 
47 India  SEARO  D  1993  1990  50.5  415  21  0  7 
Phukan 
48 India  SEARO  D  1998  1994  46.5  2432  113  11  7 
Awasthi 
49 India  SEARO  D  1998 1996  86.7  -  286  0  6 
Bang 
50 India  SEARO  D  1999  1996  58.1  1016  52  10 6 
Anand 
51 India  SEARO  D  2000  1993  11.5  5703  59  0  7 
Bang 
52 India  SEARO  D  2001  1996  52.4  -  40  10 7 
Shrivrastava 
53 India  SEARO  D  2001  1995  44  -  1000  11  7 
Ben-Li 
54 China  WPRO  B  1985  1980  11.6  85773  991  1  6 
Total   26 countries  9 subregions 
Median 
1994  
Median 
1991     17619 
Range 0-
23%   
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Appendix C: CHERG Neonatal Data Abstraction form 
 
Child Health Epidemiology Reference Group (CHERG) 
Data Abstraction Form 2004 
Neonatal Mortality 
 
General instructions: 
1.  Always feel free to ask someone if you are not sure how to answer a question 
2.  Please write legibly, and use a pencil so mistakes can be erased 
3.  When filling out the boxes during data entry please RIGHT JUSTIFY  
4.  For all coded questions CIRCLE the correct response 
5.  f information is unknown or not available - CIRCLE “9 = unknown” for coded questions, or write “N/A” 
for all other questions 
6.  If you encounter a “major flaw”, record the flaw in Section F, Question 1. Examples include a lack of 
internal consistency (e.g., a set of percentages that should sum to 100% do not sum to 100%), or methods 
so incomplete or confusing that you cannot determine what was done. 
7.  If you think of information that would greatly improve the study’s usefulness and that study investigators 
could provide, record the “request” in Section G, Question 2. 
8.  If you have additional notes or comments, record them on the last page (Section H). 
-------------------------------------------------------------------------------------------------------------- 
SECTION A. IDENTIFIERS 
 
A1.  Paper identification number 
 
A.2  Name of data abstractor: ___________________________________________________________ 
 
A3. Code for data abstractor 
 
A.4 Today’s date (ddmmyy) 
 
SECTION B. STUDY REFERENCE 
 
B1. Last name of the first author  (or a phrase if no name, e.g., “WHO Young Infants Study”): 
_________________ 
 
B2. Is the study published? (circle correct response) .................               No = 1    Yes = 2    Unknown = 9 
 
 
IF  QUESTION A2. WAS “NO”, SKIP TO SECTION C (Study design) 
 
B3. Year of publication:  
 
B4. Journal name: 
________________________________________________________________________________________ 
 
B5. Volume number:    B6. Issue number:  
 
B7. Issue month:         B8. First page number:                           B9. Last page number  
 
 
B10. Language of paper (circle only one of the following 
 
1. English      2. French      3. German      4. Italian     5. Spanish           6. Other  
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SECTION C. STUDY DESIGN 
 
C1.  Was neonatal mortality the central focus of the study? (circle)            No = 1   Yes = 2  Unknown = 9 
 
C2. If no then what was the central focus of the study? ____________________________________________ 
 
C3. Does the study examine neonatal mortality? (circle correct response) No = 1    Yes = 2    Unknown = 9 
 
    IF  QUESTION C.3. WAS “NO”, END HERE 
 
C4. What study design(s) was/were used to study neonatal mortality? 
 
4a.  Prospective cohort           No = 1    Yes = 2    Unknown = 9 
 
4b.  Retrospective cohort          No = 1    Yes = 2    Unknown = 9 
 
4c.  Cross-sectional          No = 1    Yes = 2    Unknown = 9 
 
C5. What mortality outcomes are documented? (circle correct responses and if definition used differs from the 
standard then record this here and in Section G1. e.g. if the study counts early neonatal as to the 6
th day) 
 
5a.  Neonatal mortality (death in the first 28 days of life)  No = 1    Yes = 2    Unknown = 9 
 
Definition used if different ________________________________________________________ 
 
5b.  Early neonatal mortality (death in the first 7 days of life)  No = 1    Yes = 2    Unknown = 9 
 
Definition used if different ________________________________________________________ 
 
5c.  Late neonatal mortality (death between day 8 and  28 of life) No = 1   Yes = 2   Unknown = 9 
 
  Definition used if different ________________________________________________________ 
 
5d.  Stillbirths (late fetal death after 28 weeks gestation)  No = 1    Yes = 2    Unknown = 9 
 
  Definition used if different ________________________________________________________ 
 
5e.  Early fetal death (death between 22-27 weeks gestation)  No = 1    Yes = 2    Unknown = 9 
 
Definition used if different ________________________________________________________ 
 
5f.  Perinatal mortality (stillbirths plus early neonatal deaths)  No = 1    Yes = 2    Unknown = 9 
 
Definition used if different ________________________________________________________ 
 
C6. Does the study examine neonatal morbidity? (circle correct response) No = 1       Yes = 2  Unknown = 9 
 
    IF  QUESTION C.6. WAS “NO”, SKIP TO QUESTION C9.  
 
C7. What study design(s) was/were used to study neonatal morbidity? (check all that apply) 
7a.  Prospective cohort           No = 1    Yes = 2    Unknown = 9 
 
7b.  Retrospective cohort          No = 1    Yes = 2    Unknown = 9 
 
7c.  Cross-sectional          No = 1    Yes = 2    Unknown = 9  
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C8. What morbidity outcomes are documented? (circle correct responses) 
 
8a.  Neonatal tetanus          No = 1    Yes = 2    Unknown = 9 
 
8b.  Severe infection          No = 1    Yes = 2    Unknown = 9 
 
8c.   “Birth asphyxia”          No = 1    Yes = 2    Unknown = 9 
 
8d.  Diarrhoea            No = 1    Yes = 2    Unknown = 9 
 
8e.  Congenital malformations        No = 1    Yes = 2    Unknown = 9 
 
8f.  Low birth weight          No = 1    Yes = 2    Unknown = 9 
 
8g.  Preterm birth           No = 1    Yes = 2    Unknown = 9 
 
8h.  Other (please list concisely)         No = 1    Yes = 2    Unknown = 9 
       _____________________________________________________________________ 
 
C 9. Was an intervention tested as part of the study? ......................  No = 1   Yes = 2    Unknown = 9 
 
    IF  QUESTION C9.. WAS “NO”, SKIP TO SECTION D.  
 
C10. Was the intervention allocation randomised?      No = 1    Yes = 2    Unknown = 9 
 
C11.  Briefly describe the intervention: 
____________________________________________________________ 
 
________________________________________________________________________________________ 
 
C12. What was the coverage of the intervention in the intervention arm? (circle only one of the following): 
 
1 0-19% 
 
2 20-39% 
 
3 40-59% 
 
4 60-79% 
 
5 80-99% 
 
9 Unknown 
 
C13. Briefly describe the coverage of the intervention  
 
________________________________________________________________________________________ 
 
 
C14. Was any gender specific data presented in the study ...................... No = 1   Yes = 2    Unknown = 9 
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ECTION D. STUDY METHODS: POPULATION, SETTING, AND TIME 
 
D1. Country where the study was done: _______________________________________________________ 
 
D2. Geographic setting of the study (e.g., “360 villages in the Upper River Division, eastern Gambia”): 
 
_______________________________________________________________________________________ 
   
IF THERE WAS MORE THAN ONE STUDY POPULATION (e.g.. Geetha et al in Nepal with 2 urban 
hospitals, peri-urban community and rural community) THEN COMPLETE A SEPARATE DATA 
ABSTRACTION FORM FOR EACH RELEVANT COMMUNITY-BASED SUB-POPULATION. 
 
D3. Was the study setting a research site? (circle correct response)  No = 1       Yes = 2    Unknown = 9 
 
D4. If the answer to D3. Was YES, then what was the name of the research site?  
 
________________________________________________________________________________________ 
 
D5. Was the study population selected from: (circle correct response) 
 
5a. The whole community/population      No = 1       Yes = 2    Unknown = 9 
 
5b. Health facility          No = 1       Yes = 2    Unknown = 9 
 
5c. Selection not well characterised       No = 1       Yes = 2    Unknown = 9 
 
D6. Which category or categories best describe the study population? (circle correct responses) 
 
6a. Rural            No = 1       Yes = 2    Unknown = 9 
 
6b. Urban            No = 1       Yes = 2    Unknown = 9 
 
6c. Peri-urban             No = 1       Yes = 2    Unknown = 9 
 
6d. Slum            No = 1       Yes = 2    Unknown = 9 
 
6e. Population not well characterised       No = 1       Yes = 2    Unknown = 9 
 
D7. Describe what the results are representative of: For example, the country (e.g., “Ghana”), the district (e.g.,  
“Kassena-Nankana District”), or simply “the study site” (if the results only apply to the study area). Circle 
only one of the following: 
 
1 The country       
 
2. The district      
 
3. The study site     
 
9. Unknown  
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Background maternal and neonatal services (questions D.8 to D.9) 
    
D8.  What percentage of deliveries was with a skilled attendant (midwife, doctor or nurse with midwifery 
training)? 
   Circle only one of the following: 
 
1. 0-19% 
 
2. 20-39% 
 
3. 40-59% 
 
4. 60-79% 
 
5. 80-97% 
 
6. 98-100% 
 
9. Unknown 
 
D9. Was there availability of in-patient care for neonatal emergencies?  No = 1       Yes = 2    Unknown = 9 
 
When the study was carried out (questions D10 – D14) 
 
D10. Date of mortality study start 
 
10a. Month (Jan = 1, Feb = 2, March = 3 etc Unknown = 
0)…………………………………………………… 
 
10b. Year (write the year fully e.g. 1971). …………………………………………………………… 
 
D11. Date of mortality study finish  
 
11a. Month (Jan = 1, Feb = 2, March = 3 etc Unknown = 0).  
 
11b. Year (write the year fully e.g. 1971).  
 
D12. Study period/duration of study (months).  
 
 
D13. Duration of follow-up (days) 
 
 
D14. Duration of follow-up (months) 
 
NOTE IF THE STUDY WAS A “BEFORE AND AFTER” THEN COUNT THE START AS THE 
BEGINNING OF MORTALITY DATA COLLECTION EVEN IF INTERVENTION NOT IN PLACE.   
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SECTION E . ASCERTAINMENT AND ASSIGNMENT OF DEATHS 
 
E1. Were any causes of death ascertained in this study?    No = 1    Yes = 2    Unknown = 9 
IF NO CAUSES OF DEATH WERE ASCERTAINED THEN SKIP TO SECTION F 
 
E2. Data source for assessing the cause-of-death (Circle all that apply) 
2a.  Family member’s report.          No = 1       Yes = 2   Unknown = 9 
 
2b. Verbal autopsy             No = 1       Yes = 2   Unknown = 9 
 
2c. Clinical information           No = 1       Yes = 2   Unknown = 9 
 
2d.  Post mortem            No = 1       Yes = 2   Unknown = 9 
 
2e. Other (specify)_____________________________________  No = 1       Yes = 2   Unknown = 9 
 
E3. Verbal autopsy validation (circle only one of the following): 
1. Verbal autopsy data were collected and a validation study was reported 
 
2. Verbal autopsy data were collected, but no validation was reported 
 
3. Not applicable: verbal autopsy data were not collected 
 
9. Unknown 
 
E4.     Which of the following categories of cause of neonatal death are documented in this study?  
(Circle yes for each cause that is documented) 
4a. Neonatal tetanus          No = 1       Yes = 2   Unknown = 9 
 
4b. Severe infection (sepsis, meningitis, pneumonia)    No = 1       Yes = 2    Unknown = 9 
 
4c. “Birth asphyxia”          No = 1       Yes = 2    Unknown = 9  
 
4d. Diarrhoea            No = 1       Yes = 2   Unknown = 9 
 
4e. Congenital abnormalities/malformations     No = 1       Yes = 2   Unknown = 9 
 
4f. LBW including growth retarded babies and preterm babies No = 1       Yes = 2   Unknown = 9 
 
4g. Prematurity            No = 1       Yes = 2   Unknown = 9 
 
4h. Other (please describe briefly e.g. neonatal jaundice)   No = 1       Yes = 2   Unknown = 9 
4hi________________________________________________ 
 
4hii________________________________________________ 
E5. Did at least one child have more than one cause-of-death reported  No = 1    Yes = 2    Unknown = 9 
E6. How were the deaths ascertained 
6a. Continuous surveillance by community based workers  No = 1  Yes = 2  Unknown = 9 
 
6b Repeated visits (2 or more per year) to identify deaths (Please describe regularity) 
 
No = 1  Yes = 2  Unknown = 9 
 
6c. Annual census  No = 1  Yes = 2  Unknown = 9 
 
6d. Retrospective recall  No = 1  Yes = 2  Unknown = 9 
 
6e. Other (specify)_______________________________________ 
 
No = 1  Yes = 2  Unknown = 9 
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SECTION F. MORTALITY RESULTS  
No intervention’ group (Questions F1-F4) 
Please include all births and relevant deaths in the control group of an intervention study, the ‘before’ group of a before-after study, or the whole sample of a cross sectional/descriptive study (depending on the 
study design). 
F1. Please write all the numerators and denominators for deaths in the specified time periods in the ‘no intervention’ group into the table below 
 
  Time 
period  
Number of births 
(denominator) 
Total 
number of 
deaths 
Total no of 
deaths for 
which a 
cause-of-
death was 
investigated  
No of deaths for 
which a cause-
of-death was 
assigned* 
 
Numbers of deaths by cause 
  
Live births  Still births        Tetanus  Severe infection  Birth asphyxia  Diarrhoea  Congenital 
abnormality 
LBW Preterm  Other. 
Specify 
Day 1 
 
0-24 hours 
of life  
                     
Early 
neonatal 
 
 
0-7 days                       
Late neonatal 
 
 
8-28 d 
 
                     
Neonatal 
 
 
 
0-28 d 
 
                     
Infant 
 
 
 
0-11 m 
 
                     
Early fetal 
deaths 
 
 
22-27 w                       
Late fetal 
deaths 
 
 
28-42w                       
Perinatal 
deaths 
 
 
28w-D7                       
 
* i.e. exclude the no agreement and unknown categories 
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F2. Please write all reported all-cause and cause-specific mortality rates in the specified time periods for the ‘no intervention’ group into the table below 
 Time 
period  
Reported all 
cause mortality 
rate per 1,000 
live births*
‡ 
 
Reported cause specific mortality rate per 1,000 live births 
    
Tetanus Severe 
infection 
Birth asphyxia  Diarrhoea  Congenital 
abnormality 
LBW Preterm  Other.  Specify. 
Day 1  
 
 
0-24 
hours of 
life 
            
Early 
neonatal 
 
0-7  d              
Late 
neonatal 
 
8-28  d              
Neonatal 
 
 
0-28  d              
Infant 
 
 
0-11 m 
 
            
Early fetal 
deaths*
 
 
22-27  w              
Late fetal 
deaths* 
 
28-42  w              
Perinatal 
deaths*
 
 
28w-  D7              
Low birth 
weight 
 
LBW 
 
            
Preterm 
 
 
Preterm 
 
            
* Early fetal deaths, late fetal deaths and perinatal deaths should be reported per 1000 still births and live births 
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Low birth weight data.  
F3. Please write all neonatal or early neonatal mortality data for infants in the ‘no intervention’ group into the table below. 
Number of live births 
(denominator) 
 
Number of 
live births 
who had 
birth weight 
recorded 
Total 
number of 
LBW 
infants 
Total 
number of 
LBW 
infants who 
had a 
neonatal 
death 
recorded 
Total number 
of LBW 
infants for 
which a cause 
of neonatal 
death was 
investigated 
Number of 
deaths for 
which a 
cause of 
neonatal 
death was 
assigned* 
Numbers of deaths by cause 
        
Tetanus Severe 
infection 
Birth 
asphyxia 
Diarrhoea Congenital 
abnormality 
Other 
Specify 
Neonatal (i.e. 0-28 d) 
 
 
 
    
 
 
         
Early neonatal (i.e. 0-
7d) 
 
 
    
 
 
         
* i.e. exclude the no agreement and unknown categories 
 
Preterm data.  
F4. Please write all neonatal or early neonatal mortality data for infants in the ‘no intervention’ group into the table below. 
Number of live births 
(denominator) 
Number of 
live births 
who had 
gestational 
age 
recorded 
Total 
number of 
preterm 
infants 
Total 
number of 
preterm 
infants who 
had a 
neonatal 
death 
recorded 
Total number 
of preterm 
infants for 
which a cause 
of neonatal 
death was 
investigated 
Number of 
deaths for 
which a 
cause of 
neonatal 
death was 
assigned* 
Numbers of deaths by cause 
        
Tetanus Severe 
infection 
Birth 
asphyxia 
Diarrhoea Congenital 
abnormality 
Other 
Specify 
Neonatal (i.e. 0-28 d) 
 
 
 
    
 
 
         
Early neonatal (i.e. 0-
7d) 
 
 
    
 
 
         
* i.e. exclude the no agreement and unknown categories 
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Intervention’ group (Questions F5-F8) 
Please include all births and relevant deaths in the intervention arm of an intervention study or the ‘after’ group of a before-after intervention study. 
F5. Please write all the numerators and denominators for deaths in the specified time periods in the ‘intervention’ group into the table below 
 
 Time 
period  
Number of births 
(denominator) 
Total 
number 
of deaths 
Total no of 
deaths for 
which a cause-
of-death was 
investigated  
No of deaths 
for which a 
cause-of-
death was 
assigned* 
 
Numbers of deaths by cause 
  
Live 
births 
Still births        Tetanus  Severe 
infection 
Birth 
asphyxia 
Diarrhoea Congenital 
abnormality 
LBW Preter
m 
Other. 
Specify 
Day 1 
 
0-24 
hours of 
life  
                   
Early 
neonatal 
 
 
0-7 days                     
Late 
neonatal 
 
8-28 d 
 
                   
Neonatal 
 
 
0-28 d 
 
                   
Infant 
 
 
0-11 m 
 
                   
Early fetal 
deaths 
 
22-28  w                        
Late fetal 
deaths 
 
29-42w                        
Perinatal 
deaths 
 
29w-D7                        
 
* i.e. exclude the no agreement and unknown categories 
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F6. Please write all reported all-cause and cause-specific mortality rates in the specified time periods for the ‘intervention’ group into the table below.  
 
 Time 
period  
Reported all 
cause mortality 
rate per 1,000 
live births*
‡ 
 
Reported cause specific mortality rate per 1,000 live births 
    
Tetanus Severe 
infection 
Birth asphyxia  Diarrhoea  Congenital 
abnormality 
LBW Preterm  Other.  Specify. 
Day 1  
 
 
0-24 
hours of 
life 
            
Early 
neonatal 
 
 
0-7  d              
Late 
neonatal 
 
8-28  d              
Neonatal 
 
 
0-28  d              
Infant 
 
 
0-11 m 
 
            
Early fetal 
deaths*
 
 
22-28 w                   
Late fetal 
deaths* 
 
29-42 w                   
Perinatal 
deaths*
 
 
28 w- 
D7 
                 
Low birth 
weight 
 
LBW 
 
            
Preterm 
 
 
Preterm 
 
            
* Early fetal deaths, late fetal deaths and perinatal deaths should be reported per 1000 still births and live births 
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Low birth weight data.  
F7. Please write all neonatal or early neonatal mortality data for infants in the ‘intervention’ group into the table below.  
 
Number of live births 
(denominator) 
Number of 
live births 
who had 
birth weight 
recorded 
Total 
number of 
LBW 
infants 
Total 
number of 
LBW 
infants who 
had a 
neonatal 
death 
recorded 
Total number of 
LBW infants for 
which a cause of 
neonatal death was 
investigated 
Number of 
deaths for which 
a cause of 
neonatal death 
was assigned* 
Numbers of deaths by cause 
        
Tetanus Severe 
infection 
Birth 
asphyxia 
Diarrhoea Congenital 
abnormality 
Other 
Specify 
Neonatal (i.e. 0-28 d) 
 
 
    
 
 
         
Early neonatal (i.e. 0-
7d) 
 
 
    
 
 
         
* i.e. exclude the no agreement and unknown categories 
 
 
Preterm data.  
F8. Please write all neonatal or early neonatal mortality data for infants in the ‘intervention’ group into the table below. 
Number of live births 
(denominator) 
Number of 
live births 
who had 
gestational 
age 
recorded 
Total 
number of 
preterm 
infants 
Total 
number of 
preterm 
infants who 
had a 
neonatal 
death 
recorded 
Total number of 
preterm infants for 
which a cause of 
neonatal death was 
investigated 
Number of 
deaths for which 
a cause of 
neonatal death 
was assigned* 
Numbers of deaths by cause 
        
Tetanus Severe 
infection 
Birth 
asphyxia 
Diarrhoea Congenital 
abnormality 
￿ther 
Specify 
Neonatal (i.e. 0-28 d) 
 
 
    
 
 
         
Early neonatal (i.e. 0-
7d) 
 
    
 
 
         
* i.e. exclude the no agreement and unknown categories   199
SECTION F. OTHER IMPORTANT RATES AND DATA 
 
Severe infection 
 
F9. Was severe infection assessed in this study?      No = 1    Yes = 2    Unknown = 9 
 
IF  F9  WAS ‘NO’ SKIP TO QUESTION F11.  
 
F10. What was the agent (e.g Staphylococcus aureus) involved in the severe neonatal bacterial infection 
deaths?  Give the number and percentage of each, if possible. 
 
      Agent   Number of cases   Number of deaths    Reported percentage  
F10a  __________________    _________     _________           
 
F10b  ________________   ________     _________          _________ 
 
F10c  ________________   ________     _________          _________ 
 
F10d  ________________   ________     _________          _________ 
 
 
Congenital anomalies 
 
F11. Were congenital anomalies assessed in this study?    No = 1    Yes = 2    Unknown = 9 
 
IF  F11 WAS ‘NO’ SKIP TO QUESTION F13.  
 
F12 What were the important congenital anomalies involved in the congenital anomaly deaths?  
        Give the number and percentage of each, if possible. 
 
 
Malformation  Number of cases         Number of deaths    Reported percentage  
 
F12a.  __________________________________________________________________________________ 
 
F12b   __________________________________________________________________________________ 
 
Assessment of gestational age 
 
F13. Was gestational age assessed in this study?      No = 1    Yes = 2    Unknown = 9 
 
IF  GESTATIONAL AGE WAS NOT ASSESSED SKIP TO QUESTION F15.  
 
F14.  What methods were used to assess gestation (mark all that apply)? 
 
14a. Last menstrual period (LMP)        No = 1    Yes = 2    Unknown = 9 
 
14b.Clinical assessment of the newborn       No = 1    Yes = 2    Unknown = 9 
 
14c. If clinical assessment which method (e.g. Parkin) _______________________________________ 
 
 
Assessment of birth weight / birth size 
 
F15. Was birth weight or birth size assessed in this study?    No = 1    Yes = 2    Unknown = 9 
 
IF BIRTH WEIGHT / SIZE WAS NOT ASSESSED SKIP TO QUESTION F17  
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F16.  What methods were used to assess birth weight/ birth size? (Circle all that apply) 
 
16a  Scales              No = 1    Yes = 2    Unknown = 9 
 
16b.Mother’s impression (too small, normal etc)     No = 1    Yes = 2    Unknown = 9 
 
16c. Health professional’s impression (too small, normal etc)   No = 1    Yes = 2    Unknown = 9 
 
16d. Other. Please specify. ____________________________  No = 1    Yes = 2    Unknown = 9 
 
 
Case definitions (be specific; use direct quotes): 
 
F17a. Write the case definition for a case of neonatal tetanus  
 
 
 
 
F17b. Write the case definition for a neonatal tetanus death  
 
 
 
 
F18a. Write the case definition(s) for a case of severe infection (this may require several e.g. one for sepsis, 
one for meningitis, one for pneumonia. 
 
________________________________________________________________________________ 
 
 
F18b. Write the case definition for a death due to severe infection, (this may require several e.g. one for 
sepsis, one for meningitis. Be specific; use direct quotes):  
 
________________________________________________________________________________________ 
 
 
F19a. Write the case definition(s) for a baby with “birth asphyxia” (e.g.., Neonatal encephalopathy graded 
into mild/moderate severe, or Apgar score less than 5 at 5 minutes. _ 
 
______________________________________________________________________________ 
 
 
F19b. Write the case definition(s) for a death due to “birth asphyxia:  
 
________________________________________________________________________________ 
 
F20a. Write the case definition(s) for an infant with diarrhoea.  
_______________________________________________________________________________ 
 
________________________________________________________________________________ 
 
 
F20b. Write the case definition for a death due to diarrhoea  
 
________________________________________________________________________________________ 
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F21a. Write the case definition(s) for a baby with congenital abnormalitie(s)/malformation(s).:  
(note if the case definition is for a specific abnormality e.g. neural tube defect then record below under 
specific malformations ) _ 
 
________________________________________________________________________________ 
 
F21b. Write the case definition for a death due to congenital abnormalitie(s)/malformation(s).:  
(note if the case definition is for a specific abnormality e.g. neural tube defect then record below under 
specific malformations ) 
 
 
 
F22a. Write  the case definitions for specific malformations listed in QF12. 
 
F22a. 
________________________________________________________________________________ 
 
________________________________________________________________________________ 
 
F22b. 
 
________________________________________________________________________________ 
 
F22c. 
 
___________________________________________________________________________________  
 
F23a. Write the case definition(s) for a baby with low birth weight 
 
________________________________________________________________________________ 
 
 
F23b. Write the case definition for a death in a baby with low birth weight:  
 
 
___________________________________________________________________________________  
 
 
F24a. Write the case definition(s) for a baby with preterm birth. 
 
___________________________________________________________________________________  
 
F24b. Write the case definition for a death due to prematurity. 
___________________________________________________________________________________  
 
F25. Write the case definitions for the other causes of death you recorded in QE3, QF1 and QF5 
 
F25a 
 
________________________________________________________________________________________ 
 
F25b.  
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Case fatality rate 
F26. Were case fatality rates assessed in this study?      No = 1    Yes = 2    Unknown = 9 
(no of deaths/no of episodes) 
IF  F26  IS NO SKIP TO QUESTION F28 
 
F27. List the most important case fatality rates presented in the study (List the neonatal case fatality rate if 
available. List only one rate for each cause).  
Cause Age  of 
youngest  
Age of oldest 
infant 
Number of 
deaths 
Number of 
episodes 
Reported case 
fatality rate 
(%) 
27a. Tetanus 
 
       
27b. Severe infection 
 
       
27c. Birth asphyxia 
 
       
27d. Diarrhoea 
 
       
27e.  Congenital  abnormality         
27f. LBW 
e.g. neonatal deaths among LBW 
babies  / number of LBW babies 
       
27g. Prematurity 
e.g. neonatal deaths among 
preterm babies  / number of 
preterm babies 
       
27h. Other. Specify 
 
       
 
SECTION G. POTENTIAL FLAWS AND QUESTIONS FOR AUTHORS 
 
G1. Record any potential serious flaws of the study (if none, please write “NA”): _ 
 
________________________________________________________________________________________ 
 
________________________________________________________________________________________ 
 
________________________________________________________________________________________ 
 
G2. If you think of information (that study investigators could provide) that would greatly improve the study’s 
usefulness, record what information should be requested. For example, a study reports outcomes for preterm 
and LBW babies together despite assessing gestation age, and you think the investigators could provide data 
by gestational age, which is what you ideally want. If no questions, please write “NA”.  
 
________________________________________________________________________________________ 
 
_______________________________________________________________________________________ 
 
SECTION H. RECORD ANY ADDITIONAL NOTES OR COMMENTS ON THE ARTICLE IN THE 
SPACE BELOW. 
 
________________________________________________________________________________________ 
 
________________________________________________________________________________________ 
 
 
 
 